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Thesis Outline 
 
Chapter 1  
This chapter introduces the background to this thesis, describing the cell membrane with 
a focus on the role of lipids and the importance of artificial lipid models for understanding 
the biophysical impacts of lipid domains in terms of lipid order and membrane fluidity. 
The photophysical and optical properties of BODIPY and pyrene dyes are discussed, and 
their current applications as lipid stains in live cellular imaging and sensing. Microscopy 
techniques that are the focus of the probes developed here such as confocal laser scanning 
microscopy, stimulated emission depletion (STED) microscopy and fluorescence lifetime 
imaging microscopy (FLIM) are discussed and how they are used alongside luminescent 
probes for cellular imaging.  
Chapter 2 
This chapter describes two novel BODIPY derivatives, one with a lipophilic Dppz 
pendant and one with a naphthyridyl unit conjugated to a cholesterol moiety. The 
photophysical properties of both Dppz-BODIPY and Naphthyridy-BODIPY-2-
Cholesterol are examined and compared, as well as their uptake by live CHO and HeLa 
cells, examined by confocal microscopy. Their ability to partition into lipid phases is 
examined using giant unilamellar vesicles (GUVs) and their suitability as new FCS 
probes is investigated. The ‘switch-off’ ability of these dyes in aqueous environments 
results in high contrast imaging of lipid regions in both artificial membrane models and 
live cells. 
Chapter 3 
Chapter 3 outlines two novel BODIPY-cholesterol derivatives with varying linker length 
between the BODIPY core and the cholesterol unit in order to investigate liquid-ordered 
domain partitioning. The number of available fluorescent probes capable of selectively 
staining liquid-ordered domains in artificial membrane models is very limited compared 
to their liquid-disordered staining counterparts. By incorporating an amino-hexanoic acid 
linker, BODIPY-Ahx-Chol can selectively partition into Lo domains in phase separated 
GUVs, and its use as a cell-imaging dye is investigated using confocal microscopy and 
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FLIM. The design and synthesis of this simple but effective dye increases the 
understanding of what is structurally needed in order to selectively target Lo domains. 
Chapter 4  
This chapter focuses on the design and synthesis of a novel pyrene dye PyLa and its 
ceramide derivative PyLa-C17Cer for use as a super-resolution lipid droplet stain. High 
resolution images of lipid droplets in HeLa cells treated with TNF-α are captured and the 
number of lipid droplets present is successfully resolved. The diffusion values of PyLa-
C17Cer successfully obtained on supported lipid bilayers using FCS resulting in data that 
is used to distinguish lipid order and phase. We believe that PyLa-C17Cer is the first 
example reported in literature of a pyrene derivative being used for super resolution STED 
microscopy as well as FCS. 
Chapter 5 
This body of work explores the photophysical properties of PyLa and its thiol derivative 
PyLaOT, specifically their ability to detect changes in pH and act as fluorescent ‘on-off-
on’ switches. A visiting student provided computational studies to explore the effect of 
protonation of the 3,4-dimethylamino substituents on the photophysics and compared to 
experimental data. The pH sensing capabilities of both probes is compared in both 
aqueous and organic media. The thiol functional group on PyLaOT allows for surface 
chemistry to be applied to gold surfaces and the pH effects studied when bound to this 
substrate.
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Darragh O’ Connor 
Fluorescent Probes for Lipid Droplet and Lipid Membrane Imaging 
in Cells and Models 
Thesis Abstract 
 
Cell membranes are believed to be laterally ordered into micro and nano-domains comprising 
of more fluid liquid-disordered (Ld) and more viscous liquid-ordered (Lo) phases. The latter 
subphases contain high concentrations of cholesterol and glycosphingolipids.  These so call 
lipid rafts are experimentally distinguishable on the basis of their resistance to detergent 
solubilisation and are believed to play important roles in membrane function including in 
protein trafficking and signalling as they can drive protein-protein interactions through 
sequestering of proteins to these domains.   Membrane domains in living cells are difficult to 
interrogate as they are dynamic and at sub-microscopic length scales they are outside the 
range of most conventional microscopies. However, they can potentially be imaged using 
recently developed super-resolution methods and as they are dynamic structures their 
diffusion can be measured using correlation methods. Therefore, new fluorescent probes are 
needed that can (a) partition selectively to membranous regions, (b) target the Lo and Ld 
phases selectively (c) that have appropriate photophysical properties compatible with the 
above techniques. These include large Stokes shift, high selectivity, excellent photostability, 
high molecular brightness, low cytotoxicity and high quantum yields. A key aim of this thesis 
was to design and synthesise new fluorescent probes that sequester specifically to lipid rich 
regions of cells or models and can distinguish Lo/Ld regions or lipid droplets, using confocal 
microscopy, fluorescence correlation spectroscopy (FCS), fluorescent lifetime imaging 
(FLIM) and the relatively new technique of super resolution microscopy, specifically, 
STimulated Emission Depletion (STED) microscopy.  
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Chapter 1:  Introduction 
_______________________________________________ 
 
1.1 The Cell Membrane  
The first proposed model of the cell membrane was described by Danielli et al in 1935.  This 
model described the cell membrane as a phospholipid bilayer which is between a protein 
layer.1 Following this the ‘fluid mosaic model’ was proposed by Singer and Nicolson in 
1972.2 They suggested that the cell membrane was more complex than first described by 
suggesting it behaved more like a two-dimensional fluid that inhibited lateral diffusion of 
components and consisted of regions of lipids and proteins that promoted the formation of 
‘lipid-rafts’. Since then, the understanding of the cell membrane has been greatly expanded 
on. It is now widely accepted that the cell membrane is a fluid lipid bilayer consisting of 
glycolipids, sterols and phospholipids.  It also contains a range of proteins, ~50 % by dry 
weight. This mixture of various lipids and proteins are compartmentalised into heterogeneous 
phases or domains. These specialised regions are dynamic, microdomains which aid in the 
compartmentalisation of proteins that help organise molecular assembly and enable cellular 
processes such as endocytosis and signalling. This is known as the “raft-hypothesis” and 
remains somewhat controversial and is under significant investigation.3–5 There is great 
interest in the phase separation of lipids into liquid-ordered and liquid-disordered regions. 
The liquid-ordered phase is a region more tightly-packed and ordered than the surround 
bilayer which contains high concentrations of sphingolipids and sterols and can flow freely 
in the lipid membrane bilayer.  These domains are believed to be platforms for proteins 
involved in cell-signalling.3,6 
Lipid molecules account for approximately 40 % in dry weight of most animal cell 
membranes, with phospholipids accounting for the majority of membrane lipid content. They 
are critical to cell function for two main reasons.  Phospholipids are amphipathic comprising 
a polar head group with hydrophobic tails.  They spontaneously form bilayer structures in 
aqueous environments and this bilayer plays a critical role in cell permeability where they 
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present a semi-permeable barrier between the cell and its environment. Phospholipids contain 
two fatty acid tails that can differ in length (between 14-24 carbon atoms). Phospholipids that 
contain one or more double bonds in their fatty acid tails can result in a ‘kink’ orientation 
due to unsaturated carbon bonds. This ‘kink’ causes the hydrophobic tails to be more loosely 
packed together resulting in a flexible or more fluidic membrane. These are the main 
components of   liquid-disordered phases. The most abundant lipids in biological membranes 
are glycerophospholipids, which can be sub-categorised into lamellar and nonlamellar 
according to phase behaviour.  1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) is a 
representative of the lamellar lipid family and is one of the most commonly used lipids within 
our group.  DOPC is a neutral lipid which comprises of a choline head group, consisting of 
three terminal methyl (CH3) substituents (Figure 1.1).  DOPC has a preference to self-
assemble in the lamellar phase.8 The lamellar phase can be described as the packing of long 
chain hydrophobic tail compounds consisting of a polar head group in a predominantly polar 
liquid environment. In giant unilamellar vesicles (GUVs), DOPC is the most common lipid 
used, which contributes to the formation of the liquid-disordered (Ld) phase.  
 
 
Figure 1.1 Chemical structure of 1,2-dioleoyl-sn-glycero-3-phosphocholin (DOPC) and cholesterol. 
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Cholesterol is a sterol that plays a distinct role in the cell membrane of eukaryotes.  The key 
driver for the formation of liquid-ordered domains is cholesterol. The structure of cholesterol 
consists of a hydrophobic polycyclic core to which an acyl chain tail and hydroxyl polar head 
group is attached. Cholesterol cannot form a membrane by itself but inserts into phospholipid 
bilayers with the polar head group forming hydrogen bonds with the polar phosphate head 
groups. At physiological temperatures cholesterol reduces the mobility of the phospholipid 
tails due to the rigidity of its structure, which also extends the tails of the lipid bilayer. 
Cholesterol plays a key role in the formation of liquid-ordered (Lo) domains along with 
sphingolipids of long acyl chains such as sphingomyelin (Figure 1.2).9  
 
Figure 1.2 Diagram distinguishing between liquid-disordered and liquid-ordered domains within the 
cell membrane. 
 
1.1.1 Lipid Droplets 
Lipid droplets (LDs) are dynamic intracellular organelles that regulate the storage of neutral 
lipids and recently have been discovered to be involved in many physiological processes, 
metabolic disorders and diseases.  Lipid droplets were first discovered in the nineteenth 
century by light microscopy, however they were initially ignored due to the premise that they 
had little to no function other than fat storage.  The main function of lipid droplets are the 
storage of neutral lipids such as triglycerides, sterols, steryl esters and retinyl esters.10–12 
Lipid droplets also play an important role in protecting the cell from lipid toxicity as they 
safely sequester toxic lipids such as fatty acids, toxic glycerolipids and sterols which can 
disrupt the integrity of the cell membrane.13–15 The discovery of the protein perilipin on the 
surface of lipid droplets in 1991 kick-started the interest in this organelle. Perilipin acts as a 
protective barrier against lipases which can break down triglycerides, fatty acids and sterols, 
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and therefore acts as a lipid storage regulator.  Over expression of perilipin in both animals 
and humans is a factor of obesity.   
In eukaryote cells it is thought that lipid droplets are formed from triacylglycerol (TAG) and 
steryl esters (SE) in the endoplasmic reticulum (ER).16–18 This was long hypothesised to be 
due to the presence of enzymes localised in the endoplasmic reticulum associated with 
synthesising neutral lipids (TAG and SE) for lipid droplet formation.19 The formation of an 
oil lens in the membrane of the endoplasmic reticulum followed by budding and then growth 
of lipid droplets by acquisition of proteins is one of the most widely cited models for lipid 
droplet formation, however it has been far from fully validated.20 
 
 
 
Figure 1.3 Schematic diagram of the structure of a lipid droplet.  The outer membrane contains 
phospholipids (phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol, 
lysoPC and lysoPE) and perilipin family proteins.  The inner core contains sterols (cholesterol), steryl 
esters (cholesterol ester) and triglycerides. 
 
Commonalities between cell membranes and lipid droplets have now been realised. Although 
not a bilayer, lipid droplets contain a protein-decorated phospholipid monolayer abundant in 
phosphatidylcholine that separates the hydrophobic core from aqueous cellular 
environments.21,22 Similarly to the cell membrane, lipid droplets are now being described as 
dynamic and have been found to be involved in many physiological processes including 
membrane synthesis, trafficking23,24 and inflammation25 as well as pathologies including 
atherosclerosis and diabetes26, the hepatitis C virus27, and cancer.28,29 It is for this reason that 
we developed a novel pyrene dye for specific labelling of LDs which could be used as an 
accurate quantification tool using stimulated emission depletion spectroscopy (STED). 
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1.2 Artificial Lipid Models and Self-Assembled Monolayers 
 
1.2.1 Giant Unilamellar Vesicles (GUVs)  
Due to the complex nature of the cell membrane it is necessary to be able to create artificial 
structures that can mimic the structure and phases present.  Liposomes offer the means to 
create fluidic artificial systems mimicking physiological conditions with varying degrees of 
complexity. Within this work giant unilamellar vesicles (GUVs) were created using both 
homogeneous and heterogeneous lipid compositions. Models such as GUVs can employ a 
wide variety of lipids (phospholipids, sphingolipids and cholesterol) and can also incorporate 
proteins or molecules such as ganglioside GM1.  Liposomes can be defined as spherical 
vesicles containing at least one lipid bilayer. Giant unilamellar vesicles are liposomes that 
have a diameter above one micron (1 μm). Unilamellar refers to a single bilayer while 
multilamellar consists of two or more. Liposomes can be formed by a number of methods 
and techniques. For this work it was desirable to create GUVs to enable clear visualisation 
of phase separated domains by microscopy methods. The principle of GUV formation has 
not been fully elucidated however, in literature there have been many techniques employed 
to prepare GUVs e.g. solvent evaporation30, gentle hydration31 and more commonly, 
electroformation32. Electroformation results in the formation of a disperse population of giant 
unilamellar vesicles. In the 1980s Angelova and Dimitrov were the first to produce GUVs 
using a DC electric field.32 This method was later updated by Angelova et al to produce 
GUVs using an AC electric field.33 The method consists of dissolving lipids in either 
chloroform, or sometimes a chloroform/methanol mixture, followed by deposition of this 
lipid mixture onto an electrode surface.  A counter electrode is then positioned perpendicular 
to a cell assembled between two electrodes. This cell is then filled with buffer and an electric 
field is applied between the electrodes. Over a number of hours GUVs start to form in large 
‘clusters’ containing hundreds of congregated GUVs. These clusters can remain bound to the 
electrode, however by applying a low frequency electric field this can be avoided, and GUVs 
can be collected in solution by carefully removing the buffer after electroformation is 
complete. Within this thesis, electroformation is the method used to form GUVs. 
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Figure 1.4 Diagram depicting the various sizes and morphologies of liposomes. 
 
By incorporating a phospholipid such as DOPC it is possible to create GUVs that contain 
predominantly liquid-disordered regions. The formation of liquid-ordered domains is driven 
by adding cholesterol in high concentration (<20 mol %). Therefore, by adding a mixture of 
lipids such a DOPC, sphingomyelin (SM) and cholesterol, it is possible to create GUVs 
which contain both liquid-disordered and liquid-ordered domains.  Fluorescence imaging can 
then be used for studying lipid membranes and artificial lipid membranes such as GUVs by 
incorporating a fluorescent dye into the lipid mixture prior to electroformation. Most 
fluorescent lipid membrane markers show strong preferential partitioning into the liquid-
disordered phase.34 The ability to label such lipid bilayers allows for the identification of 
lipid phases and also the ability to obtain environmental information using fluorescence 
lifetime imaging spectroscopy (FLIM) and fluorescence lifetime correlation spectroscopy 
(FLCS).   
In recent years, interest in developing new dyes to study complex membrane components has 
increased due to the growing understanding of their role in signalling and also advances in 
modern microscopy.34–37 Therefore, a need for probes capable of distinguishing lipid domains 
has risen. Today there are many commercially available probes with known partitioning 
behaviours such as Texas Red 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (TR-
DPPE), 2-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-pentanoyl)-1-
hexadecanoyl-sn-glycero-3 phosphocholine (Bodipy-PC) and as mentioned (1,1'-
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Dioctadecyl-3,3,3',3'-Tetramethylindodicarbocyanine, 4-Chlorobenzenesulfonate Salt) 
(DiD). Such probes can now be used to identify the varying physical forms of lipid phases 
by exploiting their preferential phase partitioning. Using fluorescence microscopy, GUVs 
can be used to investigate physical processes such as phase separation.38 A commonly used 
fluorescent lipid label is DiIC18(5) solid (1,1'-Dioctadecyl-3,3,3',3'-
Tetramethylindodicarbocyanine, 4-Chlorobenzenesulfonate Salt) (DiD), which is known to 
selectively partition into the liquid-disordered phase.34 The use of DiD to fluorescently label 
the liquid-disordered phase of GUVs can be seen in the reference below in Figure 1.5. Despite 
the availability of commercial probes there is always the need to design more efficient probes 
with enhanced photophysical properties. Dyes that are highly emissive, non-toxic, that can 
be used in low concentrations, that exhibit high quantum yields, show preferential 
partitioning to liquid-disordered domains or in particular to liquid-ordered domains, that are 
eligible for FLCS measurements and that can behave like a ‘switch’ i.e. only display 
fluorescence when partitioned into regions of interest are highly desirable. 
 
 
Figure 1.5 GUVs of composition DOPC/SM/Chol 4:4:2 mol % labelled with DiD (right) which is 
excluded from cholesterol rich liquid-ordered domains (shadowed regions). GUVs of composition 
DOPC/SM/Chol 4:4:2 mol % labelled with Dppz-Ar-BODIPY (left). 
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1.2.2 Supported Lipid Bilayers (SLBs) 
Another commonly used biomimetic system is a supported lipid bilayer (SLB). SLBs are 
planar lipid bilayers which are most commonly formed on top of solid transparent substrates 
such as glass and less often, polydimethylsiloxane (PDMS).39–41 These supported bilayers 
are extremely versatile, as they can be synthesised using a wide range of lipid compositions.  
 Within this body of work a supported lipid bilayer micro-cavity array on PDMS was used to 
carry out diffusion studies using the dyes outlined in chapter 4.  A sophisticated method for 
preparing micro-cavity supported lipid bilayers involves a modified version of the Langmuir 
Blodgett technique by transferring a lipid monolayer from an air water interface to the array 
surface. The first step is to form a monolayer on the chosen substrate using the Langmuir-
Blodgett technique. Using this technique, the monolayer forms as the lower leaflet of the 
bilayer, which lipid vesicles can then be absorbed and fused onto, creating the upper leaflet 
and completion of the supported lipid bilayer. The major advantage offered by this technique 
is it allows for the transfer of a highly complex lipid monolayer, defect free. The fusion of 
lipid vesicles over the monolayer results in a lipid bilayer formed across a buffer filled pore. 
One of the drawbacks of SLBs is the close proximity of the supporting substrate from the 
bilayer which frequently results in surface interactions that can affect protein and lipid 
diffusion studies. These limitations can be overcome by spanning a bilayer across a buffer 
filled micro-cavity array. In chapter 4 this technique is used to prepare supported lipid 
bilayers of mixed compositions. One containing only DOPC 100 mol %, therefore forming 
a more fluidic bilayer containing only the Ld phase, and another bilayer rich in 
sphingomyelin and cholesterol (DOPC/SM/Chol 4:4:2 mol %), resulting in a more rigid 
bilayer that contains both Ld and Lo domains. This technique also allows biomimetic 
asymmetry to be built into the membrane model. 
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Figure 1.6 Schematic diagram of PDMS supported lipid bilayer microcavity array. 
 
1.2.3 Fluorescent Self-Assembled Monolayers 
Self-assembled monolayers (SAMs) are molecular assemblies adsorbed on solid substrates 
which can be spontaneously formed from the vapour phase or more commonly, from 
solution. SAMs provide a versatile way of controlling both the chemical composition and 
physical structure of the substrate surface. Fluorescent SAMs constructed on metal surfaces 
such as gold, silver and copper as well as oxides such as ITO and SiO2 are attractive in 
applications across various domains as sensors and in optical devices.42–44 By forming 
fluorescent SAMs on nanostructured substrates or nanoparticles, the photophysical properties 
of the fluorophore can be combined with the physiochemical properties of the substrate.  
As shown in Figure 1.7, the building blocks of SAMs consist of three main constituents; the 
head group (linking group), the tail (backbone) typically consists of a hydrocarbon chain and 
the functional (active) group.45 The head group is what drives the absorption onto the 
substrate linking the tail and substrate through strong bonds. The packing and stability of the 
monolayer can be affected by the bond angle between the head group and the substrate, length 
of the hydrocarbon tail and the interactions between tails (hydrophobic forces and weak Van 
der Waals). 
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Figure 1.7 Schematic representation of a self-assembled monolayer (SAM). 
 
The immobilisation of a fluorophore on a solid substrate can impact the photophysics in a 
number of ways. Close-packing of the self-assembly can result in fluorescence concentration 
quenching. When bound to the substrate surface the mobility of the fluorophore can be 
restricted. This may reduce rotational and vibrational effects that can reduce non-radiative 
decay pathways therefore increasing fluorescence polarisation. Immobilisation on a surface 
can also lead to inaccessibility, leading to limited access of quenchers (O2), solvent and ions. 
Therefore, the fluorophore must be carefully selected or designed based on properties that 
can overcome the impacts of surface immobilisation and that also suit the target application.  
The choice of surface-active group depends on the substrate being used. It is well known that 
thiols and disulfides bond to gold and silver subtrates.47 While carboxylic acids and 
trialkoxysilanes are used to form SAMs on metal oxides.45 Alkanethiols are one of the most 
commonly utilised surface-active groups, as in its reduced state thiol has a high affinity for 
metal surfaces, particularly gold substrates. The formation of fluorescent SAMs on gold 
substrates allows for fluorescence detection of fluorophore-analyte interactions as well as the 
ability to carry out electrochemical studies on gold electrodes. Many PAHs have been used 
in fluorescent SAMs including pyrene46. As shown in Figure 1.8, chapter 5 discusses the 
application of a fluorescent SAM for multimodal pH sensing using a newly synthesised 
pyrene derivative (PyLaOT). The dye incorporates dimethylamino groups which not only 
result in a red-shift of emission but also provide pH sensitivity through protonation of the 
nitrogen atoms. PyLaOT was also designed to overcome the surface immbolisation effects 
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mentioned above. The C8 alkyl chain reduces the likelihood of quenching effects as the linker 
length decreases the probability of close-packed SAMs. At the surface the dye is more 
concentrated than it would be in solution, thus it is prone to self-quenching, however this is 
overcome in compounds with large Stokes shifts because the emitted photons do not lie 
within the absorbance tail of the compound. 
 
Figure 1.8 Schematic representation of a fluorescent SAM using PyLaOT formed on a gold substrate. 
(Diagram for visual purposes and not an accurate representation of bond angles). 
 
1.3 Introduction to Molecular Photophysics 
Figure 1.9 shows a Jablonski diagram that illustrates the photophysical deactivation pathways 
that an excited state molecule can undergo when it loses its excess energy and returns to the 
ground state. Figure 1.9 illustrates how fluorescence occurs for most organic fluorophores. 
Typically, a chromophore absorbs photonic energy leading to a transition from the ground 
state (S0) to a higher vibronic level within a singlet excited state (Sn).  It then rapidly relaxes 
to the lowest vibrational level of S1 through vibration of the molecule and its surrounding 
solvent shell, known as vibrational cascade. 
In condensed media fluorescence occurs when the molecule deactivates from this lowest 
vibrational level of the first singlet excited state to the ground state. The fluorescent lifetime 
of this emission is typically very short, of the order of 10-9 to 10-8 s. As fluorescence is spin 
allowed it typically occurs as the molecule transitions from singlet-to-singlet states. 
Fluorescence will always occur at lower energy (i.e. higher wavelengths) than absorption, 
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which is a result of the energy loss incurred during vibrational relaxation in the excited state. 
This is explained by Stokes Rule which states that the emission wavelength will always be 
at longer wavelengths than the initial absorption. 
 
 
Figure 1.9 Jablonski diagram illustrating the radiative and non-radiative processes involved in the 
absorption and resultant deactivation of a molecule following excitation by a photon of light.48 
 
Internal conversion is a non-radiative process described as the non-radiative transition 
between states of the same multiplicity (i.e. S2 → S1). This process occurs when there is an 
isoenergetic crossover between vibronic states, then rapid vibrational relaxation to the lowest 
vibrational level of that electronic state. As seen in Figure 1.9 the vibrational relaxation to 
the lowest vibrational state of S1 directly follows. 
Phosphorescence is a radiative deactivation process which is observed when an excited state 
molecule emits a photon during the deactivation process between energy states of different 
multiplicities (T1 → S0). Phosphorescence occurs when a molecule is excited from the ground 
state S0 to the singlet excited state S1 and then undergoes intersystem crossing (ISC), i.e. 
from the singlet excited state S1 to the triplet state T1.   
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ISC is an iso-energetic non-radiative deactivation process that occurs between states of 
different multiplicities (i.e. S1 → T1). This process, in principle, is forbidden due to the 
electron in the excited state having parallel spin to the ground state, however may occur due 
to spin-orbit-coupling due to heavy atoms such as Br which increase spin-orbit-coupling and 
thus increase the likelihood of intersystem crossing. The phosphorescence lifetime is longer 
than the fluorescence lifetime due to these forbidden transitions and is usually of the order of 
10-3 to 10-1 s. Fluorescence, however, is a higher energy process as it occurs at shorter 
wavelengths than phosphorescence.   
1.3.1 Quantum Yield (Φ) and Lifetime (τ) 
The luminescent quantum yield and the luminescent lifetime are two important photophysical 
properties of a fluorophore as they can be used to quantitatively assess the emission 
efficiency.  Obtaining the lifetime is important as it determines how much time is available 
for the fluorophore to interact with or diffuse through its environment.49 There are a number 
of factors that can affect the lifetime, such as the solvent used, oxygen concentration, pH and 
the presence of heavy atoms. Typically, the lifetime is independent of the fluorophore 
concentration, which makes it a useful analytical parameter. The luminescence lifetime (τ) 
of the fluorophore can be described as the average time an excited species spends in the 
excited state before photon emission. It can be expressed in terms of the radiative rate 
constant (kr) and the non-radiative rate constant (knr) indicated by Equation 1.1 
 
                                    τ =  
1
kr+ knr
    Equation 1.1 
 
The luminescence quantum yield (ϕlum) can be simply expressed as the ratio of the number 
of absorbed photons to those emitted. It can be related to the lifetime and rate constants which 
are proportional to the absorbed and emitted photon, therefore ϕ lum can be expressed in terms 
of kr, knr and τ shown by Equation 1.2. 
ϕ lum = 
kr
kr+ knr
= 𝜏. 𝑘𝑟 =   Equation 1.2 
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Thus, fluorophores with high quantum yields display bright emission, and if the rate of 
radiative rate constant (kr) is greater than the rate of non-radiative decay (knr), then the 
quantum yield will be high. The luminescent quantum yield is a key parameter in calculating 
quenching rate constants, energy transfer rates and radiative/non-radiative decay rate 
constants.50 
1.4 Fluorescent Dyes and Probes 
1.4.1 General Introduction  
There are thousands of fluorescent probes known today, with many being commercially 
available. Fluorescent probes, also known as fluorophores, are molecules which can absorb 
light at a specific wavelength and then re-emit that light at a longer wavelength. The 
development and characterisation of fluorescent probes is an ever-increasing area of interest 
due to the wide range of applications for fluorescent sensors and the abundance of 
information they can provide. Due to the strides made in synthetic chemistry and an increased 
understanding of photophysics, there has been an increase in the number of fluorescent 
probes in the literature which have been used to investigate biological, biochemical and 
physiochemical systems. Organic probes have a number of common structural and 
photophysical characteristics. They typically contain several combined cyclic or planar 
molecules with several pi (π) bonds. Other characteristics include: lambda max, luminescent 
lifetime, luminescent quantum yield, Stokes shift and molar extinction coefficient. Each of 
these characteristics will vary depending on the structure of the fluorophore and its chemical 
environment. The size, shape and polarity of the fluorophore in ground and excited state, 
along with its likelihood to photobleach are all important factors to be considered when 
creating or choosing a fluorescent probe particularly for biological imaging applications. 
When applied to life sciences fluorophores can be divided into two main categories, intrinsic 
and extrinsic. Intrinsic fluorescent probes are those that occur naturally, examples are 
nicotinamide adenine dinucleotide (NADH), chlorophyll, flavins, the aromatic amino acids 
and green fluorescent proteins (GFPs). Extrinsic fluorescent probes include modified 
biochemical and synthetic dyes that are then added to a sample to produce a specific 
fluorescent profile.  There is a great need for extrinsic fluorescent probes in the fields of 
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biological investigation of DNA and lipids as they generally do not contain any intrinsic 
fluorescence. Disadvantages of intrinsic fluorophores are that many need to be genetically 
modified which can be difficult and expensive. Many intrinsic fluorophores tend to excite 
and emit in the blue-region. It is often desirable to label the molecule with an extrinsic 
fluorophore in order to meet the requirements of modern fluorescence microscopy 
techniques. 
 
Figure 1.10 Structure of intrinsically fluorescent aromatic amino acids, tryptophan, tyrosine and 
phenylalanine.  
 
Dansyl chloride is a commonly used fluorophore for labelling proteins and is a good example 
of an extrinsic fluorescent probe. It is capable of forming covalent bonds with amines and 
histidines present in proteins.51 The dansyl groups can be excited at 350 nm which is well 
resolved from protein absorption and can emit in the region of 520 nm therefore possessing 
a large Stokes shift. Other commonly used commercial probes include rhodamines and 
fluoresceins, which are available in several derivatives. Fluoresceins are widely used for 
labelling as they have high molar extinction coefficients usually near 80’000 M-1 cm-1, high 
quantum yields (fluorescein, ϕ = 0.90, 0.1 M NaOH)52 and have a large emission range 
typically between 500-600 nm.53 Several drawbacks of fluoresceins and many commercially 
available fluorophores is their small Stokes shift, poor photostability and their tendency to 
self-quench. 
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Figure 1.11 Chemical structure of fluorescein and dansyl chloride. 
 
1.4.2 Properties of Ideal Fluorescent Probes for Imaging 
When selecting a fluorescent probe for labelling, there are certain properties and 
characteristics to take into consideration: 
Selectivity: When designing a new fluorescent probe or choosing a commercial probe for a 
specific study, it is vitally important to determine the ability of the probe to selectively target 
and emit a fluorescent response when in the presence of the studied analyte or environment. 
In the case of this study it important to design a probe that can selectively label liquid-ordered 
or liquid-disordered domains. 
Robustness: Fluorescent probes should ideally possess good photostability as well as 
chemostability. Probes that have a low tendency to photobleach (destruction of the 
fluorophore due to over exposure to high fluorescent intensity, such as high laser power) are 
highly desirable.  
Photophysical Traits: It is very important that the probe displays a high level of fluorescent 
brightness. For the probe to possess this quality it must have a high luminescent quantum 
yield and a high molar extinction coefficient. A large Stokes shift (possessing a large gap 
between the excitation maxima and the emission maxima) is also desirable, as it decreases 
the likelihood of the probe self-quenching. Narrow excitation and emission bands eliminates 
the likelihood of cross-talk with other probes when carrying out dual-labelling experiments.   
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The successful labelling of biological systems and living samples require the probes to 
possess good cell permeability, solubility and absorption and emission profiles in the near-
infrared region (NIR). 
Cell Permeability: the cells environment is largely made up of cytoplasm and plasma, 
therefore making aqueous solubility an important factor for the use of fluorescent probes in 
biological applications. A completely non-aqueous fluorescent probe may have trouble 
entering the cell and may accumulate in the cell membrane. It is important to have a good 
balance between hydrophilicity and lipophilicity so that the probe is capable of entering the 
cell, as well as then localising in subcellular units such as the nucleus and mitochondria.6,54 
For biological studies, it is desirable to have a probe that emits in the near-infrared region 
(NIR, < 600 nm) as these probes can exploit the ‘biological window’, therefore penetrating 
deeper into tissues and are also less likely to cause photodegradation to live tissues and 
cells.55,56 
It is important to note that although these are ideal properties for fluorescent probes in the 
use of fluorescence imaging, there are few probes that display all the characteristics 
mentioned above. For a given application it is desirable to design a probe which exhibits as 
many of these properties as possible. 
1.5 Introduction to Microscopy Techniques 
1.5.1 Principle of Fluorescence Confocal Microscopy 
Within this work, fluorescence microscopy is used to image the novel fluorophores within 
artificial lipid membranes and cells. This technique uses a pinhole in front of the detector 
eliminating signal from out-of-focus planes. Only fluorescence very close to the focal plane 
is detected. This results in high resolution images of greater quality and detail. However due 
to much of the light being blocked by the pinhole, there is a decrease in signal intensity which 
must be overcome by long exposure times, bright fluorophores and sensitive detectors. In a 
confocal fluorescent microscope, the sample is excited using an excitation laser. Shown in 
Figure 1.12 is a schematic diagram of a confocal microscope system. This technique directs 
a beam of light at a desired wavelength through an aperture, which is then focused by the 
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objective lens into a cone shape so that the maximum intensity of the beam is focused on a 
single spot. The luminescence from the sample is then reflected by a dichroic mirror and 
directed onto a pinhole aperture. It is this pinhole system that differs confocal from 
conventional wide field microscopy. This aperture eliminates out-of-focus light, only 
allowing light from the selected focal plane. Therefore, the light from this selected optical 
region is picked up by the detector and converted to an electrical signal.57 
 
 
Figure 1.12 Schematic diagram of the components and optical pathway in a laser scanning confocal 
microscope.  
 
1.5.2 Fluorescence Lifetime Imaging Microscopy (FLIM) 
Fluorescence lifetime imaging microscopy (FLIM) is an imaging technique that can be 
applied as a confocal method that produces an image based on the differences in the excited 
state decay rate of a fluorescent sample. Image contrast is therefore based on the emission 
lifetime of the probe rather than emission intensity. Fluorescent lifetime measurements are 
robust as they can be independent of concentration as well as other factors such as excitation 
intensity, however it can be greatly affected by the environment, pH, oxygen concentration 
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and molecular binding. For these reasons, FLIM is one of the most reliable methods for 
obtaining information about the environment of the probe.   
FLIM usually employs time correlated single photon counting (TCSPC) in order to determine 
the fluorescence lifetime. This method uses short pulses of light to excite the sample which 
then emits a photon. The lifetime decay is obtained by measuring the time taken between the 
excitation of the sample and the arrival of an emitted photon at the detector. This is the main 
principle behind TCSPC.58 The decay time, which is represented by τ, is calculated by getting 
the slope of the plot log (I) t versus t. The measurement is repeated, and each detected photon 
contributes to a histogram or decay curve which overtime, builds to give the lifetime. In 
FLIM, the detected photons are sorted into pixels based on their arrival time of detection. In 
the resulting FLIM image, each pixel is made up of the detected photons in that region, 
making up a false-colour lifetime image.59 TCSPC FLIM gives the highest time resolution 
with the best lifetime accuracy of the time resolved fluorescence imaging methods.60 Each 
pixel of a FLIM image is the fluorescent lifetime decay and not the intensity. The data 
acquired from a FLIM image is analysed by fitting it to a decay model, typically either a 
mono- or bi-exponential decay.61 Mono-exponential (single exponential) is when there is 
only one contributing fluorophore (or fluorophore environment) in the sample. Bi-
exponential or indeed multi-exponential emission decays can occur, for example, where a 
single fluorophore occupies different environments that impact the photophysics of the probe 
distinguished by their individual lifetimes. An example of this is if there are multiple 
fluorophores present, they can be distinguished based on their lifetime. Martin et al 
synthesised a ruthenium-BODIPY dyad which was bi-exponential. In aerated methanol a 
lifetime of 306 ns was attributed to the ruthenium and a second lifetime of 24 ns was 
attributed to the appendant BODIPY.62     
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1.5.3 Stimulated Emission Depletion Spectroscopy (STED) 
As discussed in section 1.5.1 confocal fluorescent microscopy is a widely used imaging 
technique and a key tool for the detection of proteins, structures and processes in cells, tissues 
and organisms.  However, the spatial resolution that can be obtained by this technique is 
limited due to the restraints caused by the diffraction limit of light.  The successful resolution 
of sub-wavelength structures using confocal microscopy is impossible and can be described 
by the Ernst Abbe equation (Equation 1.6).  This equation states that light of a specific 
wavelength λ, travelling in a medium with a refractive index n that converges with a spot of 
half-angle θ will result in a minimal resolvable distance (d) given by Equation 1.6, where 
dnsinθ is also expressed as the numerical aperture (NA) of the lens.   
 
d =  
𝜆
2𝑛 sin 𝜃 
 = 
𝜆
2𝑁𝐴 
  Equation 1.6 
Thus, a microscope cannot resolve features that are located closer to each other than λ/2NA.  
If blue light at wavelength 450 nm is taken with a numerical aperture (NA = 1), then the Ernst 
Abbe diffraction limit will be 225 nm (0.225 μm).  This is small when compared to cells that 
can range in size from (1100 μm), however considerably larger than regions of interest such 
as proteins (10 nm) or organelle components.   
A technique that has been able to overcome the diffraction limit is super resolution 
microscopy.  The first super resolution microscopy to emerge was stimulated emission 
depletion microscopy (STED).63 The development of this technique led to Stefan W. Hell, 
William E. Moerner, and Eric Betzig being awarded the Nobel Prize for Chemistry in 2014. 
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Figure 1.13 (a) Schematic diagram of an optical STED microscope with excitation laser (blue) and 
STED depletion beam (red). The depletion laser (red) overlaps the excitation laser (blue) resulting in 
a ‘donut-shape’ in the focal plane and the resulting effective detected fluorescence emission (green). 
(b) The principles of STED: A laser light is used to excite (blue) fluorescence emission (green) in the 
area of focus. The STED laser (red) is used to selectively turn off emission in the outer periphery, 
allowing for better separation of fluorescent entities.  This results in a smaller point spread function 
(green) which in turn results in much more effective fluorescence being achieved and higher 
resolution. 
 
In confocal fluorescence microscopy, fluorescence occurs by exciting the sample from S0 to 
a higher excited state S1, which after relaxation to the ground state of S1, emits a photon by 
falling from the ground state of S1 to a higher vibrational level on S0. As shown above in 
Figure 1.13 STED uses a pair of synchronised lasers to interfere with this process. The first 
laser depicted in blue (Figure 1.13 (a)) is used to excite the sample. Following this a depletion 
laser, typically red-shifted in comparison to the emission of the fluorophore is used to 
interrupt the fluorescence process by forcing the excited electron to relax into a higher 
vibrational level than the fluorescence transition, resulting in a red-shifted photon release of 
lower energy. By lowering the energy gap, a higher wavelength photon shifted to the red is 
observed. This increase in wavelength can then be used to differentiate between photons, 
allowing stimulated emission to be ignored.  The STED laser is spatially arranged in a 
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‘doughnut-shape’ designed to overlap with the excitation as shown in Figure 1.13 (b). 
Fluorescence from molecules at the periphery of the excitation focus are quenched by the 
stimulated emission as explained above, resulting in a reduction of spot size of the incident 
laser below the diffraction limit. The application of STED for imaging a sample can be seen 
in the schematic representation (Figure 1.14). A sample labelled with a fluorophore is excited 
with an excitation laser which fluoresce and result in the imaging of the sample (Figure 1.14 
(a)). Using STED, the fluorescence by some of the fluorophores present in the sample is 
quenched resulting in a more effective point spread function and higher resolution (Figure 
1.14 (a)). This improved optical resolution can be explained by Equation 1.7. 
 
𝑑 =  
𝜆
2𝑁𝐴√1+
𝐼𝑚𝑎𝑥
𝐼𝑠𝑎𝑡
     Equation 1.7 
 
Where λ is the emission wavelength, NA is the numerical aperture of the objective lens, Imax 
is the peak intensity of the STED laser within the depletion zone, and Isat is the applied STED 
laser threshold intensity, in other words the intensity that depletes 50 % of the probe’s 
emission intensity.  The intensity of the laser is proportional to the effective depletion. This 
results in the need for dyes with high photostability, able to withstand intense laser power 
and photobleaching, while maintaining a high quantum yield. Therefore, choosing a STED 
dye with the right characteristics is very important. 
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Figure 1.14 Schematic of confocal fluorescent microscopy (a) Sample is excited with an excitation 
laser (blue).  The fluorophores present within the sample are excited (red).  The fluorophores present 
then emit photons resulting in fluorescence (green).  Schematic of stimulated emission depletion 
spectroscopy (STED) (b) The sample is excited with an excitation laser (blue).  A depletion laser 
(red) is used to suppress emission in the outer periphery resulting in a ‘donut-shaped’ focal plane.  
This results in some fluorophores being excited (red) while others are depleted (yellow).  This 
depletion results in a more effective fluorescence and increases resolution. 
 
1.5.4 The Characteristics of a Good STED Dye 
The development of STED super resolution microscopy means there is now a requirement 
for dyes compatible with the technique. Many fluorescent dyes used in microscopy are 
organic based.  The commercially available dyes recommended for STED imaging include 
Atto64–66 and AlexaFluor65,67. Both sets of probes are widely used due to their high 
photostability.  One of the main disadvantages of organic fluorophores for use as STED dyes 
is their small Stokes shift.  This can result in the STED depletion laser re-exciting the probe 
due to spectral overlap between the absorption profile of the dye and the depletion laser line.   
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In chapter 4 this problem was overcome by synthesising a fluorescent pyrene derivative 
which exhibited a mega-Stokes shift in most solvents and cell samples. Dyes with large 
Stokes shifts can avoid re-excitation by the depletion laser and thus avoid transitions to dark 
states which can cause photo bleaching.68 Mega-Stokes shifted dyes such as PyLa-C17Cer 
described in chapter 4 also aid multicolour and dual-stain imaging.  Multicolour imaging is 
the ability to image more than one fluorophore at the same time.66 This requires the dyes in 
question to absorb and emit in different regions of the UV-Vis spectrum.   
As previously mentioned, it is desirable for STED dyes to have high photostability to 
withstand the high intensity of the depletion laser and avoid photo bleaching or degradation.  
The emission profile of the dye must overlap well with the depletion laser to stimulate 
effective depletion emission.  When carrying out cell and molecular biology experiments it 
is desirable to have dyes with high molecular brightness and quantum yields, able to be 
stimulated at low concentrations.  If a dye can be used effectively at low concentrations, 
cytotoxic effects during imaging experiment time-frames can be avoided.  Many commercial 
probes only address photostability and high quantum yields. 
1.6 BODIPY Based Fluorescent Probes 
1.6.1 Structure and Spectroscopic Properties 
One of the main aims of this study is to synthesise and characterise BODIPY and pyrene 
dyes containing different ligands and cholesterol conjugated derivatives to enable imaging 
and dynamic studies of the natural and artificial cell membranes. The difluoro-boroindacene 
family (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene), abbreviated (BODIPY) has gained 
popularity as fluorescent probes for imaging in recent years, mainly due to their versatility 
and tunability. They were first reported by Treibz and Kreuzer in 1968.69 BODIPY dyes 
contain a 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene core structure which can be 
functionalised at a number of positions as shown in Figure 1.15. Many derivatives have 
several advantages including good photostability, high molar extinction coefficients (< 
80,000 M-1 cm-1), exhibit quantum yields as high as 0.90, emit in the visible region (≥ 500 
nm), have sharp narrow absorption bands, good solubility and tend not to self-aggregate in 
solution. BODIPY dyes typically exhibit an intense narrow band absorbance peak at 
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approximately 500 nm which is due to a S0-S1 (π-π*) electronic transition and a shoulder at 
480 nm due to S0-S1 (π-π*) vibrational transition. A broad transition of weaker intensity at 
360-370 nm can be attributed to a S0-S2 (π-π*) transition from the dipyrromethene ligand.70,71 
BODIPY dyes tend to have lifetimes, typically in the region of 0.8-10 ns.72 
The BODIPY core has eight positions that can be readily functionalised.  Functionalisation 
at these positions can have a profound effect on the photophysical properties, enabling optical 
tuning. Some of the reactions include nucleophilic substitutions at positions 3, 5, 4 and 8, 
electrophilic substitutions at positions 2 and 6, condensation reactions at 3, 5 and 2, 6. 
Palladium catalysed coupling reactions such as Sonogashira and Suzuki–Miyaura which is 
utilised in this study, can be used at all positions except the 4–position.73  
Substituents at the 1 and 7-positions of 1,7-dimethyl-8-aryl-substituted BODIPY dyes can 
result in increased quantum yields. Studies have shown that a 1, 3, 5, 7-tetramethyl BODIPY 
core compared with a 3,5-dimethyl core results in an increase in quantum yields due to steric 
constraint, by reducing the loss of energy from non-radiative decay by preventing free 
rotation of the aryl groups at the meso-position.74  The inclusion of ortho-substituents on 
phenyl rings positioned on the 8– or meso–position can also increase fluorescent quantum 
yields. This is due to the prevention of free rotation of the external phenyl group which can 
be caused by either the ortho-substituents on the phenyl group or due to steric effects caused 
by substituents at positions 1-and 7, which lead to a reduction in energy loss form excited 
states.  
  
S-indacene       BODIPY core 
Figure 1.15 Structure and numbering of BODIPY core derived from s-indacene. 
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The BODIPY core does not show emission at long wavelength or NIR fluorescence. 
However, modifications to the core can result in red-shifted BODIPY derivatives and many 
have been reported with emission ranges between 480-700.72,75–77 By incorporating aromatic 
rings, double and triple bonds through the electrophilic positions of the BODIPY core, large 
red-shifts can be obtained by extending the π-system. Vincente et al reported a series of 3, 5-
diiodo-BODIPY complexes that had emission maxima’s ranging from 579-686 nm, the 
largest Stokes shift reported being 0.092 eV.78 Our group has also previously reported a 
naphthyridyl-BODIPY derivative which exhibited a mega-Stokes shift of 0.52 eV  and an 
emission maximum of 740 nm.76 Another successful approach to shifting the emission profile 
of BODIPY to the NIR-region is the synthesis of aza-BODIPYs. These BODIPY derivatives 
containing a nitrogen atom at the 8-position and aryl substituents at the 1, 3, 5 and 7-positions 
result in longer wavelength absorption and emission profiles shifted to the far-red.79,80 The 
photophysical properties of aza-BODIPYs make them advantageous for biological labelling, 
however the dependence on hydrophobic aryl substituents tends to cause aggregation in 
aqueous media. In order to increase hydrophilicity, aryl substituents containing sulfonyl 
groups have been used to great effect.81 
1.6.2 Synthesis of Symmetrical BODIPY Dyes 
Like many significant chemical discoveries, BODIPY was synthesised by accident when 2, 
4-diemthylpyrrole was reacted with acetic anhydride while in the presence of boron 
trifluoride diethyl etherate (BF3
.OEt2). Many years passed until its potential, especially in the 
field of fluorescent imaging was realised in the 1980s, and it wasn’t until the 1990s that 
research in creating BODIPY derivatives greatly increased. The most commonly synthesised 
BODIPYs are 8-position or meso-substituted BODIPYs due to their relative ease of 
synthesis. They can be prepared via condensation reactions of acyl chlorides with pyrroles 
followed by the addition of BF3
.OEt2 and Et3N. The reaction scheme can be seen below, 
Scheme 1.1. 
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Scheme 1.1 Reaction scheme for the synthesis of BODIPY via the condensation of acyl chlorides 
and pyrroles.73 
 
Another common synthetic route, and the method which is used by our group, is to synthesise 
BODIPY dyes using an aromatic aldehyde and two equivalents of a substituted pyrrole. 
Similar to the reaction shown in Scheme 1.1, BODIPY dyes can be formed via a knoevanegal 
type condensation reaction of aromatic aldehydes and pyrroles as shown in Scheme 1.2. This 
route requires an oxidation step and the two commonly used oxidants are p–chloranil and 
2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ). This reaction can be carried out in two 
steps or one. An 8–position substituted dipyrromethane derivative can be formed by reacting 
an aromatic aldehyde and pyrrole in the presence of TFA catalyst. This dipyrromethane 
complex can then be purified and then oxidised to form dipyrromethene or the reaction can 
be continued by directly adding either p–chloranil or DDQ as an oxidant and then treating 
with BF3
.OEt2 and Et3N. The use of either oxidant results in the formation of unwanted by-
products which require tedious purification, often needing two column chromatography 
purification steps of column chromatography followed by a recrystallisation step, in order to 
isolate the desired BODIPY product. However, this route has a clear advantage as the use of 
substituted pyrroles and benzaldehydes broaden the scope of the reaction and allow for 
further elaboration of these groups.  The advantage of the acyl chloride route is that there is 
no oxidation step required therefore requiring less purification steps and larger yields. 
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Scheme 1.2 General reaction scheme for the synthesis of BODIPY via condensation type reactions 
of aldehydes and pyrroles. 
 
The resulting products of these types of reactions are BODIPY dyes with aryl groups at the 
8- or meso–position. It would be expected that the addition of aromatic groups to an extended 
π–system would increase the electron conjugation, resulting in significant alterations of the 
absorption and emission wavelength. However, these aryl groups are typically orientated 
perpendicular to the BODIPY core, therefore modifications at this position generally do not 
result in noticeable changes in the absorption and emission wavelengths.69,82 The extent of 
rotation of the 8–position substituents are also important for the overall fluorescence of the 
complex.  Substituents at the 1, 7–positions as well as ortho-substituted groups on a meso–
positioned phenyl ring prevent free rotation of the meso–group which in turn increases the 
fluorescent brightness.82 The meso–group is important for structural versatility as it provides 
the route to structurally unique derivatives, as many BODIPY dyes are linked to other 
moieties through this position. For example, BODIPY dyes synthesised via the acyl chloride 
route have a free carboxylic acid terminal which can be readily linked to lipids, DNA and 
peptides.83,84 One area of research that has successfully exploited the meso- position is the 
design and synthesis of molecular rotors. Work carried out by the Kuimova group has used 
one of the most widely used lifetime-based rotors phenyl-BODIPY and its derivatives to 
probe lipid membrane viscosity.85–87 The dyes contain a hydrophobic alky chain attached to 
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a meso- phenyl-BODIPY which increases the likelihood of lipid partitioning. Changes in the 
lifetimes and quantum yields of these dyes due to rotation of the phenyl group at the meso- 
position can be attributed to the rigidity and viscosity of the membranes. 
1.6.3 Synthesis of Unsymmetrical BODIPY Dyes 
Condensation of acyl chlorides and aldehydes with pyrroles are two good synthetic pathways 
for synthesising symmetrically substituted BODIPYs. However, in order to synthesise 
unsymmetrically substituted BODIPYs, a Lewis acid mediated condensation of ketopyrroles 
must be carried out with another pyrrole molecule, as shown in Scheme 1.3.88 
 
Scheme 1.3 Common procedure for the synthesis of asymmetric BODIPYs from ketopyrroles. 
 
This reaction results in higher yields when electron–rich pyrroles are used and is a useful 
means to obtain BODIPY probes with different functional groups on the left and right side 
of the core. However, if electron–deficient pyrroles are used, a self–condensation side 
reaction can occur, resulting in the formation of unwanted symmetric BODIPY, thus 
lowering the yield.   
1.6.4 Functionalisation at the 2,6- positions of the BODIPY Core 
Due to our interest in designing BODIPY derivatives with polycyclic ligands at the 8- or 
meso-position to promote membrane partitioning, all BODIPY derivatives outlined in 
chapter 2 and 3 of this thesis were synthesised using aromatic aldehydes and substituted 
pyrroles as described in Scheme 1.2. It was therefore necessary to find another route to the 
functionalisation of the BODIPY core.  The most facile option was to carry out 
functionalisation reactions at the 2,6-positions. It is well established in literature that the 2, 
6-positions bear the least positive charge, this is clearly shown by the resonance structures in 
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Figure 1.16.38 Therefore they readily undergo electrophilic substitution reactions, including 
halogenation (Br, Cl and I), sulfonation, nitration and formylation.50,58,89–9 
 
 
Figure 1.16 Illustration of the resonance delocalisation of the positive charge on the BODIPY core. 
 
Halogenation, particularly bromination and iodination, have been the most common 
electrophilic substitution reactions employed at the 2- and 6-positions.  For example, 
bromination at the 2,6-positions can be easily achieved by slowly adding bromine at room 
temperature to 1, 3, 5, 7-tetramethyl substituted BODIPYs. This reaction has been previously 
used by our group to synthesise brominated BODIPY derivatives.62The addition of heavy 
atoms such as bromine and iodine at positions 2- and 6- can result in a bathochromic shift in 
the absorption and emission profiles, while decreasing the quantum yield by increasing the 
rate of intersystem crossing by facilitating strong spin-orbital coupling between singlet and 
triplet states..50 These 2,6–bromo and iodo-BODIPY dyes can also be used as intermediates 
in coupling reactions such as Suzuki–Miyaura, Sonagashira and Heck-coupling. Our group 
has previously synthesised a naphthyridyl-BODIPY complex with two diaminobenzene 
groups attached at the 2,6–positions by carrying out a Suzuki-Miyaura coupling of the 
brominated intermediate.76 
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Figure 1.17 2,6-substituted BODIPY dyes from literature, 176, 284. 
 
Another important electrophilic substitution reaction that has recently been reported for 
BODIPY derivatives is formylation via the Vilsmeier-Haack reaction.89 It involves treating 
BODIPY derivatives unsubstituted at the 2,6-positions with Vilsmeier-Haack reagent, which 
is generated by adding phosphorous oxychloride (POCl3) with dimethylformamide (DMF) at 
0 °C. This reaction is employed in the synthesis of naphthyridyl-BODIPY-2-Cholesterol and 
is discussed in chapter 2 in greater detail. 
1.6.5 Biological Applications of BODIPY 
The BODIPY fluorophore has been described as the ‘El Dorado’ of fluorescence tools92, with 
its desirable photophysical properties and outstanding chemical versatility leading to 
widespread applications, including light-harvesting arrays93,94, photodynamic therapies95–97, 
laser dyes98,99 ion/metal-sensing100–102 and hydrogen production103. One area of research that 
has seen extensive use of BODIPY is the field of bio-imaging. Their ease of synthesis and 
modification allows for tuning of optical properties, solubility and targeting, all of which 
play a vital role when imaging biological samples.  
To date BODIPY derivatives have been widely applied to cellular imaging, targeting a wide 
range of organelles. Despite its overall hydrophobic structure BODIPY has been used to 
image cytosol by substituting mono-alkoxy groups onto the boron atom, resulting in 
increased water solublitiy.104 By adding the positively charged moieties triphenylphosphine 
and triethylamine to a phenyl-BODIPY core, Gao et al successfully labelled HeLa cells with 
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no cytotoxic effects by using the cationic groups to guide the BODIPY to the mitochondria.105 
As well as specific cell organelles, BODIPY derivatives tagged with peptides or proteins 
have been used to label target proteins. Miller et al synthesised a trimethoprim (TMP) 
conjugated BODIPY capable of tagging Escherichia coli dihydrofolate reductase (eDHFR) 
fusion proteins on the plasma membrane or nucleus of wild-type mammalian cells.106 Further 
work carried out by Wu et al modified eDHFR with a thiol group so it would covalently bond 
to a similar BOIDPY-TMP derivative.107 
By functionalising fluorophores with moieties that provide an optical response to certain 
stimuli, changes in cellular environments can be detected. One of the most important 
biological parameters is pH, as it plays a role in many vital physiological processes, including 
cell growth, metabolism and ion transport. For this reason, many pH-sensitive BODIPY dyes 
have been synthesised capable of ‘Off-On’ fluorescent switching.108,109 The pH-sensitivity 
usually occurs through a photoinduced electron transfer (PeT) mechanism. Switching is 
usually dependent on the protonation of amino or phenol groups, resulting in detection of 
reversible pH changes. Work carried out by the O’ Shea group demonstrated a sophisticated 
pH-sensor based on aza-BODIPY.110 The dye consisted of an aza-BODIPY core resulting in 
NIR emission allowing for penetration of biological tissues. A polyethylene glycol (PEG) 
group was added to increase water solubility and promote uptake. The pH-sensitive moiety 
was an ortho-nitro phenolic group which upon protonation in the acidic environment of 
lysosomes exhibited a ‘switch-on’ fluorescence, easily detected through fluorescence 
microscopy. 
The popularity of the BODIPY fluorophore across a wide range of scientific fields including 
bio-imaging and sensing, combined with regular reports of new derivatives in literature like 
the examples given above, has led to a significant increase in the number of commercially 
available BODIPY dyes. Thermo Fisher Scientific is one of the largest commercial sellers of 
BODIPY dyes worldwide and they provide many probes with a range of biological 
applications, some of are shown in Table 1.1 and 1.2. 
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Some of the dyes they sell include BODIPY FL conjugates of adenosine triphosphate (ATP) 
and guanosine triphosphate (GTP) which can be used as structural probes for nucleotide-
protein binding. BODIPY FL Histamine is used to label acidic organelles in living cells. They 
also sell two of the longest wavelength amine-reactive BODIPY dyes commercially 
available, BODIPY 630/650-X and BODIPY 650/665-X. Thermo Fisher Scientific provide 
numerous excellent cellular stains for specific organelle labelling, two of which are 
commonly used to stain the golgi apparatus and endoplasmic reticulum, the red fluorescent 
BODIPY TR-glibenclamide and BODIPY TR-ceramide.  
Table 1.1 Near – IR Commercial BODIPY probes available from Thermo Fisher Scientific for 
biomolecular conjugation. 
 
 
 
Dye Chemical Structure Absorption 
Maximum 
(nm) 
Emission 
Maximum 
(nm) 
BODIPY 
630/650-X 
 
 
 
625 
 
 
640 
BODIPY 
650/665-X 
 
 
646 
 
664 
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Table 1.2 Commercial BODIPY probes available from Thermo Fisher Scientific for cellular staining. 
Dye Chemical Structure Absorption 
Maximum 
(nm) 
Emission 
Maximum 
(nm) 
BODIPY TR - 
glibenclamide 
 
 
 
 
587 
 
 
 
615 
BODIPY TR - 
ceramide 
 
 
 
 
505 
 
 
 
520 
BODIPY 
630/650-X 
 
 
 
625 
 
 
640 
BODIPY 
650/665-X 
 
 
646 
 
664 
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1.6.6 The Use of BODIPY Probes for Lipid Labelling 
One of the drawbacks of BODIPY for biological imaging is the hydrophobic nature of its 
derivatives, however an ever-expanding area of research where hydrophobicity is desirable 
is lipid membrane imaging, which is the prime focus of this study.35,36,111 As mentioned in 
previous sections, the coexistence of different lipid phases is a hotly debated topic and in 
order to investigate lipid bilayer membranes, in particular those that contain coexisting lipid 
domains, probes whose partitioning behaviour is well distinguished is needed. Lipid-rafts’ 
were originally identified as regions of cell membranes that were resistant to detergent. Also 
called liquid-ordered domains, these regions contain a high concentration of cholesterol and 
sphingolipids.9 This physical state is said to be the liquid-ordered phase and tends to be more 
compact and rigid. Although experimentation seems to suggest evidence of the existence of 
nanodomain ‘lipid-rafts’, the ability to visually detect them in living cells still causes 
controversy.  
Within cells, it is believed that ‘lipid-rafts’ are nanometer scale in length, therefore resulting 
in difficult characterisation. Modern day imaging techniques capable reaching such low 
resolutions are mainly non-fluorescent such as atomic force microscopy. De Wit et al 
developed interferometric scattering microscopy (iSCAT) which saw them image a single 
protein molecule label free.112 Work carried out by Moss and Boxer also used a non-
fluorescent technique, nano-secondary ion mass spectrometry nano(SIMS) to probe the 
distance in lipid assemblies achieving a <50 nm imaging length.113 
Despite the greater success of non-fluorescent techniques to achieve sub-diffraction limit 
imaging, there is still great interest in developing dyes that can successfully visualise phase 
partitioning, with many researchers in the field using artificial lipid models which can be 
used to create domains on micron scale. GUVs can be created in sizes of (<20 µm) resulting 
in liquid-ordered regions that are microns in length and therefore easily visualised by 
fluorescence spectroscopy. It is therefore desirable to develop fluorescent probes to be used 
for lipid membrane labelling, with emphasis on probes that can selectively differentiate 
between the liquid-ordered (Lo) and the liquid-disordered (Ld) phases.   
In recent times research into the use of BODIPY probes for lipid membrane labelling has 
gathered much interest due to the photophysical properties previously mentioned and the 
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overall lipophilic nature of the BODIPY core.  To date there has been two approaches to 
labelling domains; labelling domain components such as cholesterol, sphingolipids, 
ceramides and gangliosides with fluorescent molecules or by creating molecules that can 
mimic domain components, therefore partitioning into liquid-disordered or liquid-ordered 
domains.35,36,111,114 
 
 
Figure 1.18 Chemical structure of sphingomyelin and ceramide. 
 
A number of BODIPY lipid probes have been developed which have been applied to lipid 
domain labelling and some are commercially available. They differ depending on whether 
the BODIPY moiety is linked to the alkyl chains or closer to the head group of common 
membrane components. Thermo Fisher Scientific provides a range of BODIPY dye-labelled 
sphingolipid derivatives that include fatty acids, glycerophosphocholines and cholesteryl 
linked probes. BODIPY-PC and BODIPY-Cer are commonly used BODIPY probes for lipid 
membrane imaging, with BODIPY-PC being widely applied for general membranes as well 
as a liquid-disordered marker.115–117 Within the literature many research groups have 
published BODIPY-lipid conjugates and investigated their preference for both liquid-
disordered and liquid-ordered phases. Three acyl chain modified lipid-BODIPY derivatives 
of phosphatidylcholine (PC) and sphingomyelin (SM) have been reported. 5-BODIPY-PC, 
5-BODIPY-SM and 12-BODIPY-SM.34,118 They all contain the BODIPY core attached to 
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one of the fatty acid tails of PC and SM with varying chain length, and all three probes were 
shown to be excluded from the liquid-ordered region of GUVs and strongly partition into the 
liquid-disordered region.119 The idea that PC labelled probe would show preference for the 
liquid-disordered region is no surprise, since the liquid-disordered region has a high content 
of PC lipids such as DOPC, however the results of the SM labelled BODIPY derivatives is 
surprising.   
Liquid-ordered domains tend to be rich in sphingomyelins, and Marks et al presented data 
that showed 5-BODIPY-SM labels sphingomyelin rich domains in cell membranes.111 Sezgin 
et al also reported the fluorescently labelled ganglioside GM1 derivative (5-BODIPY-GM1) 
that showed preference for the liquid-disordered phase, despite evidence of GM1 being 
present in liquid-ordered regions.118 Samsonov et al, however, showed that BODIPY-GM1 
selectively partitioned to the liquid-ordered region of phase separated GUVs.120 The 
structural difference resulting in different partitioning behaviours is that 5-BODIPY-GM1 
has the BODIPY core attached to one of the ceramide tails of GM1, whereas the BODIPY 
fluorophore is attached to one of the sugar groups in BODIPY-GM1.  This suggests that 
having unhindered long chain fatty acid tails are important for partitioning into the liquid-
ordered phase. BODIPY-Cholesterol (TF-Chol) synthesised by Li et al is a BODIPY-sterol 
conjugate that was shown to partition into the liquid-ordered phase of GUVs.121 The 
BODIPY core is attached directly to the acyl chain of the cholesterol, leaving the hydroxyl 
tail free as seen in Figure 1.19. It is expected that within liquid-ordered domains TF-Chol 
orientates in the bilayer with the BODIPY core incorporated adjacent to the fatty acid tails 
of neighbouring phospholipids, while the lone hydroxyl group is exposed at the bilayer 
interface. Interestingly, within chapter 3 of this thesis, a BODIPY-cholesterol conjugate was 
synthesised exploiting the free hydroxyl group to form an ester bond between a carboxylic 
acid BODIPY derivative and a cholesterol moiety. Similar to TF-Chol, BODIPY-Ahx-Chol 
also showed preference for liquid-ordered domains. This suggests that cholesterol will still 
orientate into liquid-ordered domains despite the physiochemical changes to the cholesterol 
by esterification of the hydroxyl group. 
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Figure 1.19 Chemical structures of BODIPY-lipid conjugates, BODIPY-GM1, BODIPY-Cholesterol 
(TF-Chol) and 5-BODIPY-GM1. 
 
In summary, the literature suggests that BODIPY-lipid conjugates, show great promise for 
use as lipid membrane labels. The site at which the BODIPY is conjugated to the lipid seems 
to be very important in driving partitioning into either the liquid-disordered or liquid-ordered 
phase. To target the liquid-ordered phase, which is the goal for many researchers in this area, 
it seems necessary to conjugate the fluorescent label to lipids or molecules that are present 
in lipid rafts within the cell membrane, such as cholesterol, sphingomyelin, ceramides or 
ganglioside GM1. For the lipids that contain long chained fatty acid tails, partitioning studies 
seem to suggest it is important to leave these tails unblocked. To create a probe that partitions 
into the liquid-ordered phase without conjugation to one of the mentioned molecules, 
structures that mimic either cholesterol (cyclic and planar) or have a synthetic long chained 
aliphatic region appear necessary, however tuning their optical properties to suit modern 
microscopy techniques without hindering their partitioning abilities remains challenging.  
1.7 Pyrene Based Fluorescent Probes 
1.7.1 Structure and Spectroscopic Properties 
Pyrene is a polycyclic aromatic hydrocarbon (PAH) consisting of four fused benzene rings 
resulting in a conjugated aromatic system. Since its discovery in 1837 it has become one of 
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the most widely studied PAHs due to its interesting photophysical and electronic properties 
including long lived singlet excited states122,123, high quantum yields and its ability to form 
excimers via π-π interactions in both the solid state and in solution122. Due to possessing these 
qualities, pyrene has been used in many applications such as organic light emitting diodes 
(OLEDS) 122,124, DNA125 and nucleic acid126 binding, detection of lipid domain and 
membrane formation127–129 as well as sensing solvent polarity130 and pH131–133.  
 
Figure 1.20 Chemical structure of the pyrene core with positions labelled.  
 
The photophysical properties of pyrene have been well characterised.122,134,135 It has 
unusually long lifetimes136,137, moderate to high extinction coefficients and high quantum 
yields. A typical pyrene absorption spectrum shows two intense shoulders at approximately 
320 nm and 335 nm with a weaker shoulder at 306 nm as show in Figure 1.21. Pyrene 
monomer emission can exhibit five vibronic bands designated I-V. These five emission peaks 
can occur between ~375-420 nm and are attributed to π-π* transitions. Like many organic 
fluorophores, pyrene emission can become quenched with an increase in molar 
concentrations. At higher concentrations, the likelihood of a ground state pyrene and excited 
state pyrene coming into close proximity with one another is increased, resulting in the 
formation of a dimer or ‘excimer’. The formation of  excimers that can lead to a bathochromic 
shift in the emission profile with a decrease in luminescent intensity.122,138,139 The excimer 
emission appears as a broad structureless band between 420-550 nm, typically centred ~ 450 
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nm.140 Although undesirable for the applications outlined within this body of work, pyrene 
excimer fluorescence has been widely used to investigate inter- and intra-molecular 
interactions in both photophysical and biological studies.141–143 
 
Figure 1.21 Absorbance spectrum of pyrene (10 μM) in hexane (left) and subsequent monomer-
emission spectrum (right). 
 
1.7.2 Synthesis of Pyrene Charge-Transfer Derivatives 
Many groups have focused on carrying out synthetic modifications to optimise the electronic 
and photophysical properties of the core, to avoid aggregation and quenching due to π-π 
interactions.  The main strategy employed to achieve this has been to create conjugated π-
systems substituting the pyrene core with donors (D) and/or acceptors (A) that can provide 
energetically high lying occupied orbitals (HOMO) and low-lying unoccupied orbitals 
(LUMO), respectively. Some of the substituents used to extend π-conjugation include 
thiophene, piperdine, pyridine and ethynyl-bridged phenyl groups. 
Several pyrene-based charge-transfer fluorophores have been found to have different 
distinctive emission profiles, due to functionalisation and substitution of the pyrene 
core.144,145 With respect to this thesis, the core itself was not thought useful for spectroscopic 
techniques such as fluorescent confocal microscopy, FCS or STED due to its blue region 
absorption and emission. For these reasons the pyrene core alone has not commonly been 
reported in literature as a cell imaging dye. The synthesis of highly emissive pyrene 
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fluorophores has focused on adding substituents at the 1, 3 ,6 and 8-positions122 as these 
positions are more active than the remaining positions (4, 5, 9, 10 and the 2 and 7-positions), 
which are more difficult to directly substitute. The 1, 3, 6, and 8-positions of pyrene are 
preferentially suitable for electrophilic aromatic substitution (SEAr) reactions. The relative 
ease of brominating both K-region (4, 5, 9 and 10-positions) and non-K-region (1, 2, 3, 6, 7 
and 8-positions) sites on the pyrene core has led to many donor-acceptor pyrene derivatives 
being synthesised by utilising palladium-catalysed coupling reactions including Suzuki-
Miyaura145,146 and Sonogashira147 coupling. By brominating the pyrene core via electrophilic 
aromatic substitution (SEAr) reactions, 1, 3, 6, 8-tetrabromopyrene can be obtained in high 
yield (90 %). It is a common precursor widely used for designing star-shaped pyrene-based 
OLEDs/OFETs material by Suzuki/Sonogashira cross-coupling. 
 
 
Scheme 1.4 Synthetic route to tetra-substituted pyrenes using Suzuki-Miyuara and Sonogashira 
coupling reactions. 
 
Within this body of work, the highly tuneable 1,3,6 and 8-positions were exploited using 
palladium catalysed coupling chemistry.147,148 The synthesis of highly emissive, longer 
wavelength pyrene fluorophores was achieved by adding electron donating groups to non-K-
region sites, thus creating an electron charge transfer from these substituents to the pyrene 
core. These derivatives have shown to possess high quantum yields, moderate to high 
extinction coefficients, good photostability and display large Stokes shifts.148–150 
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Figure 1.22 Chemical structures of pyrene derivatives 1151, 2147, and 3149 which were synthesised 
using palladium catalysed coupling strategies at the 1, 3, 6 and 8-positions.  
 
1.7.3 Use of Pyrene for Lipid Labelling 
Nearly two decades ago, Tanhuanpää et al used pyrene-phospholipid conjugates to obtain 
fluorescent images of the plasma membrane in BHK (baby hamster kidney) cells.152 
However, to obtain good quality images, quenching strategies and background subtraction 
techniques needed to be employed. The pyrene-phospholipid was excited at 345 nm and 
emission collected at 395 nm which is not compatible with modern imaging techniques (e.g. 
super resolution) and is also undesirable for biological studies due to potential damage caused 
by UV excitation. Since then there has been very few reported pyrene derivatives used for 
cell-imaging. Jana et al synthesised pyrene-carbamate derivative to be used as phototriggers 
for realising alcohols, phenols and adenosines into live cells.153 These derivatives stained the 
cell with no apparent selectivity and required blue-region excitation. Another study carried 
out by Zhang et al reported a pyrene derivative containing an formaldehyde reactive moiety 
in order to sense formaldehyde in living cells.154 Similarly this work focused more on the 
sensing capabilities rather than the cell-imaging application and once again, the pyrene 
derivative showed no selectivity for any specific cellular regions and required 390 nm 
excitation   
In recent times synthetic strategies have been employed not only to tune the optical properties 
of the pyrene core but also to add groups to aid specific targeting. Only recently has a ‘push-
pull’ pyrene derivative been reported as an effective lipid probe for labelling lipid domains 
in phase separated GUVs.127 This derivative called PA localised in both Ld and Lo domains 
  43   
 
in GUVs, exhibiting photophysical changes in the emission profile based on phase difference. 
The dye exhibited a mega-Stokes shift in a range of different solvents and lipid compositions 
and excellent quantum yields were reported, 0.96 and 0.93 in toluene and hexane 
respectively. Photostability testing showed that PA outperformed the commercially available 
‘push-pull’ probe Laurdan, as the fluorescence intensity retention was ~70 % higher after 1 
h photoexcitation. 
 
Figure 1.23 Chemical structures of the solvatochromatic fluorescent probes Laurdan and PA. 
 
The synthetic tunability of the 1,3,6 and 8-positions of the pyrene core along with the ability 
of the fluorophore PA to distinguish lipid phase led to the design of PyLa in chapter 4. PyLa 
exploits the readiness for the 3,6 and 8-positions to undergo Suzuki-Miyaura coupling as well 
as the 1-position being easily functionalised to allow future conjugations. By incorporating 
red-shifting substituents, mainly 4-dimethylaminophenyl groups to pyrene-1-carboxylic 
acid, the resultant fluorophore PyLa obtained a mega-Stokes shifted emission, high quantum 
yields and excellent photostability.  
1.8 Conclusions 
Over the past number of years, research into cell membrane composition and cellular lipid 
content has grown considerably across a range of areas from biophysics to health and disease. 
Due to the size of lipid domains (nm), lipid droplets (<1 μm)  and membrane proteins (nm) 
within cells, the need for fluorescent dyes capable of illuminating these regions of interest 
that are compatible with techniques which can provide structural information and biophysical 
information on membrane interactions (e.g. lipid, protein or toxin) such as super resolution 
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microscopy and FCS, are of vital importance for the progression of this scientific field. It is 
therefore necessary to design dyes that have the desired biological properties (cell 
permeability, low cytotoxicity and high selectivity for lipid regions in particular liquid-
ordered domains) as well as the photophysical properties (mega-Stokes shift, high quantum 
yield and molecular brightness in the nanomolar range and high photostability) required to 
be compatible with super-resolution microscopy, FLIM, FCS and more recently multi-modal 
techniques such as STED-FCS.   
This thesis focuses on two fluorophores, BODIPY and pyrene for use in bio-imaging 
applications due to their desirable photophysical properties including intense fluorescence, 
high extinction coefficients and high quantum yields at low nanomolar to micromolar 
concentrations, as well as good photostability and relatively low cytotoxicity. As a result, 
there are now many commercially available BODIPY dyes and BODIPY-lipid conjugates 
targeted specifically for imaging. Pyrene and its derivatives have also found widespread use 
in many applications including nucleic acid binding, as organic light emitting diodes 
(OLEDS) and supramolecular photosensors, however is far less common in bio-imaging due 
to many derivatives exhibiting UV-region excitation, which incompatible for many modern 
imaging techniques. This thesis explores the design, synthesis and bio-imaging applications 
of novel BODIPY and pyrene-based dyes and their respective sterol/lipid conjugates to 
provide information and images of lipid environments in both model lipid membranes and 
live cells, with particular focus on lipid membranes, lipid droplets and phase separation of 
lipid domains. Across this body of work the approach of extending π-conjugation and 
conjugating sterols/lipids to the respective dyes was used in order to create lipid imaging 
probes that were highly selective to lipid regions and possessed desirable photophysical 
properties compatible with the techniques outlined above, resulting in high quality, low 
background images. This thesis provides an insight into lipid membranes, the artificial 
models that mimic them and the structural and photophysical requirements of successful lipid 
membrane probes. 
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2.1 Abstract 
Lipophilic BODIPY fluorophores, in which the BODIPY core bears pendant dipyrido[3,2-
a:2′,3′-c]phenazine (Dppz) or naphthyridyl and cholesterol substituents were designed and 
prepared as lipid probes for both liposomes and live cell imaging. The probes are non-
emissive in water but permeate both GUV and live cell membranes and provide high contrast 
fluorescence and lifetime imaging of membranous structures and lipid droplets in cells and 
are suitable for FCS measurements on lipid membranes. 
2.2 Introduction 
Luminophores that can segregate into membrane domains are of interest both in the study of 
live cells and in biophysical studies of membrane models as a route to understanding the 
lateral order and fluidity of lipid domains.1 Co-existing liquid phases can occur in liposomes 
comprising ternary or greater mixtures of phospholipids containing cholesterol and 
sphingomyelin. The two phases are liquid-disordered (Ld) phase and liquid-ordered (Lo) 
phase. The former lies between a liquid crystal or gel phase and the latter, which is enriched 
in cholesterol (Chol) and sphingolipids2, is closer to a liquid-crystalline phase. Both phases 
exhibit a high degree of lateral fluidity. Phase separated liposomes are widely used as models 
for raft behaviour in cell membranes and it is desirable to develop fluorescent probes for lipid 
membrane labelling that can selectively differentiate between the liquid-ordered (Lo) and 
liquid disordered (Ld) phases to enable their study.3–5 Most studies have shown that 
fluorescent probes that contain unsaturated chains have a preference to associate with the 
liquid-disordered (Ld) phase, while several polycylic aromatic hydrocarbons (PAHs) have 
exhibited preferential partitioning into to the liquid-ordered (Lo) phase.6 In the context of 
cell imaging, lipophilic probes also have the capacity to associate intracellularly into lipid 
rich domains of the cell, including the cellular membrane and lipid droplets. 
Lipid droplets (LDs) are hydrophobic cytoplasmic organelles that are responsible for the 
storage of neutral lipids. They consist of a triacylglycerol and cholesteryl ester core 
surrounded by a phospholipid–cholesterol monolayer.7,8 and range in size from 1–100 
μm.9 LDs had once been regarded as fat deposits and transport vesicles. And, whilst indeed 
their main role is lipid storage, in the last decade it has become apparent that LDs are a much 
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more dynamic organelle, storing a diverse array of proteins on their surfaces and within their 
core.10,11 
LDs have been shown to play a role in a number of physiological processes such as the 
immune response.12 In vivo inflammation, stimulates production of LDs that accumulate 
within leukocytes and become activated in mast cells13 effectors of immune reactions in 
diseases such as asthma and rheumatoid arthritis.1–16 Some of the most important advances 
in understanding the real-time dynamics of LDs has come from imaging technologies such 
as confocal microscopy.17,18 The fluorescent label Nile red has been mostly widely used as a 
selective stain to image LDs.19 But a number of emerging commercial probes for imaging 
LDs are based on BODIPY derivatives.20–24 
The 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) derivatives are attractive 
luminophores in biological and biophysical applications due to their outstanding 
photophysical characteristics; large quantum yields, sharp absorbance and emission features 
and their synthetic versatility.25–32 In the context of LDs they offer superior photochemical 
stability to Nile red33 and their optical properties can be tuned with relative ease via synthetic 
modification to the BODIPY core or meso positions. Such modification has led to diverse 
BODIPY dyes many of whom have been applied in biological labelling.34–37 Several 
BODIPY lipid probes are available commercially for bio-imaging; for example, BODIPY 
PC and BODIPY FL C5-GM1 are used to label lipid membranes.38,39 However, we are 
interested in developing lipid and phase selective probes that do not require arduous lipid 
conjugations to the fluorophore by developing probes that can spontaneously partition into 
membrane and lipid structures. 
Herein, we describe two lipid membrane partitioning BODIPY derivatives. One containing 
a naphthyridyl pendant functionalised with cholesterol and the second bearing an aryl 
BODIPY derivative with pendant dipyrido[3,2-a:2′,3′-c]phenazine (Dppz). Both probes 
exhibit intense fluorescence (quantum yields >70 %) in chloroform which is extinguished in 
water. The former chosen because the naphthyridyl-BODIPY derivative shows exceptional 
quantum yield in non-aqueous solvent (>80 %) and the latter selected because the Dppz 
moiety has been shown previously to partition into lipid membranes.40 We observe that both 
probes spontaneously assemble into GUV membranes to provide high contrast images of the 
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lipid membrane. Both also partition strongly to the Ld phases of phase separated membranes, 
where they were found to be suitable for fluorescence correlation spectroscopy. Both probes 
are also spontaneously internalised into live mammalian cells where they associate strongly 
with lipid droplets. 
2.3 Materials and Methods 
 
2.3.1 Materials 
All reagents were purchased from Sigma Aldrich (Ireland) and used without further 
purification unless otherwise stated. 1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC), 
brain sphingomyelin (BSM), and cholesterol (Chol) were obtained from Avanti Polar Lipids 
(Alabaster, AL, USA). DiD′ solid; DiIC18(5) solid (1,1′-dioctadecyl-3,3,3′,3′-
tetramethylindodicarbocyanine, 4-chlorobenzenesulfonate salt) was purchased from Thermo 
Fisher Scientific (Waltham, Massachusetts, USA). 
2.3.2 Instrumentation 
1H NMR spectra were recorded on either 400 MHz or 600 MHz Bruker spectrometer. All 13C 
NMR spectra were obtained at 150 MHz. The spectra were processed using Bruker Topspin 
NMR software. High Resolution Mass Spectrometry (HR-MS) was carried out at the Mass 
Spectrometry facility, University College Dublin. MALDI-ToF mass spectrometry was 
performed on MALDI-Q-ToF Premier instrument at Trinity College Dublin. UV-Vis spectra 
were recorded on Varian Cary 50 spectrometer. Samples were analysed in Hellma quartz 
fluorescence cuvettes, with a path length of 1 cm, and spectral range of 200–800 nm unless 
otherwise stated. Background measurements were carried out at room temperature prior to 
each measurement. Emission Spectra were recorded on a Varian Cary Eclipse fluorescence 
spectrophotometer with excitation and emission slit widths of 2.5 nm. All analyses were 
carried out using quartz cuvettes and background correction was applied prior to 
measurement. Fluorescence lifetime measurements were carried out using a PicoQuant 
FluoTime 100 Compact FLS TCSPC system using a 450 nm pulsed laser source generated 
from a PicoQuant PDL800-B box. The instrument response function was determined using 
Ludox colloidal silica solution. Lifetime decay plots were analysed using PicoQuant 
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TimeHarp software. The goodness of each fit to exponential decay kinetics was assessed 
from chi-squared values (where χ2 < 1.3) and visual inspection of residuals. 
2.3.3 Preparation of giant unilamellar vesicles (GUVs) 
Lipid stock solutions were prepared in chloroform. For preparation of Ld/Lo phase separated 
GUVs, 1-2-dioleoyl-sn-glycero-3-phosphocoline (DOPC), brain sphingomyelin (BSM) and 
cholesterol (Chol) were mixed in a molar ratio 4:4:2 to a final concentration of 5 mM. For 
lipid diffusion (FCS) studies Dppz-Ar-BODIPY and naphthyridyl-BODIPY-2-cholesterol 
were included at a concentration of 0.001 mol% in the lipid content, while for partitioning 
(confocal fluorescence microscopy) studies Dppz-Ar-BODIPY or naphthyridyl-BODIPY-2-
cholesterol, along with the lipophilic tracer dye, DiD was included at a concentration of 0.2 
mol% in lipid content prior to electroformation. DiD is known to partition strongly to the Ld 
phase of GUVs, and was therefore used to identify this phase.6 GUVs were formed by 
electroformation using the Vesicle Prep Pro (VPP) (Nanion Technologies, Munich, 
Germany). The lipids were added in 2 μL droplets onto a pair of conductive ITO slides and 
dried in a desiccator under vacuum for 45 minutes. The ITO slides were carefully placed in 
contact so as to avoid air bubbles. A voltage was then applied and increased over 10 minutes 
from 0 V to 3 V and then held for 125 minutes. The protocol was carried out at 37 °C. Once 
electroformation was completed, the GUVs were removed, diluted with 0.23 mM glucose 
solution and 0.5 % agarose solution and deposited on glass coverslides for imaging.41 For 
uptake studies, GUVs were prepared as described above by electroformation using DOPC 
100 mol%. GUVs in sucrose solution 230 mM were then diluted using an aqueous glucose 
solution 230 mM. The selected probe in chloroform was then added to this suspension to give 
a final dye concentration of 10 μM. GUVs in this mixed solution were then deposited onto a 
glass slide for microscopy. Uptake was monitored using confocal microscopy using 
fluorescence and white light imaging over a period of 1 h 45 minutes. 
2.3.4 Confocal microscopy of giant unilamellar vesicles (GUVs) 
Fluorescence imaging was carried out using a Leica TSP inverted (DMi8) confocal 
microscope. A 100× oil immersion objective was used for all measurements. A white light 
laser was used to excite the dyes. The excitation and emission wavelengths (λex/λem) were as 
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follows: 498/511–570 nm for Dppz-Ar-BODIPY, 523/532–580 nm for naphthyridyl-
BODIPY-2-cholesterol and 644/665–700 nm for DiD. 
2.3.5 Fluorescence lifetime correlation spectroscopy (FLCS) 
Diffusion coefficients for the BODIPY derivatives within labelled GUVs were obtained 
using fluorescence lifetime correlation spectroscopy, FLCS performed on a Microtime 200 
system (Picoquant GmBH, Berlin, Germany) consisting of an inverted microscope model 
Olympus X1-71 with an Olympus UPlanSApo 60×/1.2 water immersion objective. The 
fluorophores were excited with a 440 nm PicoTA from Toptica (Picoquant). The laser was 
directed onto a 440/532 rpc dichroic mirror and focused on the aforementioned objective. 
The sample fluorescence was collected through the same objective and filtered by the 
dichroic mirror, and by a 460 nm interference filter. The sample fluorescence was passed 
through a 50 μM pinhole onto a single photon avalanche diode (SPAD) detector. The 
autocorrelation functions (ACFs) were fit using SymphoTime software (Picoquant GmBH, 
Berlin, Germany) to the following eqn (2.1): 
  
                                     Equation 2.1 
where G(τ) is the autocorrelation function of fluorescence fluctuations; N is the average 
number of diffusing fluorophores in the effective volume; τ is the delay time; T is the fraction 
of molecules in the triplet state; α is the anomalous parameter; τD is the diffusion time of the 
molecules and τT is the decay time for the triplet state. Prior to performing FLCS 
measurements, confocal images of the GUVs were obtained in order to locate and identify 
suitable GUVs for measurement. The lipid bilayer of the liposome was located by z-scanning 
near the GUV membranes and locating the site of maximum intensity. Point FLCS 
measurements were then recorded for duration of 3 minutes. Measurements that exhibited 
any GUV drift were eliminated. 
2.3.5 Fluorescent lifetime imaging microscopy (FLIM) 
Fluorescence lifetime imaging was carried out using a PicoQuant 100 system attached to 
Leica TSP inverted (DMi8) confocal microscope using a 100× oil immersion objective. Each 
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sample was acquired for 120 s with a 512 × 512 resolution. A 498 nm white light laser was 
used to excite the GUV samples. Data was analysed using PicoQuant Symphotime software. 
2.3.6 Cell culture 
Two cell lines were studied; Chinese hamster ovarian (CHO-K1), an adherent mammalian 
cell line and HeLa cells, a cervical cancer cell line. The media used to culture the cells was 
Dulbecco's modified Eagle's medium (DMEM)/Hams F-12 for CHO and DMEM 
supplemented with 1 % L-glutamine for HeLa. Both were supplemented with 10% foetal 
bovine serum and 1 % penicillin–streptomycin and grown at 37 °C with 5% CO2. Cells were 
harvested or split at 90 % confluency using 0.25 % trypsin for 5 minutes at 37 °C. 
2.3.7 Confocal microscopy for cell imaging 
HeLa and CHO cells were seeded at 1.5 × 105 cells in 2 mL culture media on poly-L-lysine 
coated, #1.5 coverslips in a 6-well plate and left for 24 h at 37 °C under 5 % CO2. Dppz-Ar-
BODIPY and naphthyridyl-BODIPY-2-cholesterol were added to the wells in cell media to 
give a final concentration of 5 μM (final DMSO concentration of 0.25 %) and were incubated 
for 24 h at 37 °C with 5 % CO2. Prior to imaging, the compounds were removed, and the 
cells were washed once with PBS supplemented with 1.1 mM MgCl2 and 0.9 mM CaCl2. The 
cells were imaged live using a Leica TSP DMi8 confocal microscope with a 100× oil 
immersion objective lens. 498 nm selected from a white light laser was used to excite the 
compounds, and a 505–550 nm filter was used to collect the emission. For real-time imaging, 
both cell lines were seeded at 1.5 × 105 cells in 2 mL culture media on 35 mm high precision 
glass-bottom dishes (Ibidi, Germany) as described previously. Dppz-Ar-BODIPY and 
Naphthryidyl-BODIPY-2-cholesterol were added to Leibovitz media to give a final 
concentration of 5 μM and was added to live cells and imaged immediately using Time Series 
mode to capture images every 1 minute over a 25-minute period. To assess the mode of 
uptake, cells were prepared as mentioned above and incubated with the compounds at 4 °C 
for 24 h. Cells were washed with PBS (supplemented with 1.1 mM MgCl2 and 0.9 mM 
CaCl2) and imaged immediately. 
2.3.8 Cytotoxicity studies 
Cells were seeded in 96-well plates (Sarstedt flat-bottom cell + culture plate) at 1 × 104 for 
CHO and HeLa cells in 100 μL media for 24 h at 37 °C with 5 % CO2. Dppz-Ar-BODIPY 
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and Naphthryidyl-BODIPY-2-cholesterol were added for 20 hours at 37 °C with 5 % CO2. 
Final dye concentrations were 100, 50, 20, 10, 5 and 1 μM. The Alamar blue assay (Promocell 
GmbH) was used to measure cell viability by the addition of 10 μL resazurin reagent and 
cells were incubated for 7 h at 37 °C in the dark. Absorbance was measured using a Tecan 
96-well plate reader at 570 nm and 600 nm (corrected for background).2.4 Results and 
discussion 
2.4 Results and Discussion 
 
2.4.1 Synthesis 
The structures of the BODIPY derivatives and their route to synthesis are shown in Scheme 
2.1. 11-Bromo-dipyrido[3,2-a,2′,3′-c]phenazine under Suzuki–Miyura coupling conditions 
afforded the intermediate aldehyde 2. The aldehyde was then converted to Dppz-Ar-
BODIPY via reaction with 2,4-dimethylpyrrole, boron trifluoride diethyletherate and 
triethylamine, in the presence of an oxidant p-chloranil in DCM purged with N2. Purification 
was carried out by column chromatography on a silica gel column using 
CHCl3/MeOH/H2O/CH3COOH (80:18:2:1 v/v) as the mobile phase giving BODIPY-Ar-
Dppz as a dark red solid. Naphthyridyl-BODIPY-2-cholesterol was synthesised from the 
precursor naphthyridyl BODIPY derivative which was prepared as previously 
reported.42 The less electropositive 2- position of the BODIPY core was formylated by 
treating BODIPY dye 4 with POCl3 and DMF in dichloroethane as reported in 
literature.43 Purification of the product by column chromatography on silica gel 
(CHCl3/MeOH/H2O/AcCOOH 80:18:2:1 v/v) gave a dark purple crystalline solid. The 
aldehyde was then converted to a carboxylic acid via Pinnick-type oxidation reaction.44 This 
was achieved by treating the formylated BODIPY dye 5 with NaClO2 and NH2SO3H in THF 
and water. The compound was isolated as an orange crystalline solid. 1H NMR analysis 
confirmed the disappearance of the aldehyde peak at 9.99 ppm and thus the isolated BODIPY 
carboxylic acid intermediate 6 was subjected to the following steps without further 
purification. 6 was reacted with cholesterol in the presence of N,N′-
dicyclohexylcarbodiimide and 4-dimethylaminopyridine to give the expected naphthyridyl-
BODIPY-2-cholesterol conjugate after purification by column chromatography on silica gel 
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using (DCM/MeOH 9:1) as the mobile phase. Dppz-BODIPY and naphthyridyl-BODIPY-2-
cholesterol were characterised by mass spectrometry and 1H NMR spectroscopy and the data 
conformed to expected values.  
 
Scheme 2.1  Synthetic route to BODIPY derivatives (i) 4-formylphenylboronic acid, K2CO3, 
Pd(dppf)Cl2.DCM Toulene/H2O/EtOH (4:2:1), N2, 12 h, 54 %; (ii) 2,4-diemthyl-1H-pyrrole, TFA, 
DCM 5 h; tetrachlorobenzoquinone, Et3N, BF3.OEt2, 12 h, 29 %; (iii) POCl3, DMF, Dichloroethane, 
50 °C, 2 h, 92 %; (iv) THF/H2O (3:1), NaClO2, NH2SO3H,  25 °C, 1 h, 79 %; (v) DMAP, DCC, DCM, 
25 °C, 12 h, 96 %. 
 
 
2.4.2 Photophysical Characterisation 
Table 2.1 summaries the optical and photophysical properties of Dppz-Ar-BODIPY and 
naphthyridyl-BODIPY-2-cholesterol across a range of solvents. Both derivatives as expected, 
exhibit a S0 → S1 (π–π*) transition, centred at 500 ± 3 nm for Dppz-Ar-BODIPY and 515 ± 6 nm 
for the naphthyridyl-BODIPY-2-cholesterol in acetonitrile (Figure 2.1).46 Emission was shifted 
for both derivatives to the red with decreasing solvent polarity, but the effect was most pronounced 
for Dppz-Ar-BODIPY. Conversely, emission is extinguished for both compounds in aqueous 
media. This is similar to behaviour reported for related BODIPY structures, where aqueous 
emission switch-off has been attributed to formation of nanoaggregates due to poor solubility in 
water or due to stabilisation of charge transfer states that are non-emissive.47 
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There are some distinctions in the solvent responses. Both compounds exhibit intense 
emission in non-protic solvent with quantum yields in chloroform of 0.71 and 0.88 
respectively for Dppz-Ar-BODIPY and naphthyridyl-BODIPY-2-cholesterol respectively. 
Table 2.1 Summary of photophysical data 
Compound Solvent λ abs (nm) 
(ε =x103 M-1 cm-1) 
λ em (nm) 
 
τ lum (ns) ± SD ϕlum 
 
Dppz-Ar-BODIPY MeCN 
H2O 
DCM 
CHCl3 
MeOH 
497 (10.90) 
 514 (2.85) 
501 (12.98) 
 502 (15.51) 
 499 (7.02) 
511 
None 
518 
519 
511 
3.50 ± 0.10 
None 
3.88 ± 0.44 
4.41 ± 0.18 
3.17 ± 0.04 
3.29 ± 0.1 a 
0.35 
* 
* 
0.71 
0.17 
Naphthyridyl-
BODIPY-2-
Cholesterol 
MeCN 
H2O 
DCM 
CHCl3 
MeOH 
511 (10.93) 
521 (6.84) 
516 (11.36) 
517 (11.23) 
514(7.04) 
527 
None 
530 
531 
530 
3.84 ± 0.14 
None 
3.66 ± 0.09 
3.50 ± 0.13 
4.41 ± 0.64 
4.06 ± 0.5 a 
0.44 
* 
* 
0.88 
0.55 
All solutions were measured at concentrations of 10 μM.  Slit widths for emission were set to 2.5 nm.  
Lifetime data was recorded in triplicate and curve fitting conformed to tail fit criteria of χ2 < 1.3.  
Quantum yields were measured using Fluorescein 0.1 M NaOH (ϕ= 0.90) as standard. *Not measured. 
a Measured at 37°C. 
 
Dppz-Ar-BODIPY shows far greater sensitivity to protic media wherein it's quantum yield 
decreases to 0.17 in methanol and 0.35 in acetonitrile compared with 0.55 and 0.44 for 
naphthyridyl-BODIPY-2-cholesterol. This may be due to H-bridging to the N rich Dppz unit 
in protic solvent promoting non-radiative decay, such behaviour has been noted in Dppz 
containing luminescent metal complexes.48,49 In this instance, the increased π-acceptor 
capability of the H-bridged Dppz may promote energy transfer from the BODIPY to the Dppz 
unit to extinguish the fluorescence. The lifetime data is consistent with this trend; Dppz-Ar-
BODIPY exhibits a fluorescence lifetime of 4.41 ± 0.18 ns in chloroform that decreases with 
increasing solvent polarity. The lowest lifetime recorded was in methanol, where τ is 3.17 ± 
0.04 ns. Conversely, naphthyridyl-BODIPY-2-cholesterol exhibits a fluorescence lifetime of 
3.50 ± 0.13 in chloroform, with the longest-lived value 4.41 ± 0.64 ns occurring in methanol 
(4.41 ± 0.64 ns). As noted, the extinction of emission in aqueous media occurs for both 
compounds, and this behaviour was exploited here to enable collection of high contrast 
imaging of the probes in cells and GUVs in aqueous media. As live cell imaging studies are 
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conducted here at 37 °C we also examined the lifetime of the probes at this temperature in 
methanol and found, within experimental error that they were indistinguishable from room 
temperature values. Furthermore, over the concentration range 1 to 100 μM we found no 
evidence from fluorescence for aggregation of probe in organic media and dye absorbance 
followed Beer Lambert law as shown in Figure S2.14 (Appendix C). The concentrations used 
throughout subsequent studies are in the low micromolar range and nanomolar for FCS. 
 
 
Figure 2.1 (a) Solvent dependence absorbance curves for 3 (10 μM). (b) Solvent dependence 
emission curves for 3 (10 μM, slit widths; 2.5 nm).  (c) Solvent dependence absorbance curves for 7 
(10 μM). (d) Solvent dependence emission curves for 7 (10 μM, slit widths; 2.5 nm). *excitation line, 
no emission observed in water. 
 
 
2.4.3 GUV partitioning studies 
Dppz and naphthyridine/cholesterol moieties were exploited here as pendants to the BODIPY 
fluorophores to promote membrane association. To explore the latter, the interaction of each 
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compound with giant unilamellar vesicles (GUVs) was investigated. Uptake of Dppz-Ar-
BODIPY was monitored at 100 mol% DOPC GUVs by addition of the probe (in chloroform) 
to GUV containing aqueous solution, so that the final concentration was 10 μM, whilst 
imaging the GUVs using fluorescence microscopy. Dppz-Ar-BODIPY spontaneously 
partitions into GUVs with mission visible from the GUVs within 1 h and uptake was 
completed within 1 h 45 minutes (Figure S2.18). A low concentration of dye (10 μM) was 
used in order to ensure that any visible uptake was not due to overloading, as uptake is likely 
concentration dependent. When Dppz-Ar-BODIPY was added in a 1:1 mixture of chloroform 
and methanol it was found that uptake was completed in less than 1 h. This decrease in uptake 
time is expected due to the miscibility of methanol in water. It is important to note that the 
compounds did not emit from the background GUV solution and emission only appeared on 
partitioning of the probes into the vesicles. This property combined with the high quantum 
yields of these materials in the lipophilic environment meant that high quality high contrast 
images of the liposomes are produced even at very low concentrations of the probe. 
In order to explore if the BODIPY derivatives showed any phase preference, GUVs 
composed of DOPC/BSM/Chol (4:4:2) were prepared. Betaneli et al. have shown that this 
composition produces phase separated GUVs and that an increase in the number of phase 
separated GUVs formed can be achieved by carrying out electroformation at higher 
temperatures, followed by cooling to room temperature.50 This protocol was followed here. 
The resulting phase separated GUVs are shown in Figure 2.2(B) labelled with Ld phase probe 
DiD.6 The phase separated GUVs were prepared and labelled with Dppz-Ar-BODIPY and 
DiD or naphthyridyl-BODIPY-2-cholesterol and DiD, and the resulting structures were 
imaged using confocal fluorescence microscopy. Representative images are shown in Figure 
2.2 that clearly demonstrate that both Dppz-Ar-BODIPY and naphthyridyl-BODIPY-2-
cholesterol preferentially partition into the DOPC enriched Ld phase. The high quantum 
yields of these probes in non-aqueous environments and low aqueous emission mean 
concentrations in the low micromolar range are sufficient to yield high contrast images from 
the lipid phases, without background interference. This offers advantage over widely used 
reagents such as DiD which remains weakly fluorescent in water. Interestingly, whereas 
naphthyridyl-BODIPY-2-cholesterol appeared to be exclusively resident in the Ld phase, 
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Dppz-Ar-BODIPY whilst showing preference for Ld, also shows moderate fluorescence 
from the Lo phase. This is reflected in the fluorescence intensity plot shown in Figure 
2.2(G) and is also evident in FLIM images as shown in Figure 2.2(H). The observed Ld 
partitioning preference is likely due to rotational conformation of the DPPZ ligand in relation 
to the BODIPY core about the phenyl linker. Similarly, the orthogonality of the cholesterol 
and BODIPY units may impede it's partitioning into the tightly packed Lo domains 
naphthyridyl-BODIPY-2-cholesterol. Even though the Ld phase is enriched with both 
cholesterol and SM, and cholesterol has shown a preference for raft domains in living cells.51  
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Figure 2.2 Confocal luminescent imaging of phase separated GUVs DOPC/ESM/Chol (4:4:2).  GUV 
stained with compound Dppz-Ar-BODIPY (A), DiD (B) and overlay image (C).  GUV stained with 
naphthyridyl-BODIPY-2-cholesterol (D), DiD (E) and overlay image (F). Fluorescent intensity plot 
of Dppz-Ar-BODIPY vs DiD, images A and B (G). Fluorescent lifetime image of Dppz-Ar-BODIPY 
in GUV DOPC/ESM/Chol (4:4:2) (H).  Figures (A, B, C, D, E, F, G, H) are raw data images, without 
pre-processing.  
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2.4.5 FLIM and FLCS Studies in GUVs 
It was recently reported for related BODIPY fluorophores that the fluorescent lifetime of the 
BODIPY probes is impacted by rotational diffusion of the substituent at the meso substituted 
phenyl unit from which an estimate of bilayer viscosity of GUVs could be obtained. From 
these viscosity measurements, using the Saffman Delbruk models convincing estimates of 
the diffusion values of the probes were obtained.5 
To investigate the lifetimes of the present probes in GUVs we carried out fluorescence 
lifetime imaging. The benefit of lifetime imaging over intensity-based imaging is that it is 
independent of probe concentration. The false-colour image shown in Figure 2.2(H)shows the 
lifetime distributions of Dppz-Ar-BODIPY in GUV DOPC/ESM/Chol (4:4:2), the associated 
fitted lifetime data is shown in Table 2.2. The FLIM data from the GUVs fit best to a 
biexponential decay model. For the main component of the decay, the Dppz-Ar-BODIPY 
exhibits a lifetime of 3.46 ns, while naphthyridyl-BODIPY-2-cholesterol was 4.83 ns. The 
relatively short luminescent lifetimes of both probes mean they are oxygen independent. 
Therefore, any changes to the lifetime values can be attributed to the lipid environment and 
local viscosity. 
Table 2.2 Fluorescent lifetimes and diffusion coefficients of Dppz-Ar-BODIPY and naphthyridyl-
BODIPY-2-cholesterol in the GUVs, and in live CHO and HeLa cells 
 
 
  Ex/Em GUV 
DOPC/SM/Chol 
4/4/2 mol % 
CHO 
  
HeLa GUV 
DOPC/SM/Chol 
4/4/2 mol % 
 
λ  
(nm) 
τ  
(ns)  
  
τAmp  
(%) 
τ  
(ns)  
τAmp  
(%) 
τ  
(ns)  
  
τAmp  
(%) 
Diffusion 
Coefficient 
D 
(µm2 s-1) 
Dppz-Ar-
BODIPY 
498/511 τ1 = 
3.46 
τ2 = 
0.62  
60  
40  
τ1 = 
3.1 
τ2 = 
4.5  
84 
16 
τ1 = 
4.8 
τ2 = 
2.6  
81 
19 
  
4.18 ± 0.25 
Naphthyridyl-
BODIPY-2-
Cholesterol 
523/532 τ1 = 
4.83 
τ2 = 
1.06  
73  
27  
τ1 = 
5.5  
τ2 = 
3.1 
τ3 = 
1.1 
60 
31 
9  
τ1 = 
5.8  
τ2 = 
3.0 
τ3 = 
1.3 
57 
23 
15 
5.60 ± 0.43 
  72   
 
Interestingly, the lifetime of the Dppz-Ar-BODIPY within the GUV was shorter than 
observed in either DCM or chloroform. Whereas on the basis of microviscosity, assuming 
the dielectric constant of the bilayer core is similar to chloroform, one would expect that the 
lifetime might increase within the bilayer, particularly given the Dppz-Ar-BODIPY does 
partition albeit less preferentially into the Lo phase. This may indicate that the Dppz unit is 
oriented into the bilayer with the BODIPY oriented closer to the bilayer aqueous interface 
where it is more exposed to the aqueous environment. Conversely, more in line with 
expectation, the fluorescent lifetime of naphthyridyl-BODIPY-2-cholesterol increased in 
GUVs compared to non-protic solvent from 3.66 ns and 4.20 ns in DCM and chloroform to 
4.83 ns within the GUV. In both cases a short-lived component of the decay was observed at 
approximately 1 ns, the origin of this component is not clear but likely originates because the 
probes occupy more than one orientation at the bilayer. The shorter-lived component may 
arise from probe near the aqueous interface. Whereas one might expect a difference in 
lifetime of the probe between each phase this was not resolved for Dppz-Ar-BODIPY and so 
we can assume that the difference is small and by inference the quantum yield of the probe 
does not change substantially between the two phases. Thus we can exploit intensity 
measurements from Figure 2.2(G) to estimate the ratio of distribution of Dppz-Ar-BODIPY 
between the two phases as approximately 3:1. A key motivation in developing these probes 
was to evaluate their value as labels for FCS measurements. Ideally FCS probes should be 
capable of spontaneously partitioning into the bilayer and critically because of the very high 
susceptibility of this method to background interference, they should ideally either be highly 
localised to the region of interest, or, as in this case, only emit when at the region of 
interest.52 This property, combined with their high quantum yields and photostability meant 
they were excellent FCS probes. This is reflected in the representative auto-correlation 
functions shown in Appendix A, which show high quality ACFs with little contribution from 
triplet formation and no evidence for photodecomposition. 
Fitting the ACFs for each probe to equation (2.1) we obtained lateral diffusion coefficients 
within the phase forming DOPC/SM/Chol 4/4/2 mol% GUVs. The diffusion coefficient of 
Dppz-Ar-BODIPY was found to be 4.18 ± 0.25 μm2 s−1 while the diffusion coefficient of 
naphthyridyl-BODIPY-2-cholesterol was 5.60 ± 0.43 μm2 s−1. The distinction in diffusion 
coefficient for each probe is interesting as the composition of the GUV was identical in each 
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case. The value of 5.60 ± 1.0 μm2 s−1 for naphthyridyl-BODIPY-2-cholesterol is within the 
expected range for BODIPY probes in DOPC GUVs or in ternary GUVs at room 
temperature.53–55 As described, for confocal imaging, Figure 2.2(D), naphthyridyl-BODIPY-
2-cholesterol strongly localises to the DOPC rich region in phase separated GUVs. 
Conversely, Dppz-Ar-BODIPY was found to preferentially but not exclusively partition in 
the Ld region. Therefore, we attribute the lower diffusion coefficient observed for Dppz-Ar-
BODIPY to contribution from the probe in the Lo phase. The diffusion value is indeed 
consistent with reports for BODIPY in this phase in ternary GUVs.53,56 
2.4.6 Cell studies 
Given the spontaneous uptake of the probes by GUVs and the high contrast images they 
produce from hydrophobic regions, we explored whether the probes are taken up by live cells 
and their distribution therein. Uptake studies of Dppz-Ar-BODIPY and naphthyridyl-
BODIPY-2-cholesterol were assessed in both HeLa and CHO cells for a comparison of a 
cancer (HeLa) and non-cancer (CHO) cell lines. When added to live HeLa or CHO cells, 
both compounds are taken up instantaneously at the membrane and both Dppz-Ar-BODIPY 
and naphthyridyl-BODIPY-2-cholesterol cross the membrane of both cell lines within the 
first 5 minutes of exposure, (Figure S2.20–2.23). After 25 minutes, both probes had entered 
the cytoplasm and showed no affinity for any specific organelles. Figure 2.3 shows HeLa and 
CHO cells when incubated with 5 μM of Dppz-Ar-BODIPY and naphthyridyl-BODIPY-2-
cholesterol for 24 h in the absence of light. The probes high quantum yields mean low μmol 
concentrations are enough for efficient staining leading to bright emission from within the 
cells without any background interference because of the probe water switch properties. To 
understand better the mechanism of uptake, the cells were incubated with the probes at 4 °C 
for 24 h. It was found that the probes were readily taken up by the cells under these 
conditions, indicating uptake is passive in nature, as expected given the lipophilicity of the 
probes (Figure S2.19).  
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Figure 2.3 Confocal luminescent imaging of Dppz-Ar-BODIPY and naphthyridyl-BODIPY-2-
cholesterol in HeLa and CHO cells. Cells were incubated with 5 μM for 24 h prior to imaging. In 
each case, a wide-field image and zoomed in image shows the distribution of the compounds in the 
cells throughout the sample. 
 
Overall, Dppz-Ar-BODIPY did not emit as brightly as naphthyridyl-BODIPY-2-cholesterol from 
either cell line, which is expected based on their different quantum yields. Both Dppz-Ar-
BODIPY and naphthyridyl-BODIPY-2-cholesterol are nuclear excluding, localising within the 
cell cytoplasm, but emitting only from hydrophobic structures. Dppz-Ar-BODIPY appears to bind 
non-selectively to cytoplasmic structures assumed to be membranous or proteinaceous in nature 
whilst naphthyridyl-BODIPY-2-cholesterol accumulates and emit intensely from spherical 
punctate regions of the cells characteristic of lipid droplets (LDs) in the cytoplasm with weaker 
background staining of membranous structures.20,57,58 Naphthyridyl-BODIPY-2-cholesterol 
shows greater selectivity for LDs when compared to the lipophilic stain DiD which targets the 
general plasma membrane. LDs generally form as clusters in the cytoplasm that comprise of many 
smaller droplets, which corresponds to the localisation patterns observed here.59 We recently 
observed this selective staining of lipid droplets in related water switchable BODIPY probes, and 
confirmed using Raman spectroscopy that the punctate features labelled were indeed LDs. Such 
selective labelling of LDs is useful as their overproduction in cells is linked to pathogenesis of 
inflammatory diseases, such as obesity, diabetes and atherosclerosis and also cancer cells 
proliferate such organelles. 
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Correspondingly, the pattern of LD staining by naphthyridyl-BODIPY-2-cholesterol between 
HeLa, a cancerous cell line, and CHO cells, a mammalian cell line, can be distinguished in Figure 
2.3, which is representative of the general behaviour. On the basis of labelling the LDs are more 
numerous in the HeLa cells compared to CHO cells but the LDs form clusters in the latter. Cancer 
cells are known to show an increase in the biosynthesis of fatty acids in order to proliferate. For 
example, cholesterol metabolism pathways are modified in cancer cells where an increase in 
cholesterol levels are associated with tumour growth.60 Excessive lipids and cholesterol levels in 
cancer cells are stored in LDs,61 and recent findings suggest LDs may serve as an important energy 
source in cancer cells.62 High numbers of LDs in tumours are now considered as hallmarks of 
cancer cells and how progressive they are.10,63 For example, a higher number of LDs are seen in 
colon cancer cells and lung cancer cells (A549) compared to non-cancerous cells.64 To further 
confirm localisation of naphthyridyl-BODIPY-2-cholesterol in the LDs, both HeLa and CHO 
cells were dual stained with Nile red. Nile red showed strong colocalisation with naphthyridyl-
BODIPY-2-cholesterol in the LDs, shown in Figure 2.4. The corresponding x-y plot across a 
cluster of LDs in the cell shows the emission overlap of the two dyes in the LD regions.   
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Figure 2.4 Confocal luminescent imaging of naphthyridyl-BODIPY-2-cholesterol in HeLa cells. 
Cells were treated with 5 μM for 24 h and 700 nM Nile red for 20 minutes naphthyridyl-BODIPY-2-
cholesterol is shown in green (A), Nile red in red (B), and their colocalisation in yellow (C). The 
white cross-section and the corresponding distribution graph show their colocalisation over a cluster 
of lipid droplets (D). 
 
The selectivity of naphthyridyl-BODIPY-2-cholesterol for LDs indicates that this luminophore is 
a useful probe for imaging the LD content of cells and perhaps in distinguishing such cells. The 
toxicity of Dppz-Ar-BODIPY and naphthyridyl-BODIPY-2-cholesterol were assessed using the 
resazurin assay over a 20 h exposure to a range of concentrations in the absence of light, shown 
in Figure 2.5, where the viability of the cells exposed to the compounds was compared the viability 
of control cells that were not exposed to the compounds but were treated in the same manner. It 
was found that both probes exhibited low toxicity toward HeLa cells but depending on 
concentration both were toxic toward CHO. Naphthyridyl-BODIPY-2-cholesterol showed a dose 
response cytotoxicity toward CHO becoming strongly cytotoxic above concentrations of 20 μmol. 
By contrast Dppz-Ar-BODIPY only became strongly cytotoxic above 50 μmol. The naphthyridyl-
BODIPY-2-cholesterol showed low cytotoxicity at the concentration range, of 1 to 5 μM effective 
for imaging. The lack of toxicity of naphthyridyl-BODIPY-2-cholesterol particularly towards 
HeLa cells suggests that this compound is a suitable imaging probe of LDs in cancer cells. The 
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difference in toxicity between the CHO and HeLa cell lines may arise because the former is non-
tumorigenic whilst the latter are tumorigenic. Tumor cells can show higher resistance to cytotoxic 
substances for a number of reasons but especially due to their upregulated expression of drug 
export proteins such as P-glycoprotein.56 The low cytotoxicity of these materials toward cancer 
cell lines though should enable their use in long term monitoring of LD interactions in cancerous 
cells like HeLa, and permit study of their interactions with the other cell organelles such as the 
mitochondria, and the endoplasmic reticulum from where LDs are said to originate.17,65 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5 Cytotoxicity results of Dppz-Ar-BODIPY (dppz) and naphthyridyl-BODIPY-2-
cholesterol (Naph) in HeLa and CHO cells over 20 h exposure to the compounds. Toxicity was 
measured using the Resazurin (Alamar Blue) assay (n = 3). 
 
2.4.7 FLIM studies in cells 
Fluorescence lifetime Imaging was carried out to evaluate the luminescent lifetimes of Dppz-Ar-
BODIPY and naphthyridyl-BODIPY-2-cholesterol from within live cells. Figure 2.6 shows the 
false-colour FLIM images of both probes in HeLa and CHO cells. The average lifetimes observed 
outlined in Table 2.2, the FLIM obtained lifetimes conform to multiexponential decays and it is 
assumed that the contributing components reflects the different environments the probes occupy 
in the cell. Dppz-Ar-BODIPY exhibited two luminescent lifetimes from within the cells. 
Contrastingly, naphthyridyl-BODIPY-2-cholesterol fitted best to three lifetimes contributions. 
For the latter a short component; 1.3 ns in HeLa cells, and 1.1 ns in CHO cells is observed that is 
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not seen for Dppz-Ar-BODIPY in either cell type. As the probes were imaged under similar 
conditions, this contribution is unlikely to be attributed auto-fluorescence. Thus, we speculate it is 
due to probe occupying environments at hydrophilic/hydrophobic interfaces, as similarly short-
lived components of the decay were observed for the probes in liposomes. The lifetimes and % 
amplitudes of each lifetime component are very similar for naphthyridyl-BODIPY-2-cholesterol 
in both CHO and HeLa. Whereas for Dppz-Ar-BODIPY, while the lifetimes of the two 
contributing components are very similar in each cell type; the longest component between 4.5 
and 4.8 ns and the shorter at 2.6 to 3.1 ns. The percentage amplitude of each component is very 
different. The longer-lived component contributes approximately 80 % of decaying signal in HeLa 
compared with only 16 % in CHO.  
 
Figure 2.6 Fluorescence lifetime imaging microscopy (FLIM) of 3 and 7 in live HeLa and CHO cells. 
Cells were incubated with 5 μM for 24 h in the absence of light. FLIM image and lifetime were 
recorded with a 498 nm white light laser and the emission was collected using a band pass filter of 
510–550 nm. 
 
Consistent with steady state confocal imaging, live cell FLIM indicates that Dppz-Ar-
BODIPY emits broadly from membranous structures throughout the cytoplasm, on the basis 
of FLIM it is difficult to discriminate LD and membrane contributions for this 
compound, Figure 2.6, top, although it is likely that the deviation in amplitude of the two 
contributions to the lifetime decay for this molecule may originate from the varying 
concentration of lipid droplets between cell type. In contrast, FLIM imaging for 
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naphthyridyl-BODIPY-2-cholesterol clearly demonstrates its localisation very specifically in 
LDs seen as orange spherical structures on a red background. 
The cytoplasmic membranous structures are the origin of the longer lived 5.5 ns to 5.8 ns 
component of the decay while probe localised in LDs contribute most strongly to the shorter 
lifetime component of 3 ns. The longer lifetime from cytoplasmic membrane structures is 
consistent with the lifetime of the probe in the ternary GUVs The high lipid order as well as 
the cholesterol content in the cell membrane structures may also increase the lifetime of the 
probe.66 The shorter lifetime of the probe within lipid droplets, which are expected to contain 
lipids such as triacylglycerols and phospholipids, may be due to the lower order of these 
regions compared to lipid membranes.67 
2.5 Experimental 
 
2.5.1 Synthesis of 11-bromo-dipyrido[3,2-a,2′,3′-c]phenazine (1) 
Synthesised according to a reported method.35 Yield: brown solid, 2.064 g (5.72 mmol, 77 %). 1H 
NMR (600 MHz, CDCl3) (ppm): 9.57 (t, J = 12 Hz, 2H); 9.30 (d, J = 6 Hz, 2H); 8.54 (s, 1H); 8.21 
(d, J = 9 Hz, 1H); 8.00 (dd, J = 9, 2.2 Hz, 1H); 7.82–7.80 (m, 2H); 13C NMR (DMSO-d6) (ppm): 
152.8, 152.7, 148.5, 148.3, 142.6, 141.5, 141.2, 141.0, 134.1, 133.7, 133.6, 131.6, 130.6, 127.2, 
127.1, 124.8, 124.1. 
2.5.2 Synthesis of Dppz-benzaldehyde (2) 
11-Bromo-dipyrido[3,2-a,2′,3′-c]phenazine (1) (495 mg, 1.37 mmol), 4-formylphenylboronic 
acid (310 mg, 2.05 mmol) and dichloro[1,1′-bis(diphenylphosphino)ferrocene]palladium(II) 
complex with dichloromethane (59 mg, 0.068 mmol) was added to a mixture of toluene (20 mL) 
and ethanol (5 mL) and stirred, while being purged with nitrogen for 15 minutes. Following this 
K2CO3 (946 mg, 6.85 mmol) in water (10 mL) was added and the reaction mixture was heated at 
reflux for 24 h under nitrogen. The reaction mixture was then allowed to cool to room temperature 
and the crude product was concentrated to dryness via vacuum. The product was then dissolved 
in DCM and purified on neutral alumina by column chromatography using chloroform as the 
eluent. Yield: bright-yellow solid, 283 mg (0.732 mmol, 54 %). 1H NMR (600 MHz, CDCl3) 
(ppm): 10.07 (s, 1H); 9.56 (td, J = 4.2, 2.1 Hz, 2H); 9.21 (m, 2H); 8.53 (d, J = 1.8 Hz, 1H); 8.36 
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(d, J = 9 Hz, 1H); 8.14 (dd, J = 9, 2.4 Hz, 1H); 8.02 (d, J = 8 Hz, 2H); 7.96 (d, J = 8 Hz, 2H); 
7.74–7.32 (m, 2H); 13C NMR (CDCl3) (ppm): 191.7, 152.9, 152.7, 148.5, 145.3, 142.7, 142.2, 
141.7, 141.5, 136.0, 134.2, 133.8, 133.7, 131.6, 130.7, 130.5, 130.2, 130.0, 128.2, 127.6, 127.5, 
127.4, 124.2. HR-MS (ESI-TOF) m/z: calculated for C25H15N4O [M]
+: 387.1233 found 387.1246. 
2.5.3 Synthesis of Dppz-Ar-BODIPY (3) 
Dichloromethane (60 mL) was purged with nitrogen for 30 minutes. To Dppz-Ar-
Benzaldehyde (2) (307 mg, 0.794 mmol), 2,4-dimethylpyrrole (181 μL, 1.74 mmol) and TFA 
(cat) was added and stirred at room temperature for 5 h. Following this p-chloranil (236 mg, 0.96 
mmol) in dichloromethane (20 mL) was added and the reaction mixture was stirred for 30 minutes 
followed by the addition of BF3·OEt2 (2 mL) and Et3N (2 mL). The reaction mixture was left to 
stir overnight. The crude mixture was washed with water (2 × 50 mL) and concentrated to 
dryness via vacuum. The crude product was purified on silica gel by column chromatography 
eluent: CHCl3/MeOH/H2O/CH3COOH (80:18:2:1 v/v). Yield: dark-red solid, 140 mg (0.231 
mmol, 29 %). 1H NMR (600 MHz, CDCl3) (ppm): 9.60 (t, J = 7.2 Hz,  2H); 9.22 (d, J = 1.8 Hz, 
2H); 8.61 (d, J = 1.8 Hz, 1H); 8.42 (d, J = 3 Hz, 1H); 7.97 (d, J = 7.8 Hz, 2H); 7.77–7.75 (m, 2H); 
7.45 (d, J = 7.8 Hz, 2H); 5.96 (s, 2H); 2.52 (s, 6H); 1.44 (s, 6H); 13C NMR (CDCl3) (ppm): 155.8, 
152.7, 152.6, 143.2, 143.0, 142.6, 142.1, 141.7, 141.3, 140.9, 140.1, 135.3, 133.8, 131.3, 130.2, 
130.1, 129.0, 128.2, 127.6, 127.5, 127.0, 124.2, 121.4, 118.9. HR-MS (ESI-TOF) m/z: calculated 
for C37H27BF2N6 [M + H]
 +: 605.2329 found 605.2434 
2.5.4 Synthesis of 1,3,5,7-tetramethyl-8-[(2-fluorophenyl)-6-methoxy-1,5-
naphthyridine-3-ethylcarboxylate]-4,4′-difluoroboradiazaindacene (4) 
Synthesised as previously reported.42 Yield: brown solid, 300 mg (0.524 mmol, 54 %). 1H NMR 
(400 MHz, CDCl3) (ppm): 9.29 (s, 1H); 8.31 (d, J = 9.6 Hz, 1H); 7.48 (t, J = 7.4 Hz, 1H); 7.22 (s, 
1H); 7.19 (d, J = 2 Hz, 1H); 7.16 (dd, J = 9.5, 1.5 Hz, 1H); 6.05 (s, 1H); 6.02 (s, 1H); 4.28 (m, 
2H); 3.75 (s, 3H); 2.58 (s, 6H); 1.66 (s, 3H); 1.61 (s, 3H); 1.33 (t, J = 7.1 Hz, 3H). 
2.5.6 Synthesis of naphthyridyl-BODIPY-2-formyl (5) 
Phosphorous oxychloride (6 mL) was added dropwise to dimethylformamide (6 mL) in an ice 
batch for 5 minutes under nitrogen. The solution was allowed to warm to room temperature and 
stirred for 30 minutes. 1,3,5,7-Tetramethyl-8-[(2-fluorophenyl)-6-methoxy-1,5-naphthyridine-3-
ethyl carboxylate]-4,4′-difluoroboradiazaindacene (4) (104 mg, 0.182 mmol) in dichloroethane 
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(30 mL) was added, the temperature raised to 50 °C and the reaction mixture was stirred for 2 h. 
Following this the reaction mixture was allowed to cool to room temperature and slowly poured 
over a saturated solution of K2CO3 (100 mL) in an ice-bath. The reaction mixture was once again 
allowed to warm to room temperature, stirred for 30 minutes and then washed with water (2 × 100 
mL). The crude mixture was dried over MgSO4 and dried under nitrogen. The crude product was 
purified on silica gel by column chromatography eluent: CHCl3/MeOH/H2O/CH3COOH (80 : 18
: 2 : 1 v/v). Yield: dark-purple solid, 102 mg (0.169 mmol, 93 %). 1H NMR (600 MHz, CDCl3) 
(ppm): 9.98 (d, J =12 Hz, 1H); 9.32 (d, J = 4.8 Hz, 1H); 8.30 (dd, J = 12, 4 Hz, 1H); 7.52 (td, J = 
11.4, 4.2 Hz, 1H); 7.20 (m, 3H); 6.21 (d, J = 12 Hz 1H); 4.29 (m, 2H); 3.76 (d, J = 13.8 Hz, 3H); 
2.84 (d, J = 7.2 Hz, 3H); 2.64 (s, 3H); 1,91 (d, J = 21.6 Hz, 3H); 1.69 (d, J = 25.8 Hz, 3H) 1.35 
(td, J = 10.8, 2.4 Hz, 3H); 13C NMR (CDCl3) (ppm): 155.8, 152.7, 152.6, 143.2, 143.0, 142.6, 
142.1, 141.7, 141.3, 140.9, 140.1, 135.3, 133.8, 131.3, 130.2, 130.1, 129.0, 128.2, 127.6, 127.5, 
127.0, 124.2, 121.4, 118.9. HR-MS (ESI-TOF) m/z: calculated for C32H29BF3N4O4 [M + H]
+: 
601.2259 found 601.2234. 
2.5.7 Synthesis of naphthyridyl-BODIPY-2-carboxylic acid (6) 
Naphthyridyl-BODIPY-2-formyl (5) (60.7 mg, 0.106 mmol) was added to a mixture of THF (6 
mL) and water (2 mL) followed by the addition of NaClO2 (95.8 mg, 1.06 mmol) and NH2SO3H 
(102.9 mg, 1.06 mmol). The reaction mixture was allowed to stir for 2 hours, following which it 
was diluted with ethyl acetate and washed using an aqueous solution of sodium thiosulfate (10 % 
w/v). The organic layer was collected and dried over MgSO4. The product was concentrated to 
dryness. Yield: red-orange solid, 52.3 mg (0.084 mmol, 79 %). 1H NMR (600 MHz, CDCl3) 
(ppm): 9.34 (t, J = 4.3 Hz, 1H); 8.35–8.30 (m, 1H); 8.00–7.80 (2× dd, J = 8.4, 1.2, 9.6, 1.2 Hz, 
1H); 7.44 (t, J = 7.8 Hz, 1H); 7.24–7.19 (m, 3H); 4.35–4.26 (m, 2H); 3.78 (d, J = 4.2 Hz, 2H); 
3.73 (s, 1H); 2.88–2.65 (2× d, J = 1.2, 4.2 Hz, 3H); 1.96 (d, J = 24 Hz, 3H); 1.65 (d, J = 30 Hz, 
3H); 1.39–1.34 (m, 3H); 1.25(s, 3H). 13C NMR (CDCl3) (ppm): 164.8, 162.6, 147.8, 139.6, 122.8, 
118.6, 115.1, 61.7, 61.6, 53.7, 53.6, 29.6, 14.2, 13.8, 13.7, 13.5, 12.6, 12.3. 
2.5.8 Synthesis of naphthyridyl-BODIPY-2-cholesterol (7) 
To a stirred solution of 5 (50.3 mg, 0.0814 mmol,) and DMAP (1 mg, 0.00814 mmol) in DCM (4 
mL), a solution of cholesterol (62.9 mg, 0.162 mmol) in DCM (2 mL) was added. The reaction 
mixture was stirred for 5 min at room temperature. A solution of DCC (18.4 mg, 0.089 mmol) in 
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DCM (2 mL) was added and the mixture was stirred at room temperature overnight. The crude 
mixture was concentrated to dryness via vacuum. The crude product was purified on silica gel by 
column chromatography eluent: DCM/MeOH (9 : 1). Yield: pink-red solid, 77.5 mg (0.078 
mmol, 96 %). 1H NMR (600 MHz, CDCl3) (ppm): 9.31 (d, J = 3.6 Hz, 1H); 8.32–8.27 (m, 1H); 
7.51 (q, J = 7.8 Hz, 1H); 7.41 (m, 1H); 7.23–7.16 (m, 3H); 4.32–4.26 (m, 3H); 3.78 (d, J = 4.2 
Hz, 2H); 3.73 (s, 1H); 2.88 (d, J = 1.2 Hz, 2H); 2.66 (d, J = 4.2 Hz, 2H); 1.96 (d, J = 24 Hz, 3H); 
1.65 (d, J = 30 Hz, 3H); 1.39–1.34 (m, 3H); 1.15–1.11 (m, 2H); 13C NMR (CDCl3) (ppm): 140.98, 
121.94, 77.69, 72.03, 56.98, 56.37, 50.35, 49.41, 42.54, 42.52, 40.00, 39.73, 37.47, 36.72, 36.00, 
34.16, 32.12, 31.89, 28.44, 28,23, 25.82, 25.12, 24.51, 23.03, 22.77, 21.30, 19.61, 18.93, 12.07. 
MALDI TOF MS LD+ calculated for C59H72BF3N4O5: 984.6 found 980.6. 
2.6 Conclusions 
In summary, two novel lipophilic BODIPY fluorophores; Dppz-Ar-BODIPY and naphthyridyl-
BODIPY-2-cholesterol that exhibit fluorescence only from non-aqueous environments were 
developed as probes of membranous and lipid structures in liposomes and cells. Both probes 
readily partition from aqueous solution into giant unilamellar vesicles (GUVs). Distribution of the 
probes in ternary domain forming GUVs showed that naphthyridyl-BODIPY-2-cholesterol 
partitions 100 % into Ld domains, whereas Dppz-Ar-BODIPY partitions preferentially into Ld 
domain at a ratio of Ld/Lo of approximately 3:1. The probes were demonstrated to be suitable for 
Fluorescence Correlation Spectroscopy where they exhibited diffusion coefficients in the domain 
forming GUVs of 4.18 ± 0.25 μm2 s−1 and 5.60 ± 0.43 μm2 s−1 reflecting the different distributions 
of the probes between Ld and mixed Lo/Ld respectively. 
Both probes are readily cell permeable, taken up by passive diffusion into live HeLa and CHO 
cells where at low probe concentration they produce high contrast images selectively of the 
membranous regions of the cells. Naphthyridyl-BODIPY-2-cholesterol shows particularly high 
selectivity for lipid droplets within cells confirmed from both intensity and fluorescence lifetime 
imaging of the probes. Overall, these probes show excellent suitability as both lipid and membrane 
probes for biophysical and imaging applications. Although cytotoxic (towards non-cancer cells) 
at higher concentrations, under imaging conditions their cytotoxicity is low. The properties and 
selectivity of naphthyridyl-BODIPY-2-cholesterol suggests this probe is a useful marker for LDs 
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and in turn may find application in diagnosis and fundamental research into LD formation and 
fate which is still not fully understood. 
2.7 Supporting Material 
Supplementary data associated with this chapter can be found in Appendix A. 
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Conjugates Directs Phase Selectivity and Cellular 
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3.1 Abstract  
Lipid membrane fluorescent probes that are both domain-selective and compatible with 
demanding microscopy methods are crucial to elucidate the presence and function of rafts 
and domains in cells and biophysical models.  Whereas targeting fluorescent probes to liquid-
disordered (Ld) domains is relatively facile, it is far more difficult to direct probes with high 
selectivity to liquid-ordered (Lo) domains.  Here, a simple, one-pot approach to probe-
cholesterol conjugation is described using Steglich esterification to synthesise two identical 
BODIPY derivatives that differ only in the length of the aliphatic chain between the dye and 
cholesterol.   In the first, BODIPY-Ar-Chol, the probe and cholesterol were directly ester 
linked and in the second BODIPY-Ahx-Chol, a hexyl linker separated probe from 
cholesterol.  Uptake and distribution of each probe was compared in ternary, phase separated 
giant unilamellar vesicles (GUVs) using a commercial Ld marker as a reference.  BODIPY-
Ar-Chol targets almost exclusively the Ld domains with selectivity of >90 % whereas by 
contrast introducing the C6 linker between the probe and cholesterol drove the probe to Lo 
with excellent selectivity (>80 %). The profound impact of the linker length extended also to 
uptake and distribution in live mammalian cells.  BODIPY-Ahx-Chol associates strongly 
with the plasma membrane where it partitioned preferably into opposing micron dimensioned 
do-mains to a commercial Ld marker and its concentration at the membrane was reduced by 
cyclodextrin treatment of the cells. By contrast the BODIPY-Ar-Chol permeated the 
membrane and localised strongly to lipid droplets within the cell.  The data demonstrates the 
profound influence of linker length in cholesterol bioconjugates in directing the probe. 
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3.2 Introduction 
Lipid membranes of cells and their organelles are heterogenous and laterally organised into 
domains of different dimensions and composition. Amongst these, the existence and function 
of lipid rafts1,2 in particular, remains controversial.3–5 Rafts are believed to be tightly packed 
but mobile, cholesterol and sphingolipid-enriched, nano-platforms of liquid ordered lipid 
domain that diffuse laterally within the plasma membrane.6  Lipid rafts are implicated in 
many important membrane-based functions, including protein trafficking and cell 
signaling.3,7–10  They are often modelled in artificial membranes by using phase-separating 
lipid compositions containing sphingomyelin and cholesterol along with one or more low-
melting phospholipid, to yield co-existing immiscible liquid phases.  The two phases are 
liquid-disordered (Ld) phase and liquid-ordered (Lo) phase.  The latter contains higher 
cholesterol (Chol) and sphingolipid content than Ld and is closer to a liquid-crystalline phase. 
The Ld phase exhibits a higher degree of lateral fluidity than the Lo phase which is more 
tightly packed and also less permeable than the Ld.  Phase separated liposomes are widely 
used as models for raft behaviour in cell membranes, and the dimensions of the domains can 
be controlled by varying the identity and ratio of the lipid component.11  However, although 
domains can be imaged fairly readily in model systems such as liposomes, rafts are far harder 
to reliably detect within cells using conventional fluorescence microscopy, due to their 
putative size and dynamic nature. In particular, imaging domains within cell membranes is 
challenging because probes that work well with liposomes, typically do not remain at the 
membrane but internalise unpredictably into the interior of live cells.   
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Scheme 3.1 Synthesis of BODIPY-Cholesterol Conjugates, BODIPY-Ar-Chol (2) and BODIPY-
Ahx-Chol (6). 
 
 
Although important advances have been made in detection of rafts through label free 
methods, including for example, through interferometric scattering microscopy imaging 
(iSCAT)12, nano-secondary ion mass spectrometry nano(SIMS)13 and AFM14.  Fluorescence 
remains a key technique in many biophysical studies and probes that show phase partitioning 
can contribute to elucidation of domain structures.  With recent advances in fluorescence 
microscopy, experiments that can directly monitor both temporally and dimensionally, rafts 
in cells, their organelles and associated models using fluorescence are within reach.15  
However, such experiments require luminescent probes that are compatible with the demands 
of the method and are both capable of preferential partitioning into Lo phases and in the case 
of live cells, of remaining localised at the membrane. There are relatively few probes that 
favour, with high specificity the Lo region. The majority of probes that show phase 
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preference, partition into the liquid disordered (Ld) phase.  The most selective Lo partitioning 
probes reported, are based on polycyclic aromatic hydrocarbons.16–18,19 whose planarity 
presumably permits intercalation into the tightly packed Lo lipid/sterol structure.  Fluorescent 
cholesterol analogues have also been widely explored as fluorescent probes that favour the 
Lo phase. The fluorescent derivative cholestatrienol, for example, has been successfully used 
to probe membrane formation and structure19, cholesterol trafficking20 and sterol binding 
within human genes.21 NBD-cholesterol and its derivatives have demonstrated lipid domain 
detection in both cells and models22 and cholesterol distribution tracking in model 
membranes23.  However, across PAHs and cholesterol analogues, the fluorophore 
excitation/emission is in the ultraviolet (UV)/blue spectral region19, which typically is 
unsuitable for super-resolution imaging or correlation spectroscopy and there is limited 
opportunity for tuning their photochemical or photophysical properties without reducing their 
co-planarity. Non-PAH probes have been successfully driven to the Lo by appendage of a 
raft associating sterol or lipid, but discrimination typically, does not approach that achieved 
for Ld labelling.21  
The 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) derivatives are excellent 
luminophores for bioimaging22,23 with outstanding photophysical characteristics including 
sharp absorbance and emission features, high extinction coefficients, large quantum yields 
and photochemical robustness24–27. For these reasons, they have been widely applied to lipid 
membrane labelling in both artificial models and live cells28–34.  Furthermore, due to the 
synthetic versatility of the BODIPY core and it’s meso- positions it is amenable to 
bioconjugation. This has led to diverse  families of BODIPY dyes that have found application 
in biological labelling.35–39  Lipid tails or cholesterol have also been applied to the BODIPY 
to improve cell uptake40–42 or to label lipid membranes.21,43  The lipophilicity of the BODIPY 
core and its small size makes it attractive in this regard and indeed a number of BODIPY 
lipid conjugates are offered commercially for bio-imaging; for example, BODIPY FL C5-
GM1, BODIPY PC and TopFLuor® BODIPY.  
BODIPY modified with cholesterol and ganglioside GM1 have been applied as Lo membrane 
probes.44 However, where they have shown tendency to sequester into both domains, they 
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have been domain sensitive rather than selective, where Lo discrimination is on basis of 
domain order or lifetime rather than selectivity.18,45–47  
Such a complex was reported Kuimova et al48, where appendage of a cholesterol to phenyl-
BODIPY via a C3 linker saw some partitioning into the Lo domain. As the parent phenyl-
BODIPY partitions only to the Ld we were interested to see if incorporating additional 
carbons to the linker between the Chol and the probe might permit the Chol to localise at the 
Lo. If the distance was extended so that the hydrophobic BODIPY could orient at the partially 
hydrated boundary of bilayer core and hydrophilic interface. Comparing a directly linked 
cholesterol probe and analogue separated by a 6-carbon chain between cholesterol and phenyl 
BODIPY we observed that the former localises at the Ld while the latter shows strong 
preference for the Lo. The probes were prepared using a novel approach to cholesterol 
conjugation exploiting a one-step Steglich esterification which is very mild and less arduous 
than reported methods and should be widely applicable for cholesterol conjugation. 
Importantly, we found that the C0 cholesterol probe was internalised into the cell, whereas 
the C6 conjugate was retained at the living cell membrane where it appears to stain sterol-
rich membranes distributing in a mutually exclusive way to Ld probe DiD. 
3.3 Results and Discussion 
 
3.3.1 Preparation of cholesterol conjugates 
Scheme 3.1 illustrates the chemical structures and route to synthesis of the BODIPY-
cholesterol conjugates. Cholesterol was appended to a BODIPY core via Steglich 
esterification either directly through the pendant carboxyl group or via a C6 linker appended 
to the acid.  Detailed synthetic protocols are described in the experimental section.  In brief, 
precursor BODIPY-Ar-COOH (1),49 was reacted with dimethylaminopyridine (1 equiv.), 
N,N’-dicyclohexylcarbodiimide (DCC) (1.1 equiv.) and cholesterol (2 equiv.) in DCM to 
yield BODIPY-Ar-Chol (2) at 38 % yield after chromatographic purification.  
4-Formylphenyl-Ahx (4) was prepared by amide coupling of 4-formylbenzoic acid and 6-
aminohexanoate, which was then hydrolysed to give 4. Condensation of 4 with 2,4-
dimethylpyrrole (2.2 equiv.) yielded BODIPY-Ahx (5). The cholesterol derivative BODIPY-
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Ahx-Chol (6) was then simply prepared in 40.2 % yield using the same esterification method 
as 2. Structural characterisation was carried out using high-resolution mass spectrometry, 1H 
and 13C NMR spectroscopy and can be found in Appendix B. 
3.3.2 Conjugate Photophysical Characterisation 
Figure S3.15 (Appendix B) shows the absorbance and emission profiles of BODIPY-Ar-Chol 
and BODIPY-Ahx-Chol in dichloromethane, chloroform, acetonitrile and methanol. Both 
derivatives exhibit the S0-S1 (π-π*) transition centred at 500 ± 3 nm, and as expected, 
behaviour is nearly identical for both fluorophores across solvents.50 Emission shifts to the 
red with decreasing dielectric constant, with the exception of BODIPY-Ahx-Cholesterol in 
acetonitrile which exhibited a slight red-shift compared to dichloromethane. BODIPY-Ar-
Chol is insoluble in water whereas BODIPY-Ahx-Chol is weakly soluble but emission is 
extinguished in this medium.  
Such behaviour, observed previously, in BODIPY derivatives, maybe due to aggregation 
induced quenching.51 Both compounds exhibit intense emission in organic media with 
quantum yields of ~40 % or greater with the exception of methanol where the quantum yield 
falls below 40 % for both compounds. Interestingly, BODIPY-Ahx-Chol shows consistently 
higher quantum yields across all solvents of the two compounds.  And, correspondingly, 
BODIPY-Ar-Chol has a shorter fluorescence lifetime that decreases with increasing solvent 
polarity.  The shortest lifetime for both compounds was in methanol, where τ is 2.25 ± 0.04 
and 2.68 ± 0.002, whereas the longest lifetime was in chloroform, τ is 2.94 ± 0.002 and 3.27 
± 0.005 respectively. Photophysical data is summarised in Table 3.1.  
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Table 3.1 Summary of photophysical data 
  Solvent λabs 
 (nm) 
λem  
(nm) 
     ε 
(M-1 cm-1) 
ϕfl        τlum  
       (ns) 
Dielectric 
Constatnt 
(εr) 
   
Dichloromethane 
 
501 
 
513 
 
63460 
 
0.40 
 
2.85 ± 0.008 
 
8.93 
BODIP
Y-Ar-
Chol 
 
 
 
BODIP
Y-Ahx-
Chol 
 Chloroform 503 516 55484 0.45 2.94 ± 0.002 4.81 
 Acetonitrile 498 511 49335 0.39 2.39 ± 0.009 36.6 
 Methanol 498 513 44372 0.31 2.25 ± 0.04 32.6 
        
 Dichloromethane 501 513 64345 0.50 3.10 ± 0.001 8.93 
 Chloroform 503 518 102646 0.46 3.27 ± 0.005 4.81 
 Acetonitrile 497 516 64332 0.43 2.98 ± 0.001 36.6 
 Methanol 498 513 54070 0.39 2.68 ± 0.002 32.6 
         
All solutions were measured at concentrations of 10 μM. Slit widths for emission were set to 2.5 nm. 
Lifetime data was recorded in triplicate. Quantum yields were measured using fluorescein 0.1 M 
NaOH (ϕ= 0.90)40 a standard. 
 
3.3.3 Partitioning and Photophysics in Giant Unilamellar Vesicles 
Although widely distributed in the cell membrane, cholesterol is well-established as an 
essential component of detergent resistant membrane domains in cells and by extension in 
lipid rafts.52 In model membranes cholesterol has been shown to promote formation of Lo 
domains and partitions with greater preference into these domains than the Ld.53,54  The origin 
of cholesterol preference for Lo and its condensing effect on the membrane has been 
discussed widely in the literature.55,56 The ‘umbrella model’ described by Huang and 
Feigenson57 proposes cholesterol is shielded from unfavourable  aqueous interaction by the 
headgroups of adjacent phospholipids which act as ‘umbrellas’. Increasing cholesterol 
content causes reorientation of the phospholipids resulting in a more tightly packed and rigid 
bilayer. For sphingomyelin containing compositions, H-bonding interactions of cholesterol 
with SM are also thought to play a role in phase preference.  In principle, this preference 
makes cholesterol an attractive appendage to drive labels to the Lo domains of phase 
separated membranes.  
  96   
 
 
Figure 3.1 Confocal fluorescent imaging of phase separated GUVs DOPC/ BSM/Chol (4:4:2) mol 
%. GUV stained with compound BODIPY-Ar-Chol (A), DiD (B) and overlay image (C). GUV 
stained with BODIPY-Ahx-Chol (D), DiD (E) and overlay image (F). Figures (A–F) are raw data 
images, without pre-processing. Fluorescence intensity plot of BODIPY-Ahx-Chol (__) vs DiD (__) 
(G, H). Fluorescent lifetime image of BODIPY-Ahx-Chol(I) in a phase separated GUV of 
composition DOPC/BSM/Chol (4:4:2) with variation in lifetimes given by the colour bar. Fluorescent 
lifetime image of the difference in lifetime given by colour (Ld region = orange/yellow) and (Lo 
region = green). A 503 nm white light laser was used to excite the GUV samples and the emission 
collected between 511-570 nm.  
 
But, conjugation of bulky fluorophore to cholesterol can prevent proper insertion and block 
e.g. H-bonding interactions or shielding between the cholesterol and adjacent phospho- and 
sphingolipids due to steric or electrostatic interference. In order to investigate whether such 
steric affects could be overcome by extending a lipophilic alkyl spacer between the Chol and 
probe we introduced C6 linker between cholesterol and fluorophore (6 in scheme 3.1) and 
compared the phase distribution of this probe with one in which the cholesterol was directly 
ester linked to the probe carboxyl (2 in Scheme 3.1).  It is worth noting that by conjugating 
a cholesterol onto a fluorophore via the lone hydroxyl group it is unlikely that the fluorescent 
cholesterol derivatives will have the same characteristics of cholesterol especially behaviour 
at the bilayer interface, where typically the hydroxyl group is most exposed at the interface.  
  97   
 
To evaluate the phase distribution of each derivative, electroformed, phase-separated GUVs 
of composition DOPC/BSM/Chol (4:4:2 mol %), were incubated with BODIPY-Ar-Chol and 
DiD or BODIPY-Ahx-Chol and DiD.  The resulting structures were imaged using confocal 
fluorescence microscopy (Figure. 3.1).  Notably, each probe distributed preferentially into 
the opposing phase.  To identify the Ld phase, DiD a commercial Ld probe was included at 
a concentration of 0.1 mol % of lipid content prior to electroformation.19  
In separate studies (Figure S3.16) we confirmed that there is no cross-talk between DiD and 
the BODIPY probes. Figure 3.1A-C shows that BODIPY-Ar-Chol partitions almost 
exclusively into the Ld phase of the GUVs, where it colocalises with DiD. Remarkably, 
Figure 3.1D-F shows that BODIPY-Ahx-Chol associates preferentially to the Lo domains, 
where DiD is absent. The oppositional partitioning of the two probes is reflected also in the 
intensity profiles shown in Figure 3.1H.  As discussed below, the probes show within 
experimental error, negligible difference in quantum yield when localised at Lo or Ld, we 
can assume that the fluorescence quantum yield is unaffected by phase. On this basis we can 
roughly approximate the Lo partitioning on the basis of intensity for BODIPY-Ahx-Chol as 
(% Lo ~80 %) (Figure S3.23) and the BODIPY-Ar-Chol partitioned to the Ld at ~90 %.  The 
former may be an overestimate of BODIPY-Ahx-Chol Lo association, as although lifetimes 
are unchanged, xy scans of Lo and Ld associating probes in liposomes, prepared under the 
same probe concentrations suggest the probe at the Lo probe is slightly brighter than the Ld. 
The GUVs were imaged by fluorescence lifetime imaging (FLIM) to evaluate the effect of 
domain on probe photophysics. As described, in solution, emission from both probes fit to 
mono-exponential decay kinetics. On partitioning into the lipid membrane of the GUVs, the 
BODIPY emission decayed according to a biexponential model irrespective of the phase into 
which the probe partitioned.  The lifetime data is summarised in Table 3.2. The short 
component of the decay was within experimental error the same for both probes at 1.7 ns 
constituting 30 to 40 % of the amplitude of the decay.  Its origin is unclear but similar effects 
have been noted previously in membrane bound probes and particularly molecular rotors 
attributed to a fraction of probe that is associated/oriented at the liposomes in such a way that 
it is strongly exposed to the less viscous membrane interface.48 The dominant component of 
the decay (> 50 % of the amplitude for both probes) was longer lived.  For BODIPY-Ar-Chol 
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fluorescence lifetime was determined as 4.74 ns from the Ld phase.  By comparison for 
BODIPY-Ahx-Chol, localised at the Lo, the long component of the lifetime was recorded as 
4.92 ns (Figure 3.2).  The decay was confirmed from the Lo, by labelling with DID. 
Recalling that in chloroform BODIPY-Ar-Chol and BODIPY-Ahx-Chol exhibit emission 
decays of 2.94 and 3.27 respectively. Both dyes show a significant increase in emission 
lifetime on association with GUV attributed to the membrane rigidity/increased micro-
viscosity. Similar behaviour has been reported in other probes incorporated into 
liposomes.18,46,58    
Because of the very high selectivity of each probe for their respective phases, we were unable 
to obtain reliable lifetime data from FLIM for the probes in the opposing phases. However, 
in previous reports, where probe associates with Lo as well as at Ld domains, it has been 
noted that the increased lipid order/rigidity of the Lo often reduces non-radiative decay to a 
greater extent than in Ld leading to notably longer emission lifetimes from this domain.19 In 
a BODIPY cholesterol probe linked through a C2 linker Heikal et al reported that the probe 
partitioned into both Lo and Ld phases and that the lifetime was longer from the Lo, with 
FLIM results also indicating a stronger preference for Lo domains .46 
 
Figure 3.2 Confocal fluorescent image of a phase separated GUV of composition DOPC/BSM/Chol 
(4:4:2 mol %) co-stained with BODIPY-Ahx-Chol (green) and DiD (red) showing the different Ld 
(red) and Lo phases (green) (A). Fluorescent lifetime image (FLIM) of the same GUV showing 
BODIPY-Ahx-Chol in the Lo phase. 
 
Thus, one might have expected a significant increase in lifetime of Lo associated BODIPY-
Ahx-Chol given that its emission is already notably longer lifetime in chloroform than 
BODIPY-Ar-Chol. The negligible difference observed between BODIPY-Ar-Chol in the Ld 
and BODIPY-Ahx-Chol in the Lo thus seems initially counter-intuitive. However, we 
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speculate that the similarity in lifetimes between each probe in opposing phases arises 
because the BODIPY unit cannot intercalate deeply into Lo. It associates only when the linker 
is long enough between the cholesterol anchor and the fluorophore, to allow the cholesterol 
to partition while the probe orients at the interface of the bilayer with shallow penetration 
where photophysics are not strongly impacted by the rigidity of the Lo domain.  
3.3.4 Cell Studies 
Cell membranes contain cholesterol and sphingolipid enriched microdomains, that are 
resistant to non-ionic detergent solubilisation.  These detergent-resistant membranes (DRMs) 
have many of the characteristics of the liquid-ordered (Lo) phase in model membranes. Given 
the strong selectivity of BODIPY-Ahx-Chol probes for Lo domains in GUVs, we investigated 
if this phase preference extended to its distribution in living cells and if we could distinguish 
membrane domain distributions in a cancer and non-cancer cell line.  
Figure 3.3 shows confocal fluorescence images of live HeLa and CHO cells following their 
incubation with BODIPY-Ahx-Chol (5 µM) at 37 °C for 3 h. The imaging indicates that the 
probe localises at the plasma membranes. From z-scanning it is evident that BODIPY-Ahx-
Chol also permeates the cell as emission can be seen from membranous regions therein, but 
it is excluded from the nucleus. To examine BODIPY-Ahx-Chol distribution in the 
membrane we focused on the lower cell membrane which is intensely but highly 
heterogeneously fluorescent.59–61 In HeLa cells (Fig 3.3 A,B) discontinuous patches of sub-
200 nm to 1 µm length as well as more ordered ringed structures are intensely fluorescently 
labelled. However, in addition dark, unlabelled regions of comparable dimensions (white 
arrows) are evident across the membrane. 
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Figure 3.3 Live HeLa (A,B) and CHO cells (C,D) stained with BODIPY-Ahx-Chol (5 µM, 3 h 37 
°C). White arrows highlighting the dark regions where BODIPY-Ahx-Chol does not localise. A,C 
overlay of BODIPY-Ahx-Chol and background channels. B,D BODIPY-Ahx-Chol channel. 
 
On co-staining cells with DiD (800 nM) it was observed that, as at GUVs, BODIPY-Ahx-
Chol and DiD distributed in a mutually exclusive way in the cell membrane.  This is most 
obvious in HeLa cells where Figure 3.4A-C shows that DiD localises in the regions of the 
cell membrane from where BODIPY-Ahx-Chol is excluded.   
The membranes of live cells are so complex that it is difficult to ascertain definitively what 
is labelled. Given the propensity for the probe to stain sterol-rich domains/regions and the 
fact that DiD is excluded from many of the regions that BODIPY-Ahx-Chol is localised 
suggests it is localising at sterol-rich domains.  This may include Lo phases as well as 
caveolae at the cell membrane, protein aggregated domains and membrane bound protein. 
The staining is highly heterogenous and structured, over a range of sizes, that are difficult to 
resolve with confocal imaging.60 Interestingly, when incubated with BODIPY-Ahx-Chol 
under identical conditions, CHO cells did not show the same distribution as shown in Figure 
3.3C, D.  The probe emission from the membrane is weaker but appears to distribute more 
homogenously across the membrane with less well defined bright and dark regions. Staining 
  101   
 
of lipid droplets are evident as intense spherical features, in both CHO and HeLa images, this 
was confirmed from z-scanning which showed the features persisted outside the membrane. 
The difference between probe distribution we attribute to different membrane compositions 
between the two cell lines as HeLa is a cancer line and CHO a mammalian non-cancer line.  
The cholesterol concentration within the cell membrane is highly regulated and has been 
shown to be significantly upregulated in many cancers leading to increased lipid order, and 
caveolae are often highly prevalent in cancer cell lines.  In particular, detergent resistant/raft-
like domains have been shown to be particularly prevalent in multidrug resistant cancer cell 
lines.62–64 The distinctive membrane compositions lead to greater lipid order in the HeLa 
membrane compared to CHO.  Of note, for BODIPY-Ar-Chol in the absence of the C6 linker, 
the probe shows markedly different uptake and distribution. In both HeLa and CHO cells it 
permeates the membrane and localises with high selectively into lipid droplets (Figure 
S3.19). When co-stained with DiD, and focusing on the plasma membrane of the cell, no 
emission from BODIPY-Ar-Chol could be observed (Figure S3.20), confirming that without 
the linker, the complex does not localise in the plasma membrane in live cells. 
 
 
Figure 3.4 Live HeLa (A,B,C) and CHO cells (D,E,F) stained with BODIPY-Ahx-Chol and co-
stained with DiD, (800 nM). Overlay of channels (A,D), the BODIPY-Ahx-Chol channel in green 
(B,E) and the DiD channel in red (C,F). 
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3.3.5 Probing Cholesterol in the Cell Membrane 
In order to understand further if the BODIPY-Ahx-Chol localises in cholesterol-rich domains 
at HeLa and CHO cells, we examined if the presence of cholesterol in the membrane affected 
dye distribution. This was achieved by treating the cells with methyl-β-cyclodextrin (MβCD) 
which is widely used for cholesterol depletion from the plasma membrane, as it forms soluble 
host-guest inclusion complexes with cholesterol with high affinity.46,65 It can also deplete 
lipids from the membrane but typically to a significantly lower extent than cholesterol.66  
Cells were initially exposed to MβCD (10 mM) for 1 hour in cell media, then removed and 
washed prior to adding the BODIPY-Ahx-Chol (5 µM) to the cells. Following probe 
exposure, the cells were washed and imaged without fixing.  Figure 3.5A, B show HeLa cells 
after 2 h exposure to MβCD stained with BODIPY-Ahx-Chol. Focusing on the lower plasma 
membrane of the cell as before, after 2 hours, emission is still observed from the membrane 
and dark/unstained regions remain visible, similar to the non-cholesterol depleted cells 
(Figure 3.3A, B) however emission overall is less intense, and heterogeneity of the emission 
is much less defined.  
Furthermore, emission for BODIPY-Ahx-Chol also appears to have migrated to the plasma 
membrane periphery, with bright spots located along the cell membrane. A similar pattern of 
behaviour has been reported for other ordered-domain sequestering probes upon cholesterol 
depletion with MβCD.67 After 4 h of MβCD cholesterol depletion, the dark regions 
completely disappear, and the emission intensity of BODIPY-Ahx-Chol although more 
homogeneously distributed has decreased (4.6 a.u. to 3.3 a.u. intensity), shown in Figure 3.5 
E,F.   
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Figure 3.5 Live HeLa and CHO cells treated with MCD. Cells were treated with 10 mM MCD 
and after 2 h (A,B HeLa, C,D CHO) and 4 h, altering the cholesterol distribution in HeLa cells (E,F) 
and CHO cells (G,H). A,C,E,G showing the BODIPY-Ahx-Chol channel, and B,D,F,H showing the 
overlay of BODIPY-Ahx-Chol and background channels. 
 
Overall, our data suggests that BODIPY-Ahx-Chol uptake to the cell membrane is greater at 
the cholesterol rich cell membrane of HeLa cells and that the probe associates in part, with 
cholesterol rich domains at the membrane of HeLa cells. The distribution observed here is 
also similar to that reported by Malim et al68 and Yoshida et al69 in HeLa cells. This is 
consistent with literature where between 50 and 80 % of cell membranes have been shown 
on the basis of detergent solubilisation resistance or fluorescence polarisation to be 
cholesterol rich raft-like domains.8,70  
In the case of CHO cells, treatment with MβCD appears to have an opposite effect, where 
emission intensity Figure 3.5 G, H from the CHO membrane post treatment (3.9 a.u. to 6.9 
a.u. intensity) increases.  It is not clear why behaviour in the two cell lines on cholesterol 
depletion is so different, but our observations concur with data reported by Hao et al67 who 
observed similar behaviour in CHO cells, that they speculated might be due coalescence of 
cholesterol bounded domains into microdomains on MβCD treatment.  
Fluorescent lifetime imaging was carried out to evaluate the lifetime of BODIPY-Ahx-Chol 
from within live cells to gain further insight into the probe distribution in the membrane. 
Figure 3.6 show the false-color FLIM images of the lifetime distributions within the cell. The 
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fluorescent decay in cells fit to a bi-exponential decay, although in some cases a third 
component of the fit (lifetime <70 ps) was required to account for 
autofluorescence/background scatter (Table S3.1). 
Table 3.2 Fluorescent lifetime of BODIPY-Ar-Chol and BODIPY-Ahx-Chol within phase separated 
GUVs containing both liquid-disordered and liquid-ordered domains, as well as live HeLa cells. 
 
 
The majority of the longer-lived components comes from the membrane structures, and 
notably, BODIPY-Ahx-Chol has a slightly longer lifetime of 5.85 ns in HeLa cells (Figure 
3.6A) compared to 5.3 ns in CHO cells (Figure 3.6B). This is consistent with the higher 
content of cholesterol at the HeLa membrane which may contribute different phase 
distributions within the membrane.  Comparing these lifetimes to those derived from GUVs, 
the longer lifetime of 4.9 ns is shorter than that observed in cells presumably reflecting the 
far greater complexity of the cell membrane, its diversity of lipids and roughly 50 % in dry 
weight, protein at the membrane interface.  Interestingly, after exposure to MβCD, the 
longer-lived component of 5.85 ns in HeLa cells decreases to 5.35 ns while the shorter 
component of 2.31 ns is not affected.  
However, in CHO cells, the lifetime of the major component increases post MβCD treatment 
(Table S3.1). This data reflects the confocal images where in CHO cells the lipid regions 
appear to cluster together upon cholesterol redistribution, this is not observed for HeLa cells. 
For HeLa cells, most of the long-lived component continues to arise from the membrane post 
MβCD treatment, and the shorter lifetime of 2.23 ns is attributed to lipid droplet structures 
from inside the cells, which was observed in both confocal and FLIM images (Fig 3.6C). 
 
Ex/Em GUV DOPC/SM/Chol 4/4/2 mol %  HeLa Cells 
 λ 
(nm) 
τ 
(ns) 
 
τAmp 
(%) 
 τ  
    (ns)  
  
                       τAmp 
 
                        (%) 
BODIPY-
Ar-Chol 
(Ld phase) 
503/511-
570 
τ1 = 4.74 ± 0.17 
τ2 = 1.77 ± 0.15 
57 
43 
 
- 
- 
- 
- 
BODIPY-
Ahx-Chol 
(Lo phase) 
503/511-
570 
τ1 = 4.92 ± 0.04 
τ2 = 1.74 ± 0.15 
54 
46 
 τ1 = 5.85 ± 0.15 
τ2 = 2.31 ± 0.37 
 
67 
33 
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Figure 3.6. Fluorescent lifetime images (FLIM) of a live HeLa cell (A) and CHO cell (B) stained 
with BODIPY-Ahx-Chol (5 µM, 2h), and after treatment with MβCD (10 mM) in HeLa (C) and CHO 
(D) cells. 
3.4 Conclusions 
We demonstrate a simple approach by which phase preference of a simple BODIPY 
fluorophore can be switched between Lo or Ld at phase forming liposomes, by altering the 
number of carbons in the alkyl linker separating probe from cholesterol.  The cholesterol 
conjugation is achieved via a simple and very mild Steglich esterification reaction via probe 
carboxyl and cholesterol hydroxyl.  Phase preference in domain forming giant unilamellar 
vesicles (GUVs) confirmed, using a commercial Ld marker as reference, > 90 % Ld 
selectivity for BODIPY-Ar-Chol, where the probe is directly ester linked to cholesterol, 
which is reversed leading to approximately 80 % Lo partitioning when a hexyl linker is 
inserted between probe and cholesterol in the case of BODIPY-Ahx-Chol. The preference 
for cholesterol rich membrane persists in live cells where changing linker length has a 
profound impact on the localisation of the probe.  Unlike liposomes, BODIPY-Ar-Chol does 
not stain the membrane of live cells but is directed through the membrane and localises in 
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lipid droplets in HeLa and CHO cell lines. Whereas BODIPY-Ahx-Chol is retained at the 
membrane in live cells where it partitions into regions from where the Ld probe DiD is 
excluded.  The preference for cholesterol rich membrane is confirmed on treatment of HeLa 
cells with cyclodextrin.  Raft like, detergent resistant domains are highly prevalent in cancer 
cells and BODIPY-Ahx-Chol membrane distribution varied significantly between HeLa and 
CHO which is a non-cancer cell.   Robust fluorescent probes that can partition into and 
distinguish raft-like domains in live cells as well as in biophysical models are rare and can 
facilitate use of advanced microscopy applied to detailed studies into domains and rafts in 
cells.  Ordered lipid domains are particularly prevalent in cancer and in multidrug resistant 
cells, probes that can be targeted to such domain should be useful in developing insights into 
such models. Ongoing work will explore whether the principle of extending a long linker to 
a lipophilic probe can be applied more universally to broader families of fluorescent probes. 
3.5 Experimental Section 
 
3.5.1 Preparation of Giant Unilamellar Vesicles (GUVs) 
Lipid stock solutions were prepared in chloroform. For preparation of Ld/Lo phase separated 
GUVs, 1-2-dioleoyl-sn-glycero-3-phosphocoline (DOPC), brain sphingomyelin (BSM) and 
cholesterol (Chol) were mixed in a molar ratio 4:4:2 to a final concentration of 5 mM. For 
partitioning (confocal fluorescence microscopy) studies BODIPY-Ar-Chol or BODIPY-Ahx-
Chol, along with the lipophilic tracer dye DiD, were all included respectively at a 
concentration of 0.1 mol % in lipid content prior to electroformation. DiD is a commercially 
available lipid stain that is known to associate strongly within the liquid-disordered phase of 
GUVs. It was therefore chosen in order to identify this phase during confocal fluorescence 
microscopy experiments. GUVs were formed by electroformation using the Vesicle Prep Pro 
(VPP) (Nanion Technologies, Munich, Germany). The lipids were added in 1.5 μL droplets 
onto a pair of conductive ITO slides and dried in a desiccator under vacuum for 45 minutes. 
The ITO slides were carefully placed in contact at an angle to avoid air bubbles. A voltage 
was then applied and increased over 10 minutes from 0 V to 3 V and then held for 125 
minutes. The protocol was carried out at 37 °C. Once electroformation was completed, the 
GUVs were removed, diluted with 0.23 mM glucose solution and 0.5 % agarose solution and 
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deposited on glass coverslides for imaging. For uptake studies, GUVs were prepared as 
described above by electroformation using DOPC 100 mol %. 
3.5.2 Confocal Microscopy of Giant Unilamellar Vesicles (GUVs) 
Fluorescent confocal imaging was carried out using a Leica TSP inverted (DMi8) confocal 
microscope. A 100-oil immersion objective was used for all measurements. A white light 
laser was used to excite the dyes. The excitation and emission wavelengths (λex/λem) were 
as follows: 503/511–570 for BODIPY-Ar-Chol and BODIPY-Ahx-Chol, and 644/ 665–700 
nm for DiD  
3.5.3 Fluorescence Lifetime Imaging 
Fluorescence lifetime imaging was carried out using a PicoQuant 100 system attached to 
Leica TSP inverted (DMi8) confocal microscope using a 100 x oil immersion objective. Each 
sample was acquired for 120 s with a 512 x 512 resolution. A 503 nm white light laser was 
used to excite the GUV samples. Data was analysed using PicoQuant Symphotime software. 
3.5.4 Cell Culture and Imaging 
HeLa cells were cultured using MEM media supplemented with 2% L-glutamine, 1% MEM 
non-essential amino acid solution, 10% foetal bovine serum and 1% penicillin-streptomycin 
and grown at 37°C with 5% CO2. Cells were harvested or split at 90% confluency using 
0.25% trypsin for 5 minutes at 37°C. 
3.5.5 Confocal Microscopy for Cell Imaging 
For imaging, cells were seeded at 7 x 104 cells in 2 mL culture media on 35 mm high precision 
glass-bottom dishes (Ibidi, Germany). BODIPY-Ar-Chol and BODIPY-Ahx-Chol were 
added to cell media to give a final concentration of 5 μM and left to incubate in the absence 
of light at 37°C with 5 % CO2. Cells were washed twice with supplemented PBS (1.1 mM 
MgCl2 and 0.9 mM CaCl2) prior to imaging. The cells were imaged live using a Leica TSP 
DMi8 confocal microscope with a 100X oil immersion objective lens. Cells were excited at 
497 nm and emission was collected between 518-610 nm. Co-staining with DiD was carried 
out by adding 800 nM DiD in PBS to the cells for 20 minutes at 37°C prior to imaging. DiD 
was excited at 640 nm and emission was collected between 660-760 nm. 
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3.5.6 FLIM of Live Cells 
HeLa and CHO cells were prepared and stained as described for confocal imaging. Live 
FLIM images were acquired using SymphoTime 200, Picoquant, attached to a Leica TSP 
DMi8 confocal microscope using a 100X oil immersion objective. Each FLIM image was 
acquired for 2 minutes with 512 x 512 resolution, at 10 MHz and Resolution 16. A 497 nm 
laser was used to excite the sample, and emission collected between 520-620 nm. The data 
was analysed using PicoQuant Symphotime software. Lifetimes were fit to a tri-exponential 
decay, until a χ2 value of 0.9-1.1 was achieved. 
3.5.7 Synthesis of BODIPY-Ar-COOH (1): 
Synthesis was carried out according to modified procedure.45 DCM (60 mL) was purged with 
nitrogen for 30 min. To 4-formylbenzoic acid (500 mg, 3.3 mmol), 2,4-dimethylpyrrole (453 
µL, 7.45 mmol) and TFA (cat.) was added and kept at room temperature while stirring for 5 
hours. After the 5 hours tetrachlorobenzoquinone (p-chloranil) (973 mg, 3.95 mmol) in DCM 
(20 mL) was added and the reaction mixture was left to stir for 30 minutes followed by the 
addition of BF3.OEt2 (6.4 mL) and Et3N (6.4 mL).  The reaction mixture was left to stir 
overnight. The crude mixture was washed with water (2 x 50 mL), dried over MgSO4 and 
concentrated to dryness via vacuum. The crude product was purified on a silica gel by column 
chromatography eluent: DCM/MeOH (30:1). Yield: purple solid, 158.3 mg (0.43 mmol, 13 
%).  1H NMR :(600 MHz, DMSO-d6) δ(ppm): 9.60 (t, 2H); 9.22 (d, J=1.8 Hz, 2H); 8.61 (d, 
J=1.8 Hz, 1H); 8.42 (d, J=3 Hz, 1H); 7.97 (d, J=7.8 Hz, 2H); 7.77-7.75 (m, 2H ); 7.45 (d, 
J=7.8 Hz, 2H); 5.96 (s, 2H); 2.52 (s, 6H); 1.44 (s, 6H). 13C NMR :(150 MHz, DMSO-d6) 
δ(ppm):  155.8, 152.7, 152.6, 143.2, 143.0, 142.6, 142.1, 141.7, 141.3, 140.9, 140.1, 135.3, 
133.8, 131.3, 130.2, 130.1, 129.0, 128.2, 127.6, 127.5, 127.0, 124.2, 121.4, 118.9. HR-MS 
(ESI-TOF) m/z: calculated for C20H19BF2N2O2 369.1512 found 369.1586 
3.5.8 Synthesis of BODIPY-Ar-Chol (2): 
Bodipy-Ar-COOH (1) (100 mg, 0.272 mmol) and DMAP (32 mg, 0.0272 mmol) was 
dissolved in DCM (4 mL). Cholesterol (240 mg, 0.599 mmol) in DCM (2 mL) was added to 
the reaction mixture and stirred at room temperature for 5 min. Following this DCC (70 mg, 
0.299 mmol) in DCM (2 mL) was added and the reaction mixture was left to stir overnight). 
The crude mixture was with brine solution, dried over MgSO4 and concentrated to dryness. 
The crude product was purified on a silica gel by column chromatography eluent: 
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DCM/MeOH (30:1). Yield: orange solid, 78 mg (0.104 mmol, 38 %).  1H NMR :(600 MHz, 
CDCl3) δ(ppm): 8.17 (d, J=8.3 Hz, 2H); 7.39 (d, J=8.2 Hz, 2H); 5.98 (s, 1H); 2.50 (d, J=7.2, 
2H); 2.05-1.97 (m, 3H); 1.98-1.92 (m, 1H); 1.87-1.74 (m, 2H); 1.61-1.56 (m, 2H); 1.540-
1.46 (m, 4H); 1.36 (s, 6H); 1.35-1.32 (m, 2H); 1.28-0.98 (m, 16H); 0.92 (d, J=6.5 Hz, 3H); 
0.86 (q, J=9.4, 2.7 Hz, 3H); 0.69 (s, 3H). ). 13C NMR :(150 MHz, CDCl3) δ(ppm):  165.37, 
139.53, 130.32, 128.29, 122.96, 121.46, 75.17, 56.71, 56.16, 50.07, 43.34, 39.52, 38.22, 
37.64, 36.68, 36.19, 35.79, 31.95, 31.90, 28.22, 28.01, 27.89, 24.30, 23.83, 22.80, 22.55, 
21.01, 19.37, 18.72, 14.55, 11.88. HR-MS (ESI-TOF) m/z: calculated for C47H63BF2N2O2 
737.5055 found 737.5029 
3.5.9 Synthesis of 4-formylphenyl-Ahx (4): 
4-formybenzoic acid (1 g, 6.66 mmol), EDC (2.55 g, 13.32 mmol) and NHS (1.53 g, 13.32 
mmol) was stirred in DCM (50 mL) at room temperature for 1 h. Following this 6-methyl-
aminohexanoate (1.45 g, 9.99 mmol) in DCM (2 mL) was added with TEA (800 μL) and the 
reaction mixture was stirred overnight. The crude mixture was washed with 3 x 50 mL water, 
dried over MgSO4 and concentrated to dryness. The reaction was monitored by TLC and 
NMR and was carried through to the next step without purification. To the reaction product 
was added MeOH (15 mL) and slowly the addition of 0.1 M LiOH in MeOH/H2O (3:1). The 
reaction was stirred at room temperature for 4 h. The reaction mixture was concentrated to 
dryness and then rehydrated with water. The solution was acidified using conc. HCl until pH 
2 was achieved. The product was obtained via filtration and purified on a silica gel by column 
chromatography eluent: DCM/MeOH (80:20). Overall yield for two steps: white solid, 164 
mg (0.62 mmol, 9.4 %). 1H NMR :(600 MHz, DMSO-d6) δ(ppm): 12.02 (s, 1H); 10.08 (s, 
1H); 8.67 (t, J=12 Hz, 1H); 7.99 (q, J=17.8, 8.7 Hz, 4H); 3.26 (q, J=14.8, 7.6, 2H); 2.21 (t, 
J=7.3, 2H); 1.54-1.52 (m, 4H); 1.339-1.335 (m, 2H). 13C NMR :(150 MHz, DMSO-d6) 
δ(ppm):  193.39, 174.94, 165.73, 140.18, 138.11, 129.85, 128.34, 34.08, 29.18, 26.48, 24.71. 
HR-MS (ESI-TOF) m/z: calculated for C14H17NO4 264.1241 found 264.1236 
3.5.10 Synthesis of BODIPY-Ahx (5): 
DCM (30 mL) was purged with nitrogen for 30 min. To 4-formylbenzoic acid (500 mg, 3.3 
mmol), 2,4-dimethylpyrrole (144 µL, 1.4 mmol) and TFA (cat.) was added and kept at room 
temperature while stirring for 5 hours. After the 5 hours tetrachlorobenzoquinone (p-
chloranil) (171 mg, 0.69 mmol) in DCM (20 mL) was added and the reaction mixture was 
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left to stir for 30 minutes followed by the addition of BF3.OEt2 (1.74 mL) and Et3N (1.74 
mL).  The reaction mixture was left to stir overnight. The crude mixture was washed with 
water (2 x 50 mL), dried over MgSO4 and concentrated to dryness via vacuum. The crude 
product was purified on a silica gel by column chromatography eluent: DCM/MeOH (30:1 
followed by DCM/MeOH (90:10). Yield: orange solid, 37.6 mg (0.078 mmol, 13.4 %). 1H 
NMR :(600 MHz,CDCl3) δ(ppm): 7.91 (d, J= 8.2 Hz, 2H);  7.38 (d, J=8.16 Hz, 2H); 6.30 (t, 
J=5.58, 1H); 5.97 (s, 1H); 3.51-3.48 (m, 2H); 2.54 (s, 1H); 2.39 (t, J=7.9 Hz, 2H); 1.70-1.67 
(m, 4H); 1.48-1.47 (m, 2H); 1.35 (s, 6H). 13C NMR was not obtained due to poor solubility. 
HR-MS (ESI-TOF) m/z: calculated for C26H32BF2N3O3 482.2412 found 482.2427 
3.5.11 Synthesis of BODIPY-Ahx-Chol (6): 
To a stirred solution of 5 (32.6 mg, 0.067 mmol,) and DMAP (8.1 mg, 0.0067 mmol) in DCM 
(4 mL), a solution of cholesterol (51mg, 0.134 mmol) in DCM (2 mL) was added. The 
reaction mixture was stirred for 5 min at room temperature. A solution of DCC (15.2 mg, 
0.073 mmol) in DCM (2 mL) was added and the mixture was stirred at room temperature 
overnight. The crude mixture was washed with brine solution, dried over MgSO4 and 
concentrated to dryness via vacuum. The crude product was purified on silica gel by column 
chromatography eluent: DCM/MeOH (90:10). Yield: orange solid, 22.9 mg (0.026 mmol, 
40.2 %). 1H NMR :(600 MHz, CDCl3) δ(ppm): 7.94 (d, J=8.2 Hz, 2H); 7.39 (d, J=8.2 Hz, 
2H); 6.38 (t, J=5.46 Hz, 1H); 5.98 (s, 2H); 5.36 (d, J=4.8 Hz, 1H); 4.63-4.57 (m, 1H); 3.67-
3.64 (m, 2H); 3.52 (q, J=14.2, 7 Hz, 2H); 2.55 (s, 6H); 2.34-2.30 (m 4H); 2.02-1.91 (m, 2H); 
1.86-1.79 (m, 3H); 1.72-1.66 (m, 4H); 1.50-1.40 (m, 7H); 1.35 (s, 6H); 1.25 (s, 6H); 1.17-
1.07 (m, 7H); 1.01 (s, 3H); 0.91 (d, J-6.7 Hz, 3H); 0.86 (dd, J=6.5, 2.9 Hz, 7H); 0.66 (s, 3H). 
13C NMR :(150 MHz, CDCl3) δ(ppm):  173.23, 166.56, 155.93, 142.92, 140.35, 139.60, 
138.26, 135.22, 131.07, 128.47, 127.77, 122.78, 121.46, 76.81, 74.06, 56.63, 56.13, 49.99, 
42.30, 39.71, 39.52, 38.18, 37.00, 36.61, 36.18, 35.80, 34.30, 31.84, 29.71, 28.97, 28.24, 
28.02, 27.82, 26.23, 24.26, 24.16, 23.83, 22.83, 22.57, 21.02, 19.32, 18.72, 14.64, 14.13, 
11.85. HR-MS (ESI-TOF) m/z: calculated for C53H74BF2N3O3 850.5852 found 850.5870 
3.6 Supporting Material 
Supplementary data associated with this chapter can be found in Appendix B. 
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4.1 Abstract 
Lipid droplets are dynamic subcellular organelles that participate in a range of physiological 
processes including metabolism, regulation and lipid storage.  Their role in disease, such as 
cancer, where they are involved in metabolism and in chemoresistance, has emerged over 
recent years. Thus, the value of lipid droplets as diagnostic markers is increasingly apparent 
where number and size of droplets can be a useful prognostic.  Although diverse in size, LDs 
are typically too small to be easily enumerated by conventional microscopy. The advent of 
super-resolution microscopy methods offers the prospect of detailed insights but there are 
currently no commercial STED probes suited to this task and STED, where this method has 
been used to study LDs it has relied on fixed samples.  Here, we report a pyrene-based 
ceramide conjugate PyLa-C17Cer, that stains lipid droplets with exceptionally high precision 
in living cells and shows excellent performance in stimulated emission depletion microscopy.  
The parent compound PyLa comprises a pyrene carboxyl core appended with 3,4-
dimethylaminophenyl.  The resulting luminophore exhibits high fluorescent quantum yield, 
mega-Stokes shift and low cytotoxicity.  From DFT calculations the Stokes shifted 
fluorescent state arises from a dimethylaniline to pyrene charge-transfer transition.  While 
the parent compound is cell permeable, it is relatively promiscuous, emitting from both 
protein and membranous structures within the living mammalian cell.  However, on 
conjugation of C17 ceramide to the free carboxylic acid, the resulting PyLa-C17Cer, remains 
passively permeable to the cell membrane but targets lipid droplets within the cell through a 
temperature dependent mechanism, with high selectivity.  Targeting was confirmed through 
colocalisation with the commercial lipid probe Nile Red.  PyLa-C17Cer offers outstanding 
contrast of LDs both in fluorescence intensity and lifetime imaging due to its large Stokes 
shift and very weak emission from aqueous media. Moreover, because the compound is 
exceptionally photochemically stable with no detectable triplet emission under low 
temperature conditions, it can be used as an effective probe for fluorescence correlation 
spectroscopy (FCS). These versatile fluorophores are powerful multimodal probes for 
combined STED/FCS/lifetime studies of lipid droplets and domains in live cells. 
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4.2 Introduction 
Lipid droplets (LDs), are ubiquitous intracellular organelles rich in neutral lipids.  In recent 
years, it has emerged that LDs have much more diverse and far-reaching activity in the cell 
than merely fat storage.1–3 Evidence of their broader importance originated with discovery of 
the protein, perilipin on the surface of LDs within adipocytes.  This focused investigation 
onto their role in metabolic activity and sites of protein-protein interactions.2,4,5  The 
functions of LDs are still emerging but it is now known that they play a pivotal role in protein 
interactions, signalling, lipid metabolism and are important in immunity, infection and 
inflammation, cardiovascular disease, cancer, fatty liver disease and diabetes.6–16 In 1963, 
Aboumrad et al. observed a high quantity of lipid vesicles in the cytoplasm of a type of 
mammary carcinoma17, one of the first to link high cellular lipid content and cancer. The 
correlation between accumulations of a high number of LDs in the cytoplasm of cancer cells 
compared to normal cells has been observed in cell lines including in breast and prostate 
cancers.18 Lipid droplets play an important role in facilitating the abnormal metabolic 
pathways of cancer cells and are implicated in chemoresistance. Therefore, both from the 
perspective of interrogative tools for understanding lipid droplets and as 
diagnostic/prognostic markers, fluorescent probes capable of selectively targeting lipid 
droplets are important.   
Since both quantity and size of LDs are diagnostic parameters, probes that resolve LDs with 
high contrast from background are required. Because LDs vary widely in size from nano-
dimensioned to micron dimensioned size (notwithstanding the very large mono-droplets 
observed in adipocytes) super-resolution methods are essential for detailed quantitative 
insights.19,20 Furthermore, as LDs are motile and change dynamically in living cells probes 
amenable to live cell super-resolution are necessary and this can be a significant challenge.  
Conventional confocal fluorescence microscopy is restricted by the Abbe or diffraction limit, 
meaning that only features separated by approximately λ/2NA can be resolved, where  is 
the exciting wavelength and NA the numerical aperture of the microscope objective.  Optical 
super-resolution microscopy methods permit sub-diffraction resolution of nano-scale 
structure and a number of these methods have been commercialised.  One of the first reports 
of super resolution imaging of LDs applied structured Illumination Microscopy (SIM) and 
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demonstrated the value of using super-resolution imaging to interrogate these organelles.21 
However, SIM has a physically imposed resolution limit of about half that achievable by 
diffraction limited microscopy although specialised fluorescent probes are not necessary for 
this method.22   
In terms of versatility, STimulated Emission Depletion (STED) microscopy is an attractive 
method as it has achieved resolutions as low as 29 nm23 with 50 nm resolution readily 
achievable on commercial instruments which are well suited to LD evaluation. And, 
importantly for LDs, unlike other higher resolution localisation microscopy methods such as 
STORM and PALM, STED is amenable to live cell and dynamic investigations. 
In STED, the depletion laser must match the emission wavelength of the luminophore in 
order to stimulate its emission and the resolution of the image scales with the inverse square 
root of the STED depletion laser intensity.  Consequently, a STED probe must be capable of 
withstanding the high intensity depletion irradiation (>MW/cm2).24 Such powers typically 
cause accelerated photobleaching of commercial organic probes.  
Photobleaching/photochemistry is particularly prevalent in probes with small Stokes shifts, 
where if the STED laser excites too close to probe absorbance this can lead to population of 
undesirable excited states.  In practice, this is avoided to an extent in STED by stimulating 
emission at a wavelength far into the red tail of the emission dye spectrum.  However, this 
limits resolution as the probability of stimulated emission is reduced with reduced resonance 
of the depletion dye and the emission maxima of the probe.   
We recently reported that ruthenium(II) polypyridyl luminophores are well suited as STED 
probes due to their photostability and their large Stokes shift which permitted closer 
resonance between the emission maxima of the dye and depletion wavelength without 
excitation into destructive dark states.  The limitation of such complexes however is their 
relatively low emission quantum yields. In this work we report on the use of new pyrene-
based charge transfer fluorophores that provide high emission quantum yields but retain the 
large Stokes shift ideally needed for STED microscopy. Furthermore, contrast can be 
improved through either highly selective targeting of the probe or through environmental 
sensitivity where the probe only emits from the target site.  The probes presented in this work 
have both properties, they are selective for and emit strongly from the LD environment.25–30 
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STED is also amenable to multi-modal methods including combination with fluorescence 
correlation spectroscopy (FCS) to permit diffusional studies on probe within sub-diffraction 
limited volumes.  We, therefore, also evaluated the probes in the context of FCS which makes 
similar demands of the probe. This technique has been used extensively to study protein 
binding31–34, toxin interactions35,36 and lipid membrane structure.37–40 Fluorophores 
compatible with FCS must have high absorption coefficients and high quantum yields to 
facilitate the low nanomolar concentrations of probe used in such studies.  As per STED, 
probes must be photostable and lack low-lying dark, particularly triplet-excited states, both 
of which negatively impact the accurate fitting of the autocorrelation functions collected 
during measurements.  In addition, aggregation of the probe should be avoided, previously a 
significant problem for pyrene-based probes. 
For lipid droplet imaging BODIPY derivatives and particularly Nile Red41,42 are probably the 
most widely used probes.  Whereas BODIPY 493/503 has a small Stokes shift43 Nile Red is 
attractive because it emits only weakly from aqueous media and emits in the red region. 
However, both dyes have low selectivity, localising in general lipid regions resulting in 
strong background signal. Both are also prone to aggregate-induced quenching at high 
concentrations.  This is a drawback when probes are highly targeted as local concentrations 
may be high.  
Pyrene is a widely studied fluorophore because of its stability, high quantum yield and noted 
propensity for excimer-led photophysical changes. It has not been widely applied to 
bioimaging as it is excited and emits in the ultraviolet region. However, by exploiting the 
capacity to functionalise the pyrene core, synthetic strategies have been developed to  design 
pyrene donor-acceptor complexes that have displayed good photophysical characteristics 
with large absorption coefficients, high fluorescence quantum yields and large Stokes 
shifts.44–49 Pyrene has been exploited both as an acceptor in such complexes and as a mediator 
supporting donor and acceptor substituents.50,51 The design and synthesis of the push-pull 
pyrene dye PA by Niko et al demonstrated the potential for pyrene derivatives to be used as 
successful lipid probes, outperforming the commercially available Laurdan with excellent 
photophysical properties.52 However due to their tendency to form excimers53,54, pyrene 
derivatives have not been successfully used for FCS.  
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Herein, we present a charge-transfer pyrene compound with a mega Stokes-shifted emission 
and its C17 ceramide derivative, that fulfil the demands of both STED and FCS. They are 
highly emissive and remarkably photostable. Both are cell permeable. The parent is non-
selective and emits from lipid and proteinaceous regions whereas the ceramide derivative 
very specifically targets lipid droplets in live mammalian cells providing outstanding 
resolution and high contrast STED images of LDs in live cells.  PyLa-C17Cer also shows 
excellent FCS performance.  This is to our knowledge the first pyrene-lipid conjugate, to be 
applied to single molecule counting FCS or STED microscopy. This work demonstrates the 
value of exploiting charge transfer luminophores in STED imaging and in exploiting lipid 
conjugates for targeting lipid droplets.  
4.3 Results and Discussion 
4.3.1 Synthesis 
The structures of PyLa (4) and Pyla-C17Cer (5) and their route to synthesis are shown in 
Scheme 1. Oxidation of pyrene-1-carboxaldehyde (1) with potassium permanganate in 
pyridine and water gave pyrene-1-carboxylic acid (2) in yields similar to reported literature.55 
The compound was prepared as a free carboxylic acid unit to enable subsequent conjugation.  
Bromination of the 3, 6 and 8-positions of pyrene-1-carboxylic (2) was carried using four 
equivalents of bromine in nitrobenzene.46 Substitution of bromine dramatically reduced the 
solubility of the compound preventing characterisation.  The resulting yellow powder 
presumed to be 3, 6, 8-tris-bromo-pyrene-1-carboxylic acid was submitted to Suzuki-
Miyaura coupling with 4-(dimethylamino)phenyl boronic acid and 
tetrakis(triphenylphosphine) palladium (0) (Pd(PPh3)4) as the catalyst to afford PyLa (4) as a 
yellow powder in good yield (57 %). Lipid conjugation at the free carboxylic acid at the 1-
position was carried out via Steglich esterification following a procedure previously 
reported.56,57 Wherein, Pyla (4) was treated with N,N’-dicyclohexylcarbodiimide and 4-
dimethylaminopyridine in the presence of C17 ceramide using DCM as the solvent.  
 
  122   
 
 
Scheme 4.1 Synthesis of novel PyLa (4) and its ceramide conjugate PyLa-C17Cer (5). (i) KMnO4, 
H2O, piperidine, 100 °C, 12 h, 57 %; (ii) Br2, nitrobenzene, 140 °C, 5 h, 84 %; (iii) 4-
dimethylaminophenylboronic acid, K2CO3, Pd(PPh3)4, toluene/EtOH (2/1), 110 °C, 24 h, N2, 57 %; 
(iv) DMAP, DCC, DCM, 25 °C, 24 h, 8.6 %. 
 
 
Purification of the product by column chromatography on silica gel using eluent 
(DCM/MeOH 90:10) resulted in the isolation of PyLa-C17Cer (5) as a yellow powder with a 
yield of 8.6 %. 
PyLa (4) was characterised by 1H and 13C NMR, high-resolution mass spectrometry and high-
performance liquid chromatography. 1H NMR analysis confirmed the 18 protons contributed 
to six methyl groups on the dimethylamino phenyl groups, evident by three large singlets at 
3 ppm. The carboxylic acid proton can also be seen at 13 ppm. High-resolution mass 
spectrometry returned the expected mass of 604.2964.  1H NMR analysis confirmed the 
expected aliphatic peaks attributed to the C17 ceramide tail of PyLa-C17Cer (5) at 1.2 ppm, 
while Maldi-TOF mass spectrometry returned the expected mass as 1136.8058 ([M+)]. High-
performance liquid chromatography was carried out to determine purity, wherein a single 
peak eluted at 3.1 min with no evidence of the parent dye present.  Full synthetic protocols 
and detailed characterisation spectra are provided in Appendix C. 
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4.3.3 Photophysical Characterisation 
Figure 4.1 (a) and (b) show the absorption and emission spectra of PyLa and PyLa-C17Cer in 
acetonitrile and dichloromethane and data across a range of solvents is shown in Table S4.1 
in supplementary information.  Consistent with a charge transfer transition, in both cases 
broad unstructured absorption features with intense mega-Stokes shifted emission (Stokes-
shift exceeding 100 nm) in all solvents is observed.  Both compounds show negative 
solvatochromism, the effect is weak in PyLa-C17Cer but pronounced in PyLa. Where the λmax 
absorbance centred at 396 nm in methanol and 399 nm in acetonitrile shifts to 431 nm in 
dichloromethane.  This is unexpected for a charge transfer transition58, but the effect is 
attributed to changes to the pKa of the carboxyl unit in PyLa with solvent. The carboxylate 
is expected to be stabilised in high dielectric and protic solvents with the neutral carboxyl 
prevalent in low dielectric, non-protic solvent. This conclusion is supported by DFT 
computation, shown below, that reflects comparable shifts to higher energy for the 
carboxylate compared to the acid.  Correspondingly, the apparent solvatochromism is much 
weaker in PyLa-C17Cer as it lacks the carboxyl moiety, although the trend, but for acetonitrile 
is similar.   
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Figure 4.1 Absorption (dashed line) and fluorescence emission (solid line) spectra of (a) 4 and (b) 5 
in DCM red (-) and CH3CN black (-). Both dyes were absorbance matched at 0.4 absorbance intensity 
(a.u). 
 
In methanol, emission is centred at 525 nm and 510 nm for PyLa and PyLa-C17Cer 
respectively.  The emission maxima shift to 552 nm and 562 nm in DCM for each compound 
and markedly red shifts in acetone to 580 nm and 592 nm respectively.  In acetonitrile the 
behaviour diverges, with PyLa centred at 520 nm and PyLa-C17Cer at 582 nm.  Notably, as 
shown in Table S4.1, the emission quantum yield and lifetime had also significantly 
diminished for PyLa-C17Cer in this solvent. 
Both probes show oxygen independent fluorescence lifetimes that show modest solvent 
dependence, particularly for PyLa-C17Cer, (Table S4.1). The fluorescence lifetimes of PyLa 
and PyLa-C17Cer at 4.42 ns and 4.34 ns are comparable in DCM, but the lifetimes of PyLa-
C17Cer are shorter by approximately 1 ns compared with PyLa in more polar solvents. PyLa-
C17Cer has notably lower quantum yield than PyLa. In DCM, the quantum yield of PyLa is 
0.4 compared with 0.1 for PyLa-C17Cer and in acetonitrile PyLa exhibits a quantum yield of 
0.49, compared to 0.08 for PyLa-C17Cer.  
77 K emission spectra were obtained for both compounds (Figure S4.16–17) in butyronitrile. 
Importantly from the perspective of fluorescence correlation spectroscopy, there was no 
evidence of a phosphorescent state, as previously discussed, population of triplet states can 
contribute interference in the autocorrelation function in FCS.59  
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The molar extinction coefficient of PyLa was determined as > 20,000 M-1 cm-1 in 
dichloromethane, acetonitrile and methanol.  This value is close to the literature value for 
other donor acceptor pyrene-based compounds.46 Ceramide substitution reduces the 
extinction coefficient across all solvents.  Notably, both PyLa and PyLa-C17Cer are almost 
non-fluorescent in aqueous media. Representative spectra on water titration into methanol 
solutions are shown in supplemental materials (Figure S4.13-4.14).  Since Density Functional 
Theory (DFT) calculations, vide infra, on PyLa showed very little difference in the lowest 
energy levels in both dichloromethane and water, an electronic explanation for the impact of 
water on emission is not clear. (full details of calculations in Appendix C).  Aggregation 
induced quenching due to hydrophobic-hydrophobic interactions in water, may be the origin 
of the emission extinction. However, in organic solvent, plots of absorbance and emission 
intensity versus concentration of PyLa and PyLa-C17Cer in dichloromethane over the range 
0.5-50 µM yields a straight line (Figure S4.19) suggesting aggregation does not occur in non-
polar media at least.  Pyrene tends towards π-π stacking and excimer formation53,59 and 
absence of this behaviour here, in organic solvent at least, is attributed to the orthogonal 
orientation of the dimethylaminophenyl groups attached to PyLa. 
4.3.4 Computational Studies 
To gain more insight into the optical behaviour of the compounds, DFT calculations were 
performed on the parent pyrene, PyLa, both in the acid or carboxylate form and as a model 
methyl ester derivative to mimic the ceramide compound.  The main purpose of these 
calculations was to model the lowest energy singlet excited state and to understand if the 
solvent medium causes a significant change to the optically accessible excited state that might 
account for the very low emission intensity in water and the negative solvatochromism 
observed for PyLa. A number of basis sets were used ranging from the large 6-
311++G(d,p)60,61 to the more tractable double zeta quality 6-31G(d)62–64 or LanL2DZ65 sets.  
TDDFT methods were used to characterise transition to singlet excited states and these 
transition energies were used to simulate the UV/visible spectrum.66,67 The hybrid density 
function method (B3LYP) or the Coulomb attenuated model (camB3LYP) were used or these 
calculations. Calculations were conducted using two solvent media water and 
dichloromethane (DCM).  All model chemistries (method/basis set combinations) explored 
underestimated the transition energy to the lowest energy singlet state by approximately 3000 
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cm-1 and consequently the smaller 6-31G(d) or LanL2DZ basis sets were considered adequate 
to simulate the UV/visible spectra (see supporting information for the excitation energies 
obtained using various basis sets, Appendix C).  The large 6-311++G(d,p) basis set was used 
to model the electron density difference maps of the excited states of the acid and the 
carboxylate of PyLa. 
Notably, the simulated UV/visible spectra of the acid in either water or DCM are similar. 
The spectrum in water suffers a minor bathochromic shift of some 200 cm-1 (Figure 4.2).  
The nature of the lowest energy singlet state is identical in both solvents and consists mainly 
of a dimethylaminophenyl-to-pyrene charge-transfer state.  
 
 
Figure 4.2 The simulated UV/visible spectra (TDDFT/B3LYP/6-31G(d)) of PyLa in water (blue) and 
DCM (orange) showing the electron density difference map for the first singlet excited state where 
the regions of reduced electron density compared to the ground state are indicated in blue and the 
regions of increased electron density in red; the vertical energy to the first excited state is indicated 
by an orange vertical line,  the simulated spectrum of the carboxylate species in water is presented as 
in black including the electron density difference map for its first singlet excited state indicated by 
the black vertical line; the spectrum of the methyl ester is red. 
 
Consistent with experiment, a substantial hypsochromic shift of some 2300 cm-1 measured 
in methanol and acetonitrile reflects the formation of the carboxylate species in these 
solvents.  The simulated spectrum of the carboxylate ion exhibits a similar (2700 cm-1) shift 
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compared to the acid spectrum.  Construction of an electron density difference map for its 
first singlet excited state confirmed that this state is also a dimethylaminophenyl-to-pyrene 
charge-transfer state.   
Media that can facilitate the ionisation of the parent acid will result in the observed 
hypsochromic shift of both the absorption and emission bands.  Obviously, this effect is not 
observed in the ester compound which lacks an acid functionality, which also explains the 
much weaker solvent shifts for the ceramide derivatives. To explain the large Stoke’s shifts 
observed for these systems, we examined the changes to the structure in moving from the 
ground-state (GS) to the lowest singlet state (S1) in the parent acid compound in water.  These 
calculations were conducted at the B3LYP/LanL2DZ level.  The principal structural change 
in moving from the GS to S1 involves a change to the relative planes of the pyrene centre and 
the dimethylaminophenyl units.  In the ground state, the average angle between these planes 
is 48.7  while in S1 the angle drops to 44.7 . Using the optimised structure for S1, the 
TDDFT method was applied to provide the energy difference between the GS at the S1 
geometry and the S1 at the S1 optimised geometry.  The Stoke’s shift predicted by calculation 
is 1800 cm-1, compared to an experimental shift of approximately 4000 cm-1. It should be 
stressed that the experimental shift reflects shifts in the band maxima which are subject to 
distortion because of vibronic coupling.  
Thus, as described, computational data indicate that the reduced emission in water is not due 
to a change in the origin of the optical transition.  However, given that the anionic form of 
the parent pyrene persists in water it is unlikely that aggregation of the pyrene moieties will 
occur in aqueous environments.  Although there is some evidence in baseline drift that might 
suggest that aggregation is occurring in water the Stokes shift of the emission would preclude 
self-quenching in aggregates, indeed the material remains emissive in the solid state. A 
similar light-switch behaviour has been observed for cationic ruthenium systems, where 
triplet emission is quenched in water but returns when the complex is in a hydrophobic 
environment.  The ability of water to quench emission has been explained by the interaction 
of the luminescent excited state with water molecules which are hydrogen bonded to 
uncoordinated peripheral nitrogen atoms on complex.  It is possible that a similar process is 
responsible for quenching the luminescence for the pyrene compounds. Irrespective of the 
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origin of the reduced emission in water the phenomenon is useful in the context of STED 
imaging. 
4.3.5 Cell Studies 
To determine uptake and distribution of the Pyrene series in live cells, HeLa cells were 
incubated with 2 μM of PyLa or PyLa-C17Cer for 1-6 h to determine uptake. As the Pyrene 
dyes emit extremely weakly from aqueous solution, live uptake was initially difficult to 
follow, however emission from the cytoplasmic structures can been seen after 1 h incubation 
(Figure S4.22) at 37 °C in the absence of light. Figure 4.3A shows PyLa in live HeLa cells 
after 2 h incubation where it appears to emit brightly from the endoplasmic reticulum. On 
ceramide substitution, PyLa-C17Cer distributes inside the cell in a similar pattern to PyLa, 
but in addition localises to brightly stained spherical punctate spots (Figure 4.3B). Both dyes 
are nuclear excluding and emit brightly within the cell giving high quality images at a low 
concentration of 2 µM. The Pearson’s Coefficient, which quantifies the degree of 
colocalisation of two fluorophores, was determined to be 0.88 for PyLa and 0.63, for PyLa-
C17Cer with ER Tracker Red, signifying a higher degree of colocalisation for PyLa in the 
ER. In addition, PyLa-C17Cer also localises at lipid droplets present in some of the cells, 
attributed to the bright punctate spots.  This was confirmed by colocalisation studies with 
Nile Red (Figure 4.3E), a well-known commercial lipid droplet stain. To understand the 
mechanism of uptake, HeLa cells were incubated with PyLa and PyLa-C17Cer at 4 °C for 4 
h. Interestingly, although both dyes remained permeable to the cell membrane at this 
temperature, there was negligible change in uptake rate or localisation in PyLa at 4 oC  
(Figure S4.23) whereas uptake of PyLa-C17Cer was reduced at this temperature and 
distribution changed, with appearance of PyLa-C17Cer only in the ER without localisation to 
LDs.  This result suggests that in both PyLa and PyLa-C17Cer cell permeation is by passive 
diffusion whereas uptake by LDs is temperature dependent. This may be due to an active 
mechanism at the LDs or due to the reduced fluidity of the droplet membranes at lower 
temperature.  
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Figure 4.3 Confocal imaging of live HeLa cells stained with 2 μM PyLa (A) and PyLa-C17Cer (B) 
for 2 h. For LD stimulation HeLa cells were incubated with TNF-α (10 ng/mL) for 16 h in media, and 
then incubated with PyLa-C17Cer for 2 h (C). All samples were excited at 405 nm and the emission 
was collected between 520 -620 nm. Pyrene series emission channel and overlays with background 
fluorescence are shown. Colocalisation of PyLa-C17Cer with ER Tracker RED (D), with PyLa-C17Cer 
in green, ER Tracker Red in red, and their colocalisation in yellow. Colocalisation of PyLa-C17Cer 
and Nile red in HeLa cells treated with TNF-α (E), with PyLa-C17Cer in green, Nile Red in red, and 
their colocalisation in the lipid droplets in yellow 
 
The cytotoxicity of PyLa and PyLa-C17Cer was assessed using the Alamar Blue assay. After 
24 h exposure to the Pyrene series, PyLa has an IC50 value of 88.1 µM, while interestingly, 
PyLa-C17Cer exhibits a higher IC50 value of 47.9 µM in the absence of light. This may be 
due to the lipophilicity of the ceramide derivative.  Nonetheless it was found that 80 % of the 
cells remained viable after 24 hours exposure to 5 μM of PyLa-C17Cer, which is more than 
twice the concentration of 2 μM required for imaging (Figure 4.4). Cell viability was 
compromised at concentrations exceeding 25 μM for PyLa-C17Cer where it decreases to 60 
% but this level of cytotoxicity was not observed until 100 μM of PyLa.  The low toxicity 
under imaging concentrations over long exposure times will allow for imaging over long-
time frames. To date there have been relatively few reports of pyrene derivatives in cells, and 
those reported have shown to induce moderate toxicity on the cells.68,69    
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Figure 4.4 Cytotoxicity of PyLa and PyLa-C17Cer in live Hela cells over 24 h in the absence of light. 
Viability was determined using the Alamar Blue resazurin assay. (n=3). 
 
It is important to note that PyLa-C17Cer does not induce phototoxicity in HeLa cells (Figure 
S4.24-4.25). To confirm this, live HeLa cells stained with PyLa-C17Cer were irradiated (Ex 
405 nm, 0.06 mW/cm2 compared to 0.03 mW/cm2) at 5-minute intervals, then imaged to 
assess cell integrity using DRAQ 7, a commercial viability probe that only enters the nuclei 
of dead cells.  Cells remained viable after 30 minutes continuous irradiation, and cell 
morphology remained.  
To further confirm that the punctate spots observed in cells stained with PyLa-C17Cer were 
attributable to LDs, we stimulated inflammation in the cells to increase the number of LDs 
present using TNF-α (Bio-techne Ltd.).  TNF-α is a cell signalling protein that has been 
shown to increase production of LDs. 15 HeLa cells were incubated with TNF-α (10 ng/mL) 
for 16 h, and PyLa-C17Cer (2 μM) was added to the cells after stimulation. Figure 4.3C shows 
live HeLa cells, post this process, revealing a dramatic increase in the number of brightly 
emitting spherical features stained with PyLa-C17Cer. Co-staining with Nile Red further 
confirmed that PyLa-C17Cer and Nile Red colocalise (Figure 4.3E), with a Pearson’s 
Coefficient of 0.73.  Interestingly, this process was repeated using the parent compound 
PyLa, but it was found not to enter the LDs, instead remaining in the ER after TNF-α 
stimulation (Figure S4.26).  LDs are formed at the ER membrane, where neutral-lipid-
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synthesising enzymes are located.70 LD biogenesis occurs when neutral lipids accumulate 
between the two leaflets of the ER membrane, which are then thought to bud from the ER to 
form the cytosolic structures.71,72 The presence of the ceramide tail, a neutral lipid chain, 
likely promote  PyLa-C17Cer’s entry to the LD on TNF-α stimulated biogenesis facilitated 
by its localisation on the ER. As demonstrated, without the ceramide, the probe is unable to 
enter the LDs.  
To evaluate if the probes environment can be distinguished on the basis of fluorescence 
lifetime in the ER and LDs, fluorescence lifetime imaging of PyLa and PyLa-C17Cer was 
carried out in live cells. Figure 4.5 shows the confocal fluorescence image and the 
corresponding false-colour FLIM image of the dyes in live HeLa cells. The fluorescent 
lifetime of PyLa was measured to be 4 ns in the ER (Figure 4.5 A(iii)). On the other hand, 
PyLa-C17Cer exhibits bi-exponential fluorescent decay in the LDs of 3.18 ns and 5.9 ns, 
where 3.18 ns is the prevalent component of the emission decay (81 %), shown in Figure 4.5 
B(iii). As the lifetimes of the Pyrene series are not sensitive to oxygen, the changes in 
lifetimes can be attributed to the lipid environment of the cell. Figure 4.5 D shows the 3D 
FLIM of a group of lipid droplets stained with PyLa-C17Cer in a live HeLa cell. Here the 
distribution of the two lifetimes can be seen within the image, where the longer-lived 
component is localised at the surface and attributed to the tighter packed lipids at the interface 
of the lipid droplet (red), while the shorter component, which is more abundant is tentative, 
is attributed to the free lipids in the core of the LD (green).73–75 LDs can be found to form in 
clusters, and appear to fuse, a process called LD fusion, where the surface of the initial 
droplets become continuous and the contents merge.76 This process gives an elongated 
spherical profile to the LDs in the X-Z, which is seen in the 3D FLIM image that some LDs 
are spherical while others are non-elongated and spherical i.e. not in the fusion process (ESI 
Video 1). But in both types of LDs, the lifetime distribution remains the same. 
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Figure 4.5 FLIM imaging of PyLa and PyLa-C17Cer in live HeLa cells. The corresponding confocal 
images showing the Pyrene emission channels and overlay with backlight (A (i) and B (i)), the Pyrene 
emission channel only (A (ii) and B (ii)), and the false-colour fluorescent lifetime images (A (iii) and 
B (iii)). A close up of a group of lipid droplets (C (i)) highlighted in the white box in B (iii) and 3D 
FLIM Z-stack through a group of lipid droplets demonstrates the two distinct lifetimes (C (ii)) Scale 
bar 5 µm.  
 
4.3.6 STED Super-Resolution Imaging of Lipid Droplets in Live HeLa Cells 
Given the localisation of PyLa-C17Cer to LDs, which are sub-diffraction limit dimensioned, 
we examined the performance of PyLa-C17Cer as a STED nanoscopy probe.  In this regard, 
it is essential that the probe be suitable for live cell STED and so all of the subsequent 
experiment and discussion is based on live cells. Figure S4.17 shows the excitation and 
emission profile of PyLa-C17Cer in DCM and shows that the 660 nm STED depletion laser 
lies well with the red end of PyLa-C17Cer’s emission (___) profile. Live Hela cells were 
incubated with TNF-α (10 ng/mL) for 16 h, to insure a high number of LDs for imaging, and 
the cells were stained with PyLa-C17Cer (2 μM, 2 h). Images were obtained using a Leica 
TSP8 microscope with a 660 nm STED depletion laser, the cells were maintained at 37 oC 
during the entire process. Figure 4.6 shows the confocal and corresponding STED images of 
the resulting live HeLa cells. Both confocal and STED images demonstrate high quality 
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images at low concentrations and negligible background are obtained (A and B). Figure 4.6 
(D,F) focuses on a small region of interest containing LDs. In the confocal image (D) there 
appears to be a single, large LD with a diameter of 0.864 µm (blue arrow), however by 
applying STED imaging (F), it is evident that this feature is resolved into 3 distinct LDs with 
diameters of 0.339 µm, 0.385 µm, and 0.319 µm. Similarly, Figure 4.6 (H) shows a single 
LD unresolved under confocal, with a diameter of 0.801 µm that is resolved into two well-
distinguished LDs of similar size under STED (J), with diameters of 0.341 µm and 0.449 µm. 
The corresponding plot profile (K) clearly demonstrates the single LD from the confocal 
image (__) to be resolved to two LDs after applying STED (__). Figure 4.6 not only 
demonstrates a clear increase in the uniformity of LDs compared to confocal but also a 
significant increase in resolution is achieved by using PyLa-C17Cer and STED microscopy. 
This result is important as LDs are known to form in clusters and, the number of LDs has 
been demonstrated to be a prognostic marker for cancer aggression.76  
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Figure 4.6 Confocal versus STED images of PyLa-C17Cer in live HeLa cells. The blue and red arrows 
highlight regions of interest in the whole cell (A and B), and their corresponding images focusing on 
LDs (C and D) showing the improved resolution of LDs after applying STED (E and F). Scale bars 
= 10 µm and 1 µm. The comparison of confocal versus STED on a second HeLa cell (G and I) 
zooming in on what appears to be a single lipid droplet in the confocal image (H), is resolved to reveal 
two separate lipid droplets after applying STED (J). Scale bars = 10 µm and 1 µm. The corresponding 
plot profile (K) demonstrates the single LD in the confocal image (--) two resolved lipid droplets in 
the STED image (--) from a single lipid droplet in the confocal.  HeLa cells were stimulated with 
TNF-α (10 ng/mL) for 16 h prior to adding PyLa-C17Cer (2 µM, 2h), and was excited using a 405 nm 
laser, and depleted using a 660 nm STED laser. 
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To determine the average size of LDs, images were collected of many HeLa cells. The 
apparent diameter of LDs was measured (Image J) to obtain the full width half maximum 
(FWHM) for confocal and STED (Figure S4.31-4.32). We found that LD size ranged 0.41-
0.96 μm in confocal, with the average FWHM to be 0.537 ± 0.154 μm. However, STED 
greatly improved the resolution, where the range of size changed significantly to 0.294 - 0.52 
μm, and an average size of 0.384 ± 0.06 μm was recorded.  Therefore, enabled by the pyrene 
ceramide probe resolution was improved in cells by over 100 nm, with significant narrowing 
of the standard deviation of droplet radii.  
STED performance of PyLa-C17Cer indicates it has excellent photostability. Photo resistance 
is critical in a good STED probe as irreversible photoreaction inhibits stimulated emission 
and photostability is important for dynamic studies to enable repeated imaging/scanning over 
time. To confirm photo resistance, we compared the photostability of PyLa-C17Cer to that of 
Nile Red in live HeLa cells. The cells were imaged under STED conditions continuously for 
20 minutes with a pixel dwell time of 2.43 µs and 0.03 W/cm2 incident laser power to assess 
for photobleaching. Figure 4.7 shows the normalised log plot decays of the emission 
intensities at each frame for PyLa-C17Cer and Nile Red (Figure S4.34). As expected, the 
emission intensity for each, decreases with every acquired STED image. We determined the 
rate constants for photobleaching as 3 x 10-4 s-1 for PyLa-C17Cer and 1 x 10
-3 s-1 for Nile Red.  
The photostability of PyLa-C17Cer is shown to be as good as the commercial probe Nile Red 
under the same STED imaging conditions, with PyLa-C17Cer bleaching at a slower rate, with 
greater than 70 % of fluorescence intensity retained after 20 minutes of continuous 
irradiation, compared with less than 40 % for Nile Red. It is important to note that throughout 
STED irradiation, the HeLa cells were not compromised, with no evidence of phototoxic 
effects (Figure S4.34). This result is significant as it indicates the probe is suitable for 
dynamic STED imaging of live cells over extended periods. 
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Figure 4.7 Photostability of PyLa-C17Cer (●) and Nile Red (●) over 20 minutes of continuous STED 
imaging of live HeLa cells. The rate of decay was estimated by fitting the data to a first order decay 
model and rates of fluorescence intensity loss were determined as 1 x 10-3 s-1 for Nile Red compared 
with 3 x 10-4 s-1 for PyLa-C17Cer. Nile Red was excited at 560 nm and emission collected between 
580-670 nm. PyLa-C17Cer was excited at 405 nm, and emission collected between 520-620 nm.  
 
4.3.7 FLIM Studies at Lipid Bilayers 
As both PyLa and PyLa-C17Cer selectively stain lipid-rich regions in live mammalian cells, 
their ability to partition into artificial lipid membranes was also evaluated. Fluorescence 
lifetime imaging was carried out to ascertain the luminescent lifetimes of PyLa and PyLa-
C17Cer when incorporated into lipid bilayers; both at DOPC bilayers and phase-separated 
lipid composition of DOPC/SM/Chol 4:4:2 mol %.77 Figure 4.8 shows the false-colour FLIM 
images of both probes in phase separated lipid bilayers. The average lifetimes are reported in 
Table 4.2. The measured lifetimes of both PyLa and PyLa-C17Cer conform to bi-exponential 
decays and it is assumed that the contributing components, as with the LDs reflect the 
surrounding lipid environment and media. The short components of the decay ranging from 
0.89-1.20 ns were observed for both dyes in both DOPC 100 mol % and DOPC/SM/Chol 
4:4:2 mol % bilayers. This component is tentatively attributed to probes oriented at the lipid 
aqueous interface. The long component of the fluorescence decays and their % amplitudes 
are very similar for PyLa and PyLa-C17Cer across both lipid bilayer compositions.  In DOPC 
(100 mol %) PyLa exhibits a lifetime of 3.62 ns while PyLa-C17Cer is 3.93 ns.  Interestingly 
both dyes are longer-lived when partitioned into the phase separated composition at 4.03 ns 
for PyLa and 4.06 ns for PyLa-C17Cer.  This increase in lifetime is attributed to the increased 
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rigidity of the lipid bilayer due to the presence of liquid-ordered domains not present in 
DOPC 100 mol % bilayer.78 
 
 
 
 
 
 
Figure 4.8 Fluorescence lifetime imaging microscopy (FLIM) of PyLa on lipid bilayer of 
composition DOPC/SM/Chol 4:4:2 mol % (A) and PyLa-C17Cer on lipid bilayer of composition 
DOPC/SM/Chol 4:4:2 mol % (B). Both dyes were used at a concentration of 10 μM. FLIM image 
and lifetime were recorded with a 405 nm pulsed laser and the emission was collected using a band 
pass filter of 550 – 700 nm. 
 
Table 4.1 Fluorescent lifetimes of PyLa and PyLa-C17Cer in lipid bilayers DOPC 100 mol % and 
DOPC/SM/Chol 4:4:2 mol % 
 
 
 
 
 
 
 
 
4.3.8 Later Mobility of PyLa-C17Cer in Suspended Lipid Bilayers 
We then evaluated PyLa-C17Cer as a probe in fluorescence correlation spectroscopy whereby 
it was included in a microcavity supported lipid bilayer.33 Diffusion studies were carried out 
on DOPC 100 mol % bilayers and on DOPC/SM/Chol 4:4:2 mol % compositions suspended 
across the microcavities.  We have shown previously that MSLBs exhibit the fluidity of 
liposomes but with much improved stability and addressability.  The bilayers were labelled 
with PyLa-C17Cer at a concentration of 10 nM which constitutes approximately a ratio of 
  Ex/Em Bilayer 
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1:50,000 dye:lipid. To accurately identify and distinguish the bilayer at the top planar regions 
of the array and bilayer suspended over the cavities for the FLCS experiment, both 
reflectance and fluorescence images were recorded (Figure 4.7 A, B and C). Autocorrelation 
functions (ACFs) were then recorded for bilayer at each (planar and cavity) surface region. 
The ACFs obtained were fit to the 2-dimensional model described in equation 4.1 to obtain 
the lateral diffusion coefficient of PyLa-C17Cer in the bilayer. 
𝐺(𝜏) =
1
𝑁(1−𝑇)
[1 − 𝑇 + 𝑇𝑒
(−
𝜏
𝜏𝑇
)
] [1 + (
𝜏
𝜏𝐷
)
𝛼
]
−1
  Equation 4.1 
Where G(τ) is the autocorrelation function of fluorescence fluctuations; N is the average 
number of diffusing fluorophores in the effective volume; τ is the delay time; T is the fraction 
of molecules in the triplet state; α is the anomalous parameter; τD is the diffusion time of the 
molecules and τT is the decay time for the triplet state. The lateral diffusion of Py-C17Cer was 
obtained from transient 2-D time by the following relation D = ω2/τD. In order to determine 
the confocal volume using excitation 450 nm, a reference dye Atto-425 in water at 25 °C 438 
μm2.s-1 was used to calibrate the system.79 Figure 4.9 (g) shows the autocorrelation functions 
obtained for PyLa-C17Cer in MSLBs comprised of DOPC and the ternary lipid mixture.  The 
ACFs are of high quality with no evidence for artefactual effects, e.g. from triplet state.  
Fitting these functions (solid lines) to equation 4.1, the lateral diffusion of PyLa-C17Cer in a 
DOPC suspended lipid bilayer above filled microcavities was found to be 10.18 ± 1.8 μm2.s-
1.  The α coefficient was 0.99 ± 0.02, suggesting that the diffusion is normal Brownian. This 
value is consistent with previous reports for phospholipid membranes at microcavity arrays, 
e.g. for a DOPC lipid bilayers, Basit et al found comparable diffusion coefficient for DOPE-
Atto655 from FLCS.33 GUVs have also shown comparable diffusion values for membranes 
composed of DOPC.80  
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Figure 4.9 Confocal images of spanned lipid bilayers on microcavities array. (a) shows reflectance 
images collected using OD3 filter to position the laser on cavities; (b) and (c) shows the fluorescence 
of PyLa-C17Cer on lipid bilayers at 10 nM in (a) DOPC and (b) DOPC/SM/Chol. (d) and (f) shows 
the removal of background acquired by Fluorescence Lifetime Correlation Spectroscopy (FLCS): (d) 
photon histogram from time correlated single photon counting (TCSPC) and (f) FLCS filters from 
signal (black) and background (grey); (g) Normalised autocorrelation functions (ACFs) for PyLa-
C17Cer above buffer filled microcavities for DOPC (circles) and DOPC/SM/Chol (2:2:1) (triangles). 
Fitted ACF curves (dash line). h) Fluctuating photon-count time trace from a single point 
measurement (60 s) in the lipid membrane plan for DOPC lipid bilayer.  
 
By comparison at the ternary microcavity supported bilayer; DOPC/SM/Cholesterol (4:4:2), 
the diffusion coefficient of PyLa-C17Cer found was determined as 0.59 ± 0.09 μm2.s-1, with 
α coefficient of 0.87 ± 0.12.  The low diffusion and α values indicate that PyLa-C17Cer 
partitions to liquid-ordered domains, as similar mobility was found for such ordered phases 
in GUVs and α coefficient < 1, indicates that ceramide is in a lipid enclosed environment 
formed by obstacles to its diffusion.39 This is, to the best of our knowledge the first example 
of a pyrene-lipid conjugate applied to fluorescence correlation spectroscopy.  The suitability 
of this probe to FCS is consistent with its performance in STED where many of the same 
characteristics are required. Our data suggests that this probe is well suited to advanced 
microscopy techniques such as STED/FCS (Table 4.2).  
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Table 4.2 Fluorescence correlation spectroscopy data for PyLa-C17Cer in supported lipid bilayers of 
composition DOPC 100 mol % and DOPC/SM/Chol 4:4:2 mol %. 
 
*Concentration of dye used was 10 nM.  Mean and standard deviations obtained from at least 
20 different measurements across two samples. 
 
4.4 Conclusion 
Pyrene-based Donor-Acceptor derivatives that exhibit intense emission in non-aqueous 
media with weak emission from water were prepared as bio-probes for lipid droplets and 
membranous structures. When conjugated to a ceramide tail the pyrene probe specifically 
targets with high selectivity, lipid droplets in live cells.  The outstanding photostability of 
these compounds their mega-Stokes shifted emission and low background from aqueous 
regions enabled multi-modal imaging of LDs in live HeLa cells. To obtain super resolution 
imaging by stimulated emission depletion microscopy requires high photostability and it was 
shown that PyLa-C17Cer performs to a high standard when compared to Nile Red. The pyrene 
probe provided resolution of droplets separated by less than 80 nm and the average droplet 
diameter could be accurately measured wherein it had been assessed as 894 nm from confocal 
imaging, it was determined as 294 nm by STED.  The impact of TNF-α treatment of live 
HeLa cells in terms of droplet number and density could be readily followed using this probe 
by STED microscopy.  The high intensity emission of the probe meant it was suitable for 
imaging at concentrations much lower than its IC50.  Using fluorescence lifetime imaging 
two different lipid environments could distinguished.  Given the similar demands of STED 
and fluorescence correlation spectroscopy we then evaluated the ceramide probe for study of 
lipid diffusion using FCS using microcavity supported lipid bilayers labelled with the 
ceramide probe. The negligible triplet yield from the pyrene probes, their photostability and 
high quantum yielded excellent auto-correlation functions from which diffusion coefficients 
     
 
Lipid Bilayer Composition Diffusion 
Coefficient  
[µm²/s] 
α 
  
N 
  
  
PyLa-C17Cer DOPC 100 mol % 10.18 ± 1.8 0.99 ± 0.02  6.17 ± 2.38   
 
DOPC/SM/Chol 4:4:2 mol 
% 
0.59 ± 0.09 0.87 ± 0.12 3.64 ± 1.08   
  141   
 
for 100 % DOPC bilayers were obtained as 10.18 ± 1.8 compared with 0.59 ± 0.09 for a 
phase forming lipid composition of DOPC/SM/Chol 4:4:2 mol %. The data indicates 
significant partitioning of the ceramide probe into the liquid ordered phase of the MSLBs.     
This, to our knowledge, is the first example of a pyrene derivative used in super-resolution 
STED microscopy and one of the first examples of LD imaging in live cells by STED. The 
work highlights the value of using charge transfer luminophores in STED and demonstrates 
the use of ceramide to drive targeting of LDs.  We hope that the multimodal probes 
demonstrated here will facilitate dynamic studies into lipid droplet biogenesis and 
quantitation in live cells advancing understanding of these important organelles. 
4.5 Supporting Material 
Supplementary data associated with this chapter can be found in Appendix C. 
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Chapter 5:  pH Dependence of Dimethylaniline 
Functionalised Pyrene Fluorophores; Dual Colour 
Switching in Solution and SAMs 
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5.1 Abstract 
A pyrene charge transfer fluorophore with three ionizable N,N-dimethylaniline moieties was 
explored as an interfacial pH switch.  The parent carboxylate compound and the thiolated 
derivative were shown by spectroscopy combined with DFT calculation to be successively 
and reversibly protonated.  Protonation leads to progressive decrease of intensity of the 550 
nm centred N,N-dimethylaniline to pyrene charge transfer emission which on protonation of 
the third site, leads to extinction of this transition and evolution of an intense blue (450 nm) 
pyrene-centred emission.  Concomitant loss of the charge transfer absorbance was observed, 
and the changes are reversed on neutralisation of pH. A self-assembled monolayer of the 
thiolated derivative was prepared on gold and found from voltammetry of Ferricyanide/ 
Ferrocyanide probe to form close packed monolayers. The probe voltammetry, label-free 
electrochemical impedance spectroscopy of the film was monitored as a function of pH and 
progressive, but reversible protonation steps were reflected in decreasing film resistance.  
The Stokes shift of the probe prevents self-quenching so a broad, charge transfer fluorescence 
centred around 540 nm was recorded for the self-assembled monolayer whereas per solution, 
progressive and reversible reduction in intensity was observed.  The facile assembly, 
impedance and optical switching make these materials potentially interesting as on–off or 
two colour on-off-on fluorescence switches with potential applications in logic gates or in 
responsive surface applications.  
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5.2 Introduction 
Molecular switches are the functional units of molecular logic gates exemplified in the 
ground-breaking work of de Silva et al.1 In organic-based molecular logic gates, switches 
that modulate fluorescence signal in response to external stimuli such as pH, ions, potential 
or light are widely explored.2–7  The most common format is a single colour process, where 
the fluorescence signal is modulated between on and off states in response to stimuli.8–11  An 
attractive alternative, as it is less prone to artefact, e.g. from background in the dark state, is 
to use multicolour luminophores that can switch between at least two well resolved emissive 
states.12  
In the context of pH there are very many examples of pH induced on-off fluorescence 
switches,13–16 but fewer that exhibit multiple emissive states. 17,17–19 
The immobilisation of fluorescent switches at conducting surfaces is a facile means to 
interface the molecular with the macroscopic leading to read (external stimuli) write 
(response) signal that have application across diverse domains from molecular opto-
electronics to biosensing.14,20  
Pyrene is an attractive and widely used fluorophore because of its well understood 
photophysics, its intense, long lived and solvent sensitive emission and tendency to form 
fluorescent excimers.21  Pyrene has featured in a number of charge transfer derivatives 
functionalised with donor groups that reduce the energy gap between the frontier orbitals 
leading to compounds that exhibit large Stokes shifts and high quantum yields.19,22–25  
We previously demonstrated that functionalising pyrene with three dimethylaniline moieties 
generated a charge transfer compound with desirable photophysical properties, including 
mega-Stokes shifted fluorescence, high quantum yield and excellent photostability that 
rendered them suitable for diverse imaging applications including fluorescent confocal 
microscopy, stimulated emission depletion spectroscopy (STED) and fluorescence 
correlation spectroscopy (FCS).26   
Dimethylamino (DMA) groups are ionisable and where they participate in charge transfer 
transitions this can have a profound effect on the absorbance and photophysics of the donor-
acceptor compound.27 We were therefore interested to understand if sequential ionisation of 
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the of the pyrene could enable it to serve as a switch.  We report herein on the pH dependent 
photophysics, in solution and on immobilisation at an interface, of two pyrene derivatives, 
the previously reported 3,6,8-tris(4-(dimethylamino)phenyl)-pyrene-1-carboxylic acid 
(PyLa)26 and its newly synthesised thiol derivative 3,6,8-tris(4-(dimethylamino)phenyl)-
pyrene-octanethiol (PyLaOT). Both fluorophores bear three electron dononating N,N-
dimethylaniline groups that have been covalently linked via Suzuki-Miyaura coupling to the 
pyrene chromophore acting as an extended-bridge to the carboxylic acid or octanethiol group 
at the 1-position.  
The absorption and emission properties of PyLa and PyLaOT as a function of solvent and 
pH are described. In addition, the pH-dependent fluorescent and electrochemical impedance 
properties of SAMs of PyLaOT on a gold surface is reported. Detailed photophysical and 
electrochemical interrogation are supported by theoretical insights from time dependent 
density functional theory (TD-DFT) calculations. Our data indicates sequential protonation 
of the compound leads to switchable and reversible fluorescent and optical changes that are 
also active in interfacial films PyLaOT.   
 
 
Figure 5.1 Structure of pyrene dyes PyLa (1) and PyLaOT (2). 
 
5. 3 Results and Discussion 
 
5.3.1 Synthesis 
PyLa (1) was synthesised as previously reported and thiolated using an amide coupling 
reaction with PyLa and 8-amino-octhanethiol using PyBOP coupling. PyLaOT was prepared 
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by via an amide coupling reaction with PyLa and 8-amino-octhanethiol using PyBOP in N,N-
dimethylformamide at room temperature over 24 h. PyLaOT (2) was characterised by 1H and 
13C NMR and Maldi-TOF mass spectrometry. Detailed synthesis and characterisation spectra 
are provided in the Electronic Supplementary Information (Appendix D). 
 
 
5.3.2 Computation and pH dependent Absorbance 
To gain insight into the pH dependent ground state absorption properties of PyLa, TD-DFT 
calculations on the fully optimised ground state equilibrium geometries of PyLa and its 
mono- (PyLa13, PyLa16 and PyLa18), di-protonated (PyLa236, PyLa238 and PyLa268) and 
tris-protonated forms (PyLa31) were performed (see  Figure 5.2, Figure S5.7 and 
Tables S5.1-6). The nomenclature is as follows: the first number indicates the total positive 
charge (number of attached protons), whereas the following number(s) indicate(s) the 
position(s) of the attached protons(s). The vertical excitation energies and oscillator strengths 
of PyLa were obtained from TD-DFT calculations (20 lowest excited states) using a triple-ζ-
valence-polarisation (TZVP) basis set based on the integral equation formalism of the 
polarizable continuum model (IEFPCM) of acetonitrile. The calculations were performed by 
means of four functional with different amounts of Hartree-Fock exchange: B3LYP (20%), 
PBE0 (25%), M06-2X (54%)31 and CAM-B3LYP (19-65%). As the experimental absorption 
spectrum of PyLa in acetonitrile is very well described using the CAM-B3LYP hybrid 
functional (cf. Figure S5.6), the TD-DFT simulations of the mono-, di- and tris-protonated 
forms were performed on this level of theory. To describe the influence of different 
mesomeric forms; PyLa13, PyLa16 and PyLa18 or PyLa236, PyLa238 and PyLa268 on the 
ground state absorption properties, their oscillator strengths were statistically weighted using 
the Boltzmann distribution as defined in equation (1), where pi is the probability of state i, Ei 
the energy of state i (cf. Table S5.2), kB the Boltzmann constant, T the temperature and n the 
number of investigated derivatives belonging in each case to one total charge. 
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Equation 5.1  
 
TD-DFT simulations on PyLa indicate, that lowest energy absorbance originates from the S1 
state attributed to a charge-transfer (CT) state originating from the DMA substituents in the 
3-, 6- and 8-position (HOMO) to the pyrene moiety (LUMO).  This agrees with previous 
assignment of a mono DMA substituted pyrene reported by Techert et al25. The shoulder at 
around 370 nm is assigned to a CT state from the DMA substituent in the 6-position to the 
LUMO of the pyrene (see Figures S5.5–7 and Table S5.1)). The width of the lowest energy 
absorption band can be related to superimposition of different electronically coupled states 
due to the free rotation between the DMA and the pyrene moiety (inhomogeneous spectral 
line broadening). An angle of 65° leads to the largest electronic coupling between the donor 
and acceptor moiety.25  In Figure 2 the simulated absorption spectra of PyLa (A) and its tris-
protonated species (D) as well as the Boltzmann statistically weighted simulated absorption 
spectra of the mono- (B) or di-protonated species (C) are plotted and compared to 
experimental data, which was obtained from PyLa (50 µM) in acetonitrile titrated against 
known concentrations of perchloric acid.‡  Due to overlapping protonation equilibria 
isolation of pure protonations states experimentally was not possible, but the spectra 
correspond to points along the pH titration where spectral change had plateaued (Appendix 
D).  The experimental spectra show the PyLa at pH 5.5, can be attributed predominantly to 
the mono-protonated species, at pH 4.4 to the di-protonated and pH 1.5 to the tri-protonated 
species.  By adding at least one equivalent of acid, i.e. on protonation of the carboxylate to 
form uncharged PyLa species, the absorption bands with maxima at 262 nm (4.73 eV) and 
400 nm (3.10 eV) are bathochromically shifted by 0.05 and 0.21 eV, respectively. TD-DFT 
simulate a similar bathochromic shift by 0.21 eV when going from the PyLa-anion to PyLa.  
At pH 5.5 the absorption maximum red-shifts to 408 nm. A similar shift of 0.04 eV is 
observed in the simulated vertical excitation energies when transforming the neutral PyLa 
into the mono-protonated derivatives PyLa13, PyLa16 and PyLa18 (Figure 5.B). Of note, 
DFT calculations predict similar ground state energies for those cations (∆Emax = 3 meV). At 
pH 4.4 the absorption feature at around 408 nm forms a bathochromically shifted shoulder 
on the main absorption band centred around 380 nm. This absorption feature is shifted 
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hypsochromically as the pH is decreased to 1.5. According to TD-DFT results the absorption 
feature at around 408 nm can be assigned to  contributions of both, the S1 states of PyLa13, 
PyLa16 and PyLa18 as well as  PyLa236, PyLa238 and PyLa268 (Figure 5.2B and 5.2C) and 
the maximum at 380 nm can be attributed to the tri-protonated species PyLa3368 which 
dominates at pH 1.5 (Figure 5.2D). Overall, TD-DFT calculations predict a progressive 
hypsochromic shift of 0.34 eV when going from PyLa to PyLa3368, which is in good 
agreement with the experimentally observed shifts.    
 
Figure 5.2 (A) TD-DFT simulated UV-Vis spectra of PyLa with experimental (-) spectrum in 
acetonitrile (c = 50 μM). (B) Simulated UV-Vis spectra (B3LYP/TZVP//CAM-B3LYP/TZVP in the 
IEFPCM of acetonitrile) of the monoprotonated species PyLa13, PyLa16 and PyLa18 in comparison 
to the experimental UV-Vis spectrum of PyLa in acetonitrile at apparent pH 5.5 (c = 50 μM). (C) 
Simulated UV-Vis spectra (B3LYP/TZVP//CAM-B3LYP/TZVP in the IEFPCM of acetonitrile) of 
the di-protonated species PyLa236, PyLa238 and PyLa268 in comparison to the experimental UV-
Vis spectrum of PyLa in acetonitrile at apparent pH 4.4 (c = 50 μM). (D) Simulated UV-vis spectra 
(B3LYP/TZVP//CAM-B3LYP/TZVP in the IEFPCM of acetonitrile) of the tris-protonated species 
PyLa31 in comparison to the experimental UV-Vis spectrum of PyLa in acetonitrile at apparent pH 
1.5 (c = 50 μM). Chemical structures for B and C can be found in Appendix D Figure S5.7. 
As expected, PyLaOT shows similar pH dependent absorbance spectra to PyLa. Although 
the spectra are cleaner and exhibit a pseudo-isosbestic point (because of super-imposed 
  155   
 
equilibria a true isosbestic point is not observed) around 400 nm.  This is because without 
the carboxylate, there is one less ionisation step. The neutral species exhibits an absorption 
maximum at 418 nm. This value remains the same at pH 5.5. However, a decrease in intensity 
is observed. By pH 4.8 the maximum is bathochromically shifted by 50 meV to 424 nm with 
a further decrease in intensity. At pH 4 the absorption feature at 418 nm is replaced by an 
intense, structured band with a maximum at 384 nm. This maximum is blue-shifted by 
50 meV to 378 nm at pH 1.5 (Figure 5.3B). 
In phosphate buffered saline (PBS) solution both, PyLa and PyLaOT show similar behaviour, 
although the evolution of the spectral features appears more complicated, because of aqueous 
solvation. The absorption maximum of PyLa in PBS at approximately 417 nm can be seen to 
undergo a decrease in intensity and red-shift with decreasing pH (Figure S5.13). Loss of the 
absorption feature at 417 nm occurs below pH 3.0, at which point the solution becomes 
colourless (Figure S5.19).  
A blue-shifted absorption shoulder with a maximum at 380 nm appears and increases in 
intensity with increasing pH. Behaviour again is similar for PyLaOT (Figure S5.15). 
Extraction of ground state and excited state pKa values from the data is difficult because of 
superimposition of multiple equilibria. Instead, comparison of calculated and experimental 
data was used to identify pH at which each ionisation state was predominant. Obviously at 
neutral and acidic pH the neutral and fully protonated species could be isolated. In subsequent 
studies we use pH 7.4, pH 5.5, pH 4.4 and pH 1.5, those at which the individual neutral, 1+, 
2+ and 3+ states of the compounds are dominant. Notably, the pH induced changes are 
reversible. The absorption spectrum of the neutral species was recovered on addition of 
excess of base (Figure S5.15-16). 
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Figure 5.3 Absorption and emission spectra of PyLa (1) (A,C) and PyLaOT (2) (B,D) in acetonitrile 
using titrations of perchloric acid. Both absorption spectra (A,B) show decrease in absorbance max 
and slight red-shift with decreasing pH. Disappearance of this absorbance shoulder is observed below 
pH 4 with the formation of a pyrene like absorbance max at approximately 378 nm which then 
increases in intensity with decreasing pH. The emission maxima of both PyLa (C) and PyLaOT (D) 
decreases with decreasing pH. At pH 4 the charge-transfer emission band at 520-552 nm is replaced 
by a band in the UV region at approximately 426-430 nm, which resembles the emission of a pyrene 
core. This emission band the increases with decreasing pH. Excitation and emission slit widths were 
set to 2.5 nm and 5 nm PyLa (C) and PyLaOT were excited at 384 nm and 392 nm respectively to 
coincide as close as possible to isosbestic point. All samples were (c = 50 μM). * Signal difference is 
so great that the pyrene signal saturates the detector.   Figure S5.20 shows pyrene emission   at lower 
slit width. 
 
5.3.3 Photophysical Characterisation 
The photophysical properties of PyLa and PyLaOT are summarised in Table S6 (Appendix 
D). As reported for PyLa, both compounds exhibit broad, unstructured and intense mega-
Stokes shifted emission that persists across a range of solvents.  The absorbance spectra of 
PyLa, noted previously, exhibits an unexpected negative solvatochromism32, where for 
example, λmax of PyLa centred at 396 nm in methanol and ethanol shifts to 431 nm in 
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dichloromethane. For PyLaOT in the same solvents, the effect is far less pronounced, λmax 
shifts from 398 and 404 nm to 410 nm respectively for these solvents indicating as before 
that the unusual solvatochromism and can be attributed to changes of the pKa of the carboxyl 
group of PyLa with solvent. DFT calculations shown above indicate that the carboxylate is 
stabilised in high dielectric and protic solvents with the neutral carboxyl prevalent in low 
dielectric, non-protic solvent. 
Both dyes exhibit single exponential, oxygen independent fluorescence decays within the 
range 2-4.5 ns (Table S5.7). The lifetimes of PyLa and PyLaOT are comparable in more polar 
solvents such as 1-butanol and 2-propanol, where the lifetimes of PyLa are 2.7 ns and 2.4 
respectively compared to 2.7 ns and 2.1 ns for PyLaOT. The lifetimes of PyLaOT tend to be 
approximately 1 ns shorter than PyLa across a range of solvents. The most noticeable 
difference is in dichloromethane where PyLa exhibits a lifetime of 4.4 ns which is nearly 
double that of PyLaOT (at 2.6 ns). As expected, the quantum yields for the charge transfer 
emissions (in neutral solution) follow similar trends. For example, PyLa exhibits a quantum 
yield of 0.4 in DCM compared to quantum yield of 0.73 for PyLaOT.  77 K emission spectra 
obtained for both probes (Fig. S5.9-10) show that across a range of solvents, the expected 
hypsochromatic shift is obtained with no evidence of phosphorescence.33 
 
5.3.4 pH-Dependent Fluorescence in Solution 
The effect of pH on the fluorescence of the probes was investigated under analogous 
conditions to the absorbance studies.  Figure 3 shows that the fluorescence intensity of PyLa 
and PyLaOT decreases with decreasing pH in acetonitrile, until the charge-transfer emission 
band at approximately 520 nm for PyLa and 552 nm for PyLaOT is eventually extinguished 
below pH 4.  At this pH, an intense emission feature centred at approximately 430 nm grows 
in with decreasing pH and maximises at pH 1.5. According to the experimental and 
computational results on the pH dependent absorption properties, this emission feature is 
assigned to the tris-protonated species. The emission changes are reversible and charge 
transfer emission is restored when the solution is neutralised.  (Figure S5.13-16).  Notably, 
the emission for the fully protonated form is very intense and its maxima and computation 
indicate that it is a pyrene π-π* centred transition. Exciting at 384 nm, the pyrene centred 
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emission, shows vibrational progression (433 nm and 458 nm), with no evidence of excimer 
emission.  This is not surprising, given the 3+ charge on the complex and orthogonal 
orientation of the substituents which both would be expected to impede the self-association 
characteristic of pyrene. 
Thus, between the extremes of pH 7.4 and pH 1.5 the compounds exhibit two colour pH 
switching. The behaviour, albeit weaker for the CT transition, is observed in both aqueous 
and organic solvents. We previously reported PyLa displays negligible emission in deionised 
water.33 In PBS solution pH dependent changes in PyLa can be observed using maximum slit 
widths, however emission intensity is very weak compared to acetonitrile .  It is evident from 
the data that with each sequential protonation of the dimethylaniline group the emission 
intensity is reduced, which, as the emission wavelength of the CT transition does not change 
significantly, may be related to the reduction in oscillator strength of the CT transition as the 
contributing dimethylaniline groups are sequentially protonated.34,35   
5.3.5 Formation of the PyLaOT SAM sensing layer on gold 
In the interest of creating an interfacial switch, we explored if the pH dependent photophysics 
persist in a self-assembled monolayer (SAM) of PyLaOT.  PyLaOT SAMs were prepared by 
overnight adsorption of a micromolar concentration solution of the compound in contact with 
gold electrode.  As shown in Figure 5.4a, the modified electrodes were investigated at 
pH=7.4, 5.5, 4.4 and 1.5, corresponding approximately to the neutral, mono- di and tris-
protonated forms of PyLaOT, by cyclic voltammetry in contact with a 1:1 mixture of 1 mM 
[Fe(CN)6]
3-/4- as redox probe. The Ferricyanide/ Ferrocyanide probe was used to interrogate 
monolayer formation as the voltammetry of the compound is outside of the potential window 
of gold.26 The bare gold electrodes show the expected, reversible redox cycle for the probe 
(black) with a peak separation (Ep) of 65 mV. The formation of well-packed monolayer is 
confirmed from inhibition of the Faradaic process for the redox probe, evident as decreased 
current and increased peak-peak separation of [Fe(CN)6]
3-/4- voltammogram. The impact is 
pH dependent.  At pH 7.4. the cathodic and anodic current is decreased to about 30% of that 
of the unmodified electrode, and the peak-peak separation increases from 65 to 666 mV. For 
pH 5.5 (green), 4.4 (blue) and 1.5 (cyan), Ep was measured as 654, 595 and 137 mV 
respectively.  Notably, the Ep at pH 1.5, for tris-protonated PyLaOT is significantly 
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decreased to 137 mV compared to the neutral species (666 mV), although it remains quasi-
reversible.  Concomitantly, the peak current has recovered to roughly 70% of the bare 
electrode. This may be due to the combined effects of looser packing of the monolayer due 
to electrostatic repulsion between the charged compounds at acidic pH and electrostatic 
interaction of the [Fe(CN)6]
3-/4-  with the positively charged SAM.  
Crucially, on returning the SAM modified electrode to electrolyte at neutral pH (to evaluate 
the stability of the SAM under acidic conditions), we observed that the peak to peak 
separation is restored (consistent with inhibition of [Fe(CN)6]
3-/4-  electrochemistry at the 
SAM coated electrode) to almost identical values (Ep= 593 mV, magenta) as observed at 
neutral pH. This confirms the pH induced changes at the electrode are reversible and the 
SAM remains stable. 
We then evaluated the pH dependent impedance (EIS) of the SAMs.  Figure 5.4b shows the 
Nyquist plot for bare gold and SAM modified electrode in the presence of redox probe. The 
bare gold electrode (black open symbol) which can be described as a semicircle near the 
origin of real axis (Z) at high frequencies followed by a linear plot at low frequencies with 
a slope of unity. Nyquist plots for the gold electrode after SAM modification shows a clear 
change in impedance data as the surface of gold electrode blocks almost all faradaic current. 
This can be attributed to the insulating nature of PyLaOT SAM, again this is consistent with 
formation of a well-packed monolayer. The diameter of the semicircle for the PyLaOT 
modified gold electrode (Figure 5.4b and c, red open symbol) is a measure of the charge 
transfer resistance, RCT which is considerably increased compared to bare gold electrode. 
However, the low frequency region, is no longer linear and cannot be fit (dotted line) 
adequately by a simple Randles circuit as shown in dashed box in inset Figure 5.4c. 
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Table 5.1: Effect of pH on the resistance and capacitance of PyLaOT faradaic processes 
 
*Values derived from the modified Randles circuit except for the bare gold electrode and SAM 
modified electrode at pH 1.5 for which the data were fit to the unmodified Randles circuit. 
Similar observations were made for the SAM modified electrode at both pH of 5.5 and 4.4. 
Conversely, for the case of pH 1.5, the shape of the impedance data is the same as that of the 
unmodified electrode albeit with considerably higher RCT than that of bare gold electrode. 
Both bare gold and PyLaOT modified SAM at pH 1.5 (cyan) could be fit adequately using 
standard Randles circuit. However, the impedance measurement of the SAM modified 
electrode in the absence of redox probe (non-Faradaic) resulted in nonlinear behaviour which 
is not expected for a simple insulator (Figure 5.4d). 
Parameters Bare gold pH 7.4 pH 5.5 pH 4.4 pH 1.5 After wash 
Rs/ 159  20 70.8  1.2 75.3  1.8 75.4  1.3 72.5  1.2 76.6  1.4 
RCT/k 0.12  0.01 1.44  0.02 1.25  0.03 1.20  0.02 0.23  0.06 1.08  0.05 
C/µF 5.59  0.03 0.46  0.002 0.45  0.014 0.42  0.02 0.45  0.01 0.45  0.002 
RT/M  0.26  0.05 0.23  0.03 0.25  0.02  0.30  0.01 
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Figure 5.4 (a) The CVs of bare gold electrode and gold electrode after SAM modification at different 
pH’s in 1mM [Fe(CN)6]3-/4-  (1:1) and 0.1M KCl. Scan rate was 50 mV s-1. Nyquist plot represent the 
impedance spectra (imaginary versus real impedance) of bare gold and PyLaOT SAM with 1mM 
[Fe(CN)6]3-/4-  (1:1) mixture as redox probe in 0.1M KCl solution at varied pH (7.4, 5.5, 4.4 and 1.5). 
Frequency measured from 0.01 Hz to 104 Hz, with amplitude of 10 mV, applied potential 0.26 V 
versus Ag/AgCl. Inset shows the expanded region of(b). In all the cases experimental measured data 
points are shown as open symbol and solid line represents the fit to the modified Randles circuit. (c) 
Illustrates the experimental EIS data of PyLaOT SAM at pH 7.4 (open symbol), and the solid and 
dotted lines are the fit to the modified Randle circuit (inset) and standard Randles circuit (circuit 
within the dashed box, inset) respectively. Rs, solution resistance; RT resistance through the PyLaOT; 
RCT, charge transfer resistance; CPE, constant phase element; W, Warburg impedance. (d) Nyquist 
plot in the absence of redox probe for PyLaOT SAM at different pH in 0.1 M KCl. In each case, the 
experimental data (open symbol) were fit to the equivalent circuit shown. 
 
Nevertheless, the EIS data could be fit with a simple circuit (inset, Fig. 4d) comprising of a 
capacitor with a resistance in parallel. These results suggest that the presence of an additional 
internal resistance, RT, that can be added in parallel to the Randles circuit as shown in inset 
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of Figure 5.4c. The EIS data at pH 7.4, 5.5 and 4.4 then gives an excellent fit (solid line in 
Figure 5.4c and 5.4b) to the experimental data using the modified Randles circuit. For 
quantitative insight, we extracted the resistance as well as the capacitance values of the 
PyLaOT SAM by fitting the EIS data to the circuit shown in Figure 5.4c (inset) and the fit 
parameters are tabulated in Table 1. Note that a constant phase element (CPE) was used 
instead of pure capacitor to improve the quality of data fitting. The complex impedance of a 
CPE can be defined as 1/(jQ)m, where Q is analogous to a capacitance,  is the angular 
frequency and m is a real number which varies between 0.5 to 1 (m=1 correspond to pure 
capacitor and m=0.5 correspond to Warburg element). In our case for Faradaic process, m 
was found to be 0.86. The capacitance did not change significantly with decreasing pH. Given 
the inverse relationship between the thickness of the film to the capacitance, it confirms, as 
expected that the thickness of the PyLaOT did not change, i.e. that the film is stable. 
Consistent with probe voltammetry EIS reverts to the neutral pH after washing SAM 
modified electrodes at pH 1.5 resulted in recover of very similar RCT values to that of the 
initial EIS data at pH 7.4.  
From the above electrochemical data, it is clear the SAM can be sequentially and reversibly 
protonated without significantly affecting the integrity of the monolayer.  In the intermediate 
pHs e.g., for the case of predominantly mono (pH, 5.5) and di-protonated (pH, 4.4) PyLaOT 
the RCT decreases slightly compared to the neutral SAM suggesting the packing arrangement 
of pyrene is modestly perturbed and that the charge on the layer impacts the lateral packing 
within the monolayer, which is expected given the charge on the film. The effect of pH is 
significantly greater for probe electrochemistry than EIS, suggesting as indicated above that 
redox probe-SAM electrostatic interactions are important in the observed behaviour. 
5.3.6 pH-Dependent Fluorescence on Solid Substrates 
Given the SAMs are pH responsive and stable, we then investigated if the reversible 
photophysical pH response of PyLaOT in solution, persists in the self-assembled monolayers.  
As the SAMs are on a reflective surface, a microscope was used to collect the fluorescence 
spectra. Under 458.7 nm, the self-assembled monolayers show an intense and broad 
fluorescence centred around 530 nm in contact with water. Notably, the films strong 
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emissivity indicates that the probes are likely oriented upright on the surface, thus avoiding 
quenching by the gold surface 
The effect of pH on the emission spectra of PyLaOT bound to a planar gold electrode was 
studied also using fluorescence microscopy under 458.7 nm excitation using an Ar ion laser. 
The modified gold electrode was placed in contact with PBS buffer and the pH varied using 
concentrated HCl.  Representative fluorescence spectra are shown in Figure 5.5.   
Interestingly, consistent with solution behaviour, between 7.4 and 1.5 there is a continuous 
decrease in the emission intensity.  attributed to progressive protonation of the DMA groups 
in the 3-, 6- and 8-position of the pyrene. Interestingly, we do not see complete extinction of 
emission but beyond pH 3 the fluorescence intensity remains relatively constant with over 
85 % intensity compared with neutral pH. As the pyrene emission appears at around 433 nm 
and cannot be excited at 458.7 nm (requiring UV excitation), we were unable to confirm its 
switch-on in this experiment. The absence of complete extinction of emission may suggest 
that the due to either differences in local pH and dielectric (as the monolayer is not likely to 
behave as bulk) and/or inaccessibility of the final DMA unit there may be differences in 
interfacial and solution photophysical behaviour.  Nonetheless, upon neutralisation the 
charge transfer emission is recovered in terms of peak maxima and band shape. However, 
approximately 15 % of emission is lost, which may be attributed to some degradation of the 
SAM under laser irradiation, as comparable loss was not observed from impedance studies. 
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Figure 5.6 Fluorescence emission spectra of PyLaOT SAM (absorbed from 1 mM ethanolic solution) 
onto flat gold and submerged in PBS as function of pH by using microlitre titrations of HCl (A). 
Fluorescence emission spectra of PyLaOT on gold submerged in PBS showing restoration of the 
fluorescence intensity by increasing the pH (B). 
 
5.4 Conclusions 
In summary, we present two-colour pH modulated fluorescent switches based on a previously 
reported pyrene core functionalised with carboxylate or a surface-active alkane thiol and 
three ionisable dimethylaniline moieties. Detailed pH dependent photophysical data, 
supported by computational studies demonstrate that the parent compound undergoes 
sequential protonation steps that increasingly confines dimethylamino to pyrene charge 
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transfer transition to the deionised dimethylaniline donor units.  Upon complete protonation 
of the dimethylamino substituents the emission switches from a Stokes shifted charge transfer 
fluorescent approximately 540 nm to an intense pyrene emission centred at 424 nm. 
The thiolated charge-transfer compound forms a stable self-assembled bilayer on gold, 
confirmed by ferrocyanide probe voltammetry and label-free impedances spectroscopy 
which both confirmed presence of a close packed monolayer.  Both methods demonstrate 
that the film undergoes sequential and reversible protonation steps, that on formation of fully 
ionised, 3+ compound, renders the film both dramatically more conducting reflected in a large 
decrease in charge transfer resistance and in large decrease of peak to peak separation of the 
ferrocyanide voltammogram. The resistance of the film is recovered on neutralisation of the 
film.  The self-assembled monolayers remain strongly luminescent and switching the pH 
between neutral and acidic progressively and reversibly switches the charge transfer 
transition off.  Thus, these interfacial films look promising as an approach dual-modal and 
multicolour pH switches. 
5.5 Supporting Material 
Supplementary data associated with this chapter can be found in Appendix D. 
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Chapter 6: Conclusions and Future Perspectives 
_______________________________________________ 
 
This thesis focused on the design and synthesis of novel fluorescent dyes based on two series 
of fluorophores, BODIPY and pyrene for application in imaging lipid environments in cells 
and sensing lipid domain formation in artificial model membranes. Both BODIPY and 
pyrene were selected due to their many desirable photophysical and structural traits. Both 
fluorophores and their derivatives exhibit high molecular brightness, quantum yields, 
photostability and molar extinction coefficients. Structurally they are lipophilic in nature and 
highly tuneable. Many BODIPY and pyrene derivatives reported in literature, exhibit low 
cytotoxicity at imaging concentrations, emit in the red to NIR region and can be used at low 
micromolar concentrations, all desirable traits for biological imaging. By incorporating 
lipophilic moieties including Dppz, naphthyridine, octanethiol as well as cholesterol and 
ceramide, a range of fluorophores were synthesised and used to study lipid-domains and lipid 
regions within artificial lipid models and live cells, using a wide range of techniques 
including confocal fluorescent microscopy, FLIM, FCS and in chapter 4, STED microscopy. 
The reported fluorophores and their respective lipid/sterol conjugates displayed high 
selectively to lipid regions in both model membranes and live cells, with focus on Ld 
domains, Lo domains and lipid droplets.  
In chapter 2, Dppz-BODIPY was prepared using to investigate whether the Dppz ligand 
could be successfully used as a cholesterol mimic to aid lipid partitioning when bonded to a 
fluorophore, as its ability to intercalate in DNA has been widely reported. The fluorophore 
was synthesised using Suzuki-Miyuara coupling and knoevanegal type condensation. Dppz 
is a polycyclic aromatic hydrocarbon similar in size to cholesterol with similar planarity. It 
was thought that the Dppz ligand would not only contribute to the overall lipophilicity and 
thus targeting of lipid regions, but that it may also intercalate within lipid domains. Due to 
the excellent photophysical properties of a similar naphthyridine-BODIPY derivative within 
the group, a naphthyridyl-cholesterol conjugate was also explored. Interestingly both dyes 
displayed emission only from non-aqueous environments which resulted in high quality, low 
background images of both live cells and GUVs. Dppz-BODIPY and naphthyridyl-BODIPY-
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2-Cholesterol displayed cytotoxic affects to non-cancer cell lines at high concentrations, 
however were relatively non-cytotoxic to HeLa cells under imaging concentrations (low 
micromolar). The successful incorporation of both dyes into GUVs resulted in phase 
separated images and FLIM data. The high photostability combined with high quantum 
yields and low propensity to access triplet excited states meant the probes are well suited for 
FCS. Diffusion coefficients were measured for both Dppz-BODIPY and naphthyridyl-
BODIPY-2-cholesterol in phase separated GUVs. Interestingly naphthyridyl-BODIPY-2-
cholesterol displayed a high selectivity for lipid droplets within live cells HeLa cells. The 
selective targeting of lipid droplets was further explored in chapter 4. These probes displayed 
good suitability for use as both lipid and membrane probes in cells and artificial lipid models, 
however they both showed preference for liquid-disordered domains. 
Chapter 3 further explored lipid partitioning probes with focus on selectively targeting liquid-
ordered domains in artificial lipid models. Very few liquid-ordered partitioning probes are 
reported in literature, with many partitioning into both Ld and Lo domains, but exhibit 
different excitation, emission or lifetime, depending on the domain environment. Many 
successful Lo probes exploit conjugation with known Lo associating lipids/sterols, mainly 
cholesterol. Hence, a simple BODIPY-phenyl-cholesterol conjugate was investigated with 
respect to the distance between the BODIPY fluorophore and the cholesterol moiety. By 
using Steglich esterification the lone hydroxyl group of cholesterol was exploiting, resulting 
in a facile synthesis for cholesterol conjugation. Using this synthetic route, two derivatives 
BODIPY-Ar-Chol and BODIPY-Ahx-Chol, differing in the distance between fluorophore 
and cholesterol were prepared. The addition of a C6 amino-hexanoate linker between the 
BODIPY core and the cholesterol unit resulted in the difference between Lo and Ld 
partitioning. Confocal fluorescent images were successfully obtained of both BODIPY-Ar-
Chol and BODIPY-Ahx-Chol illuminating Ld and Lo domains respectively. FLIM data was 
acquired to relate the difference in luminescent lifetime to the structural environments of the 
individual lipid regions. Both dyes were successfully used to stain membranous regions in 
cells with focus on the partitioning BODIPY-Ahx-Chol into what we believe are sterol-rich 
domains. Both HeLa and CHO cell lines were treated with cyclodextrin to investigate what 
effect this had on the partitioning behaviour of the dyes and cellular structure. FLIM was 
used to compare the structural significance on the photophysics of the dyes. BODIPY-Ahx-
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Chol is a simple yet effective fluorophore that offers insight on the structural requirements 
of Lo partitioning. Further investigations will be carried out in order to determine if this 
strategy for Lo targeting is viable using a number of different fluorophores. 
Chapter 4 describes the synthesis of a novel pyrene derivative PyLa and its C17 ceramide 
conjugate PyLa-C17Cer. By exploiting the relative ease of brominating the 3,6 and 8-
positions of the pyrene core, palladium catalysed Suzuki-Miyaura coupling was used to 
incorporate dimethylaniline substituents, resulting in a bathochromic-shift in the emission 
and the formation of a charge-transfer fluorophore. By functionalising the pyrene core with 
a carboxylic acid at the 1-position, Steglich esterification was applied to conjugate on a 
ceramide, which is a known to associate within lipid droplets. The photophysical properties 
of PyLa including mega-Stokes shift, high quantum yields, excellent photostability and good 
extinction coefficients combined with the targeting of the ceramide resulted in a fluorescent 
ceramide conjugate that was demonstrated to selectively target lipid droplets and could be 
used for STED super resolution microscopy. Due to the excellent photostability and lack of 
triplet excited states PyLa-C1Cer was also successfully used to obtain FCS diffusion data on 
supported lipid bilayers of varying lipid compositions. This, to the best of our knowledge, is 
the first example of a pyrene derivative used in super-resolution STED microscopy and FCS. 
Chapter 5 explored in further detail the photophysical properties of PyLa with focus on the 
pH sensitivity of the 4-dimethylaminophenyl substituents. The coupling of octanethiol to 
PyLa resulted in the derivative PyLaOT, which is capable of binding to gold surfaces and 
displays the same pH sensitivity as PyLa. The dimethylaniline groups were shown to exhibit 
three ionisation states. As a result of protonation, the charge transfer transition from the 
dimethyaniline substituents to the pyrene core is gradually inhibited and these changes can 
be detected in the emission profiles of both fluorophores. This process was monitored by the 
disappearance of the initial charge-transfer band and the appearance of a newly 
hypsochromatically shifted band in the absorption and a switch-off emission. Computational 
studies carried out by C. Müller on the parent fluorophore PyLa predicting the photophysical 
properties of the protonated species which was then compared to experimental results. 
Electrochemistry was carried out on the thiol derivative PyLaOT investigating the effect of 
pH when a self-assembled monolayer if formed on a gold electrode, in efforts to build a two-
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colour interfacial pH switch. Results showed that the same changes seen in the photophysical 
data with respect to changes in pH can be seen in the impedance data, resulting in a decrease 
in resistivity with decreasing pH that can be restored when brought back to a neutral 
environment. Future work to emerge from this chapter will focus on incorporating the thiol 
derivative PyLaOT onto our gold microcavity arrays. This work will involve forming a 
PyLaOT self-assembled monolayer onto the gold substrate of the microcavity array. A 
supported lipid bilayer of varying lipid composition consisting of phospholipids, 
sphingomyelin, cholesterol and the protein bacteriorhodopsin will be suspended on top the 
cavities and filled with PBS buffer. Bacteriorhodopsin is a protein that acts a proton pump 
that can capture and use light to move protons across membranes resulting in a proton 
gradient. The change in pH caused by the bacteriorhodopsin will be detected by the PyLaOT 
monolayer in the microcavities, using fluorescence techniques, thus resulting in a molecular 
machine type artificial membrane model. 
For the BODIPY and pyrene lipid/sterol conjugates further work is ongoing concerning the 
synthesis of mega-Stokes shifted alkyne derivatives that can be used to create fluorescent 
sulfatide conjugates via click chemistry reactions. Sulfatides are a class of sulfolipids that are 
found not only in the myelin sheath but also the extracellular leaflet of the plasma membrane. 
Sulfatides are of great biological interest as they are known to bind to many bacteria such as 
E. coli and viruses including HIV-1, influenza A and hepatitis C. The focus of future work 
will centre on synthesising fluorescent sulfatide conjugates with desirable photophysical 
properties that are compatible with FCS and STED. These fluorophores will be incorporated 
into lipid domains within our supported lipid bilayer microcavity arrays, and using a 
combination of confocal fluorescent microscopy, FCS, FLIM and STED, protein-lipid 
interactions will be investigated by studying the viral protein hemagglutinin (HA) on 
supported lipid bilayer microcavity arrays.  
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Appendix A 
Supporting information associated with Chapter 2. 
S2.1. Multinuclear NMR and Additional Characterisation 
 
Figure S2.1 1H NMR (600 MHz) of (1) in CDCl3 
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Figure S2.2 1H NMR (600 MHz) of (2) in CDCl3 
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Figure S2.3 13C NMR (150 MHz) of (2) in CDCl3 
 
Figure S2.4 1H NMR (600 MHz) of (3) in CDCl3 
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Figure S2.5 13C NMR (150 MHz) of (3) in CDCl3 
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Figure S2.6 1H NMR (600 MHz) of (4) in CDCl3 
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Figure S2.7 1H NMR (600 MHz) of (5) in CDCl3 
Figure S2.8 13C NMR (150 MHz) of (5) in CDCl3 
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Figure S2.9 1H NMR (600 MHz) of (6) in CDCl3 
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Figure S2.10 13C NMR (150 MHz) of (6) in CDCl3 
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Figure S2.11 1H NMR (600 MHz) of (7) in CDCl3. Inset Cholesterol peaks accounting for 57H 
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Figure S2.12 1H NMR (600 MHz) of (7) in CDCl3. Inset naphthyridyl peaks accounting for 15H 
S2.2 Additional Photophysics 
For Dppz-Ar-BODIPY an investigation into the effect of water on the luminescent emission 
was carried out.  A 10 µM solution of Dppz-Ar-BODIPY in acetonitrile was prepared.  3 mL 
of this solution was taken and the luminescent emission of Dppz-Ar-BODIPY was obtained 
in acetonitrile.  Water was titrated into the sample, agitated and left to stand.  Following this 
the emission spectrum was obtained.  This was repeated in 30 μL titrations until 10 % of the 
sample volume had been added.  The results showed that a 50 % decrease in emission 
intensity was observed upon adding 300 μL of water. 
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Figure S2.13 Emission spectra of Dppz-Ar-BODIPY (3) acetonitrile 5 mL (λex 501 nm, 10 µM, slit 
widths 2.5 nm). A total volume of 300 µL of water was titrated, resulting in a volume change of 6 %, 
shown in the graph inset. * indicates contribution from the excitation source. 
Figure S2.14 Concentration dependence study of Dppz-Ar-BODIPY (3) and naphthyridyl-BODIPY-
2-cholesterol (7) in acetonitrile.  
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Figure S2.15 Time correlated Single Photon counting trace for Dppz-Ar-BODIPY (3) in Chloroform 
(10 µM) with IRF (red) at room temperature. 
 
 
Figure S2.16 Fluorescent lifetime imaging decay for naphthyridyl-BODIPY-2-cholesterol (7) in 
GUVs DOPC/BSM/Chol 4:4:2 mol % (10 µM). 
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Figure S2.17 (A) Fluorescent correlation spectroscopy autocorrelation function for Dppz-Ar-
BODIPY in GUVs DOPC/BSM/Chol 4:4:2 mol % at concentration 0.001 mol % at room temperature. 
(B) Naphthyridyl-BODIPY-2-cholesterol (7) in GUVs DOPC/BSM/Chol 4:4:2 mol % at 
concentration 0.001 mol % at room temperature. 
 
 
 
Figure S2.18 Uptake of Dppz-Ar-BODIPY in GUVs of composition DOPC 100 %. Dppz-Ar-
BODIPY in CHCl3 was added to a solution of GUVs in glucose 230 mM to give a final concentration 
of 10 μM.  Uptake was monitored over a 105-minute period using confocal microscope and images 
after A) 60, B) 75, and C) 105 minutes.  
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S2.3 Cell Studies 
 
 
 
Figure S2.19 Confocal imaging of CHO and HeLa cells incubated with 5 μM Dppz-Ar-BODIPY and 
naphthyridyl-BODIPY-2-Cholesterol compound at 4°C for 24 h, showing the overlay of the BODIPY 
and background channels (column 1) and the BODIPY channel only (column 2). 
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Figure S2.20 Live uptake of Dppz-Ar-BODIPY in live CHO cells. 5 μM of Dppz-Ar-BODIPY in 
cell media was added to CHO cells, and the uptake was monitored over 25 minutes using confocal 
microscopy, showing the overlay channels (column 1) and the emission of the BODIPY channel only 
(column 2). 
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Figure S2.21 Live uptake of Dppz-Ar-BODIPY in HeLa cells. 5 μM of Dppz-Ar-BODIPY in cell 
media was added to HeLa cells, and the uptake was monitored over 25 minutes using confocal 
microscopy, showing the overlay channels (column 1) and the emission of the BODIPY channel only 
(column 2). 
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Figure S2.22 Live uptake of naphthyridyl-BODIPY-2-Cholesterol in HeLa cells. 5 μM of 
naphthyridyl-BODIPY-2-Cholesterol in cell media was added to HeLa cells, and the uptake was 
monitored over 25 minutes using confocal microscopy, showing the overlay channels (column 1) and 
the emission of the BODIPY channel only (column 2). 
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Figure S2.23 Live uptake of naphthyridyl-BODIPY-2-Cholesterol in CHO cells. 5 μM of 
naphthyridyl-BODIPY-2-Cholesterol in cell media was added to CHO cells, and the uptake was 
monitored over 25 minutes using confocal microscopy, showing the overlay channels (column 1) and 
the emission of the BODIPY channel only (column 2). 
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Figure S2.24 Control of Nile Red imaging settings without Nile Red present. To ensure there was no 
cross talk between naphthyridyl-BODIPY-2-Cholesterol and Nile Red for the colocalisation studies, 
HeLa cells stained with naphthyridyl-BODIPY-2-Cholesterol (5 μM) were imaged using the Nile Red 
imaging settings, without any Nile Red present in the sample. The cells (A) showed no emission from 
the Nile Red channel (B). C and D represent the naphthyridyl-BODIPY-2-Cholesterol imaging 
settings to show that naphthyridyl-BODIPY-2-Cholesterol was present in the sample.  
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Appendix B 
Supporting information associated with Chapter 3. 
S3.1 Experimental Details 
 
S3.1.1 Materials 
All reagents were purchased from Sigma Aldrich (Ireland) and used without further 
purification unless otherwise stated. 1,2- Dioleoyl-sn-glycero-3-phosphocholine (DOPC), 
brain sphingomyelin (BSM), and cholesterol (Chol) were obtained from Avanti Polar Lipids 
(Alabaster, AL, USA). DiD solid; DiIC18(5) solid (1,10 -dioctadecyl-3,3,30 ,30 -
tetramethylindodicarbocyanine, 4-chlorobenzenesulfonate salt) was purchased from Thermo 
Fisher Scientific (Waltham, Massachusetts, USA). High purity fluorescein was purchased 
from Fluorochem Ltd. 
S3.1.2 Instrumentation 
1H NMR spectra were recorded on either 400 MHz or 600 MHz Bruker spectrometer. All 
13C NMR spectra were obtained at 150 MHz. The spectra were processed using Bruker 
Topspin NMR software. High Resolution Mass Spectrometry (HR-MS) was carried out at 
the Mass Spectrometry facility, University College Dublin. Absorbance spectra were carried 
out using a Varian Cary 50 spectrometer. Samples were analysed in Hellma quartz 
fluorescence cuvettes, with a path length of 1 cm, and spectral range of 280–800 nm unless 
otherwise stated. Background measurements were carried out at room temperature prior to 
each measurement. Fluorescence emission spectra were obtained using a Varian Cary Eclipse 
fluorescence spectrophotometer with excitation and emission slit widths of 2.5 nm. All 
analyses were carried out using quartz cuvettes and background correction was applied prior 
to measurement. The lifetime of the excited state was measured using a PicoQuant FluoTime 
100 Compact FLS TCSPC system using a 450 nm pulsed laser source generated from a 
PicoQuant PDL800-B box. Lifetime decay plots were analysed using PicoQuant TimeHarp 
software. The goodness of each fit to exponential decay kinetics was assessed from chi-
squared values (where χ2 < 1.3) and visual inspection of residuals. Giant unilamellar vesicles 
were prepared using the Vesicle Prep Pro (VPP) (Nanion Technologies, Munich, Germany). 
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Fluorescent confocal imaging was carried out using a Leica TSP inverted (DMi8) confocal 
microscope. A 100-oil immersion objective was used for all measurements. A white light 
laser was used to excite the dyes. The excitation and emission wavelengths (λex/λem) were 
as follows: 503/511–570 nm for BODIPY-Ar-Chol and BODIPY-Ahx-Chol 644/ 665–700 
nm for DiD and. 
S3.2 Structural Characterisation 
 
 
Figure S3.1 1H NMR (600 MHz) of 1 in DMSO-d6. 
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Figure S3.2 13C NMR (150 MHz) of 1 in DMSO-d6. 
 
 
 
Figure S3.3 HR-MS (ESI-QTOF): Single Mass Analysis of (1) indicating [M + H]+. 
 
  B4   
 
 
Figure S3.4 1H NMR (600 MHz) of 2 in CDCl3. 
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Figure S3.5 13C NMR (150 MHz) of 2 in CDCl3. 
 
 
Figure S3.6 HR-MS (ESI-QTOF): Single Mass Analysis of 2 indicating [M + H]+. 
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Figure S3.7 1H NMR (600 MHz) of 4 in DMSO-d6. 
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Figure S3.8 13C NMR (150 MHz) of 4 in DMSO-d6. 
 
 
Figure S3.9 HR-MS (ESI-QTOF): Single Mass Analysis of 4 indicating [M + H] +. 
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Figure S3.10 1H NMR (600 MHz) of 5 in CDCl3. 
 
 
Figure S3.11 HR-MS (ESI-QTOF): Single Mass Analysis of 2 indicating [M]+ 
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Figure S3.12 1H NMR (600 MHz) of 6 in CDCl3. 
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Figure S3.13 13C NMR (150 MHz) of 6 in CDCl3. 
 
 
Figure S3.14 HR-MS (ESI-QTOF): Single Mass Analysis of 6 indicating [M + H] +. 
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S3.3. Additional Photophysical Data 
 
 
Figure S3.15 (a) Solvent dependent absorbance curves for 2 (10 μM). (b) Solvent dependent emission 
curves for 2 (10 μM, slit widths; 2.5 nm). (c) Solvent dependent absorbance curves for 6 (10 μM). (d) 
Solvent dependent emission curves for 6 (10 μM, slit widths; 2.5 nm). 
 
Quantum yield determination: The quantum yields for 2 and 6 in a range of solvents was 
calculated using fluorescein as a reference. Fluorescein (in 0.1 M NaOH) (φ =0.90)3. 
Solutions were prepared, and absorbance matched, and the optimal excitation was taken as 
wavelength of intersection. Fluorescence emission spectra were obtained using slit widths 
2.5 nm and the following equation was used to calculate the quantum yields. 
x = st *(Areax/Areast)*(2x/2st) 
where the x and st refer to the fluorescence quantum yield of the sample and fluorescein 
standard, respectively. Areax and Areast are the integrated emission intensities for the sample 
and fluorescein standard, respectively. x and st is the refractive index of the solvent for the 
sample and fluorescein standard, respectively.  
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Figure S3.16 Normalised emission spectra of a mixed solution of chloroform containing both 
BODIPY-Ahx-Chol (5 μM) (6) and DiD (5 μM). BODIPY-Ahx-Chol and DiD have emission maxima 
of 516 nm and 675 nm respectively. This shows that there is no crosstalk between dyes when used in 
GUV experiments, using emission filters as stated in experimental sections. For the spectrum of 
BODIPY-Ahx-Chol, the sample was excited at 503 nm using an excitation slit width of 2.5 nm and 
an emission slit width of 5 nm. For the spectrum of DiD, the sample was excited at 503 nm using an 
excitation slit width of 2.5 nm and an emission slit width of 5 nm. 
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Figure S3.17 Time correlated single photon counting trace for BODIPY-Ar-Chol (2) in methanol (10 
µM) with IRF (red) at room temperature (A) and for BODIPY-Ar-Ahx-Chol (6) in methanol (10 µM) 
with IRF (red) at room temperature (B). 
  
A 
B 
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S3.4 Cell Imaging 
 
 
 
Figure S3.18 CHO cells stained with BODIPY-Ahx-Chol (5 µM, 2h), showing a group of CHO cells 
(A-C) and a second cluster of cells (D-F). A, D – BODIPY channel. B, E – overlay of BODIPY 
channel and background channel. C, F – background channel. 
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Figure S3.19 Confocal imaging of live HeLa cells stained with BODIPY-Ar-Chol (5 µM, 37 °C, 3 
h). 
 
 
Figure S3.20 Confocal imaging of live HeLa cell co-stained with DiD (800 nM) (A), BODIPY-Ar-
Chol (5 µM) (B), and the overlay of both channels (C). Emission from the BODIPY-Ar-Chol channel 
is low as the focus is on the cell membrane, where it does not localise. 
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Figure S3.21 Confocal image of a live HeLa cell stained with BODIPY-Ahx-Chol, focused at the 
membrane of the cell (A), and the corresponding FLIM lifetime distribution image (B). FLIM was 
acquired by exciting at 497 nm for 2 minutes. 
 
 
 
 
 
 
 
 
Figure S3.22 Confocal image of a live HeLa cell stained with BODIPY-Ar-Chol, focused at the 
membrane of the cell (A), and the corresponding FLIM lifetime distribution image (B). FLIM was 
acquired by exciting at 497 nm for 2 minutes. 
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S3.5 Giant Unilamellar Vesicle (GUV) Studies 
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%𝐿𝑜 =
𝐹(𝐿𝑜)
𝐹(𝐿𝑜) + 𝐹(𝐿𝑑)
 𝑥 100 
 
     
Figure S3.23 Calculation of Lo% and Ld% was carried out using intensity profiles through scanning 
confocal fluorescence images as given by the examples above. Representative scanning confocal 
fluorescence images of phase were obtained of separated GUVS labelled with BODIPY-Ahx-Chol 
(A) BODIPY-Ar-Chol (B) respectively. The distribution of these molecules is revealed by the 
fluorescence intensity (green). The fluorescence intensities of the Lo and Ld phases, F(Lo) and F(Ld) 
respectively, were determined from the peak maxima of the line scan, where the different phases were 
identified by the Ld phase markers DiD (fluorescence not shown).  
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Table S3.1 Fluorescent lifetimes of BODIPY-Ahx-Chol in live HeLa and CHO cells, with and 
without treatment using MβCD (10 mM, 4 h) 
 
Table S3.2 Fluorescent lifetimes of BODIPY-Ar-Chol in live HeLa 
 
 
 
 
 
 
 
  
   HeLa cells CHO cells 
 
 τ  
(ns)  
  
τAmp  
(%) 
τ  
(ns)  
  
τAmp  
(%) 
Control  τ1 = 5.85 ± 0.15 
τ2 = 2.31 ± 0.37  
67.6 
32.5 
 
  
τ1 = 5.3 ± 0.01 
τ2 = 2.4 ± 0.05 
  
63.8 
29.3 
  
MβCD  τ1 = 5.35 ± 0.25 
τ2 = 2.23 ± 0.17  
63.6 
36.5 
  
τ1 = 5.85 ± 0.05 
τ2 = 2.89 ± 0.21 
  
68.3 
32.7 
 
  
 
                        HeLa Cells 
  τ  
    (ns)  
  
                       τAmp 
 
                        (%) 
BODIPY-
Ar-Chol  
 
τ1 = 5.26 ± 0.09 
τ2 = 1.65 ± 0.14 
  
63.5 
37.5 
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Appendix C 
Supporting information associated with Chapter 4. 
S4.1 Experimental Section 
 
S4.1.1Materials  
All chemical reagents were purchased from Sigma Aldrich (Ireland) and used without further 
purification unless otherwise stated.  1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 
brain sphingomyelin (BSM), cholesterol (Chol) and N-heptadecanoyl-D-erythro-sphingosine 
C17 Ceramide were obtained from Avanti Polar Lipids (Alabaster, AL, USA). Nile Red 
technical grade was purchased from Sigma Aldrich (Ireland). 
S4.1.2 Instrumentation 
1H and 13C NMR spectra were recorded on a 400 MHz or 600 MHz Bruker spectrometer 
respectively and the solvent stated.  The spectra were processed using Bruker Topspin NMR 
software.  High Resolution Mass Spectrometry (HR-MS) was carried out at the Mass 
Spectrometry facility, University College Dublin. MALDI-ToF mass spectrometry was 
performed on MALDI-Q-ToF Premier instrument at Trinity College Dublin.  Elemental 
analysis was carried out using an Exeter Analytical CE 440 elemental analyser at the 
Microanalytical Laboratory, University College Dublin.  Analytical HPLC was performed 
on a Varian 940-LC Liquid Chromatograph using an Agilent C18 column (4.6 250 mm) and 
the solvent system stated.  Flow rates were kept at 1.6 mL/min and run times were 20 minutes. 
PDAD was used for peak detection and the analysis was followed by monitoring 280 nm and 
430 nm channels. UV – Vis absorption spectra were recorded on Varian Cary 50 
spectrometer.  Samples were analysed in Hellma quartz fluorescence cuvettes, with a path 
length of 1 cm, and spectral range of 330 – 800 nm unless otherwise stated.  Background 
measurements were carried out at room temperature prior to each measurement.  Emission 
Spectra were recorded on a Varian Cary Eclipse fluorescence spectrophotometer with 
excitation and emission slit widths stated.  All analyses were carried out using quartz cuvettes 
and background correction was applied prior to measurement. Fluorescence lifetime 
measurements were carried out using a PicoQuant FluoTime 100 Compact FLS TCSPC 
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system using a 450 nm pulsed laser source generated from a PicoQuant PDL800-B box.  The 
instrument response function was determined using Ludox colloidal silica solution.  Lifetime 
decay plots were analysed using PicoQuant TimeHarp software.  The goodness of each fit to 
exponential decay kinetics was assessed from chi – squared values (where 2 <1.3) and visual 
inspection of residuals. 
S4.1.3 Preparation of Supported Lipid Bilayers 
The lipid bilayers were prepared by a hybrid method using Langmuir-Blodgett – Vesicle 
Fusion methods inspired by Basit et al1. The lipid bottom layer is formed by transferring a 
lipid monolayer by Langmuir-Blodgett technique (KSV Nema). The surface pressure was 
controlled by a Wilherm platinum balance. Lipid solution was spread at the sub-phase surface 
(MiliQ water, pH 7.4) and left to evaporate for about 15 min. The lipid monolayer was 
transferred at 32mN/m. To prepare liposomes lipids dissolved in chloroform were mixed to 
PyLa-C17Cer at ratio of 5000:1 mol and dried gently against nitrogen flow. Dried lipids were 
suspended in PBS buffer by vortex agitation, then liposomes were prepared by lipid extrusion 
(Avanti Lipids) with 0.1um PC membrane. Liposomes composed of raft composition were 
extruded at 50oC and kept at this temperature to assure proper lipid fluidity. After liposomes 
introduction to the microfluidic chamber vesicle’s solution were left to react for 30 min. To 
remove any residual liposomes, the vesicle solution is purged with PBS buffer.    
S4.1.4 Fluorescence Lifetime Correlation Spectroscopy  
Diffusion coefficients for labelled supported lipid bilayers were obtained using fluorescence 
lifetime correlation spectroscopy, FLCS performed on a Microtime 200 system (Picoquant 
GmBH, Berlin, Germany). The system consists of an inverted microscope model Olympus 
X1-71 with an Olympus UPlanSApo 60x/1.2 water immersion objective.  The fluorophores 
were excited with a 440 nm PicoTA from Toptica (Picoquant).  The laser was directed onto 
440/532rpc dichroic mirror and focused on the aforementioned objective.  The sample 
fluorescence was collected through the same objective and filtered by the dichroic mirror and 
by a 460 nm interference filter. The sample fluorescence was passed through a 50 µM pinhole 
onto a Single Photon Avalanche Diode (SPAD).  The autocorrelation functions (ACFs) were 
fit using SymphoTime 2.3 software (Picoquant GmBH, Berlin, Germany) to the following 
equation (S4.1): 
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𝐺(𝜏) =
1
𝑁(1−𝑇)
[1 − 𝑇 + 𝑇𝑒
(−
𝜏
𝜏𝑇
)
] [1 + (
𝜏
𝜏𝐷
)
𝛼
]
−1
  (Equation S4.1) 
 
Where G(τ) is the autocorrelation function of fluorescence fluctuations; N is the average 
number of diffusing fluorophores in the effective volume; τ is the delay time; T is the fraction 
of molecules in the triplet state; α is the anomalous parameter; τD is the diffusion time of the 
molecules and τT is the decay time for the triplet state.  The bilayer was located by scanning 
the microscope along the z-axis to identify peak fluorescence intensity. A minimum of nine 
measurements were taken and any outliers were disregarded.  Autocorrelation curves were 
fit to a 2D model to determine the diffusion coefficients. All lipid bilayers used in the FLCS 
experiments were labelled with PyLa-C17Cer at a concentration of 10 nM.  The confocal 
volume was determined by prior calibration using Atto 425, fitting the resulting 
autocorrelation function using the known diffusion coefficient of the dye at 20 °C. The free 
diffusion of Atto 425 was calculated with equation S4.2 following the water viscosity 
correction2:  
𝐷(𝑇) = 𝐷(25℃)
𝑇
298.15𝐾
8.9.10−4 𝑃𝑎.𝑠
𝜂(𝑇)
   (Equation S4.2) 
  Where D is the dye diffusion and η is the viscosity of water.  
S4.1.5 Fluorescence Lifetime Imaging (FLIM) of Supported Lipid Bilayers 
Fluorescence lifetime imaging was carried out using a PicoQuant 100 system attached to 
Leica TSP inverted (DMi8) confocal microscope using a 100x oil immersion objective.  Each 
sample was acquired for 120 s with a 512 x 512 resolution. A 405 nm pulsed laser was used 
to excite the dyes in supported lipid bilayers and in live cell samples.  Data was analysed 
using PicoQuant Symphotime software. 
S4.1.6 Cell Culture 
HeLa cells, a cervical cancer cell line, were cultured. The media used to culture the cells was 
MEM media supplemented with 2% L-glutamine, 1% MEM non-essential amino acid 
solution, 10% foetal bovine serum and 1% penicillin-streptomycin and grown at 37°C with 
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5% CO2. Cells were harvested or split at 90% confluency using 0.25% trypsin for 5 minutes 
at 37°C. 
S4.1.7 Confocal Microscopy for Cell Imaging 
HeLa cells were seeded at 1.5 x 105 cells in 2 mL culture media on poly-L-lysine coated, 
#1.5 coverslips in a 6-well plate and left for 48 h at 37°C under 5% CO2. PyLa and PyLa-
C17Cer were added to the wells in cell media to give a final concentration of 2 μM (final 
DMSO concentration of 0.5%) and were incubated for 2 h at 37°C with 5% CO2. Prior to 
imaging, the compounds were removed, and the cells were washed once with PBS 
supplemented with 1.1 mM MgCl2 and 0.9 mM CaCl2. The cells were imaged live using a 
Leica TSP DMi8 confocal microscope with a 100X oil immersion objective lens. A heated 
box covered the stage to keep the temperature at 37°C. A 405 nm laser was used to excite the 
compounds, and a 520-620 nm filter was used to collect the emission.  
For real-time imaging, cells were seeded at 1.5 x 105 cells in 2 mL culture media on 35 mm 
high precision glass-bottom dishes (Ibidi, Germany) as described previously. PyLa and 
PyLa-C17Cer were added to Leibovitz media to give a final concentration of 2 μM and was 
added to live cells and imaged immediately using Time Series mode to capture images every 
1 minute over a 25-minute period. To assess the mode of uptake, cells were prepared as 
mentioned above and incubated with the compounds at 4°C for 4 h. Cells were washed with 
PBS (supplemented with 1.1 mM MgCl2 and 0.9 mM CaCl2) and imaged immediately.  
To induce lipid droplet production, HeLa cells were seeded and incubated as described 
previously. TNF-α (Bio-techne Ltd) was added to the cells to give a final concentration of 10 
ng/mL in Hela media, and cells were incubated for 16 h in the absence of light at 37°C and 
5% CO2. PyLa-C17Cer (2 μM) was added to the cells for 2 h prior to imaging. 
S4.1.8 Phototoxicity 
Phototoxicity HeLa cells were seeded at 1.5 x 105 on 35 mm glass bottom culture dishes and 
incubated for 48 h. The media was removed, and cells were washed with PBS supplemented 
with 1.1 mM MgCl2 and 0.9 mM CaCl2 and transferred to a 37°C heated stage. 2 μM of 
PyLa-C17Cer in HeLa media for 2 h. Prior to imaging, the dye was removed, cells were 
washed with supplemented PBS, and DRAQ 7 (1:100) was added to the live cells. The Time 
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Series mode on a Leica TSP DMi8 confocal microscope was used. DRAQ 7, which stains 
the nucleus of dead cells, was excited at 633 nm and collected between 635 -720 nm. Cells 
were scanned continuously using the PyLa-C17Cer settings (0.06 mW/cm2) for 5-minute 
intervals, imaging with the DRAQ 7 settings between intervals to assess viability. For the 
control, cells were set up as described above, and DRAQ 7 (1:100) in HeLa media was added 
to the live cells. They were scanned continuously using the Pyrene settings and imaged after 
each interval to assess for DRAQ 7 uptake. 
S4.1.9 Cytotoxicity Studies 
Cytotoxicity Studies HeLa cells were seeded in 96-well plates (Sarstedt flat-bottom cell+ 
culture plate) at 1 × 104 in 100 μL media for 24 h at 37°C with 5 % CO2. PyLa and PyLa-
C17Cer were added for 20 hours at 37°C with 5 % CO2. Final dye concentrations were 100, 
50, 20, 10, 5 and 1 μM. The Alamar blue assay (Promocell GmbH) was used to measure cell 
viability by the addition of 10 μL resazurin reagent and cells were incubated for 7 h at 37°C 
in the dark. Absorbance was measured using a Tecan 96-well plate reader at 570 nm and 600 
nm (corrected for background subtraction). 
S4.1.10 FLIM of Live HeLa Cells 
HeLa cells were prepared and stained as described for confocal imaging. Live FLIM images 
were acquired using SymphoTime 200, Picoquant, attached to a Leica TSP DMi8 confocal 
microscope using a 100x oil immersion objective and heated stage set to 37°C. Each FLIM 
image was acquired for 2 minutes with 512 x 512 resolution. A 405 nm laser was used to 
excite the sample, and emission collected using a 520-620 nm filter. The data was analysed 
using PicoQuant Symphotime software. Lifetimes were fit to a mono-exponential decay for 
PyLa, and bi-exponential decay for PyLa-C17Cer, until a X
2 value of 0.9-1.1 was achieved.  
S4.1.11 STED Imaging of Live HeLa cells 
HeLa cells were seeded at 1.5 x 105 cells in 2 mL culture media on poly-L-lysine coated, 
#1.5 coverslips in a 6-well plate and left for 24 h at 37°C under 5 % CO2. TNF-α was added 
to the cells to give a final concentration of 10 ng/mL in Hela media, and cells were incubated 
for 16 h in the absence of light at 37°C and 5% CO2. PyLa-C17Cer (2 μM) was added to the 
cells for 2 h prior to imaging. The dye was removed, and the cells were washed x2 for 2 
minutes with supplemented PBS. To acquire STED images, a Leica DMI8 confocal system 
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with STED lasers was used. A 405 nm laser (PicoQuant) was used to excite PyLa-C17Cer, 
collecting the emission between 520-620 nm, using a 100X oil immersion objective. Images 
were scanned at 2408 x 2408 resolutions, using a scan speed of 0.032 frame/s. A line 
accumulation of 6 was used to eliminate as much background as possible. A time gating 
system was used to remove any autofluorescence and was set to 1.5-12 ns. A 660 nm 
depletion laser was used to acquire the live cell STED images. Images were deconvolved 
using Huygens Professional software. All data and FWHM analysis were carried out on raw 
images before deconvolution process using Image J and OriginPro. 
S4.1.12 Photostability 
HeLa cells were prepped for STED as described above and stained with either PyLa-C17Cer 
(2 μM) or Nile Red (1 ng/mL). The samples were imaged using the optimum STED settings. 
A 405 nm laser was used to excite Pyla-C17Cer, collecting the emission between 520-620 
nm, and a 560 nm white light laser was used to excite Nile Red collecting the emission 
between 580-670 nm with a 100X oil immersion objective. The STED 660 nm at 0.05 W was 
used for both samples. The images were acquired at 1024 x 1024 resolutions every 1 minutes 
for 30 minutes at a pixel dwell time of 2.43 μs. The emission intensity of a selected area in 
both samples was measured at each time interval over the 20 minutes and plot to show 
stability over time. 
 
S4.1.13 Computational Studies 
The quantum chemical calculations were undertaken using the Gaussian 16 programme 
suite.3 The B3LYP hybrid functional was used with a range of basis sets as indicated.4-5 Initial 
structures were obtained from molecular mechanics methods.  The polarisable continuum 
model6-7 was used to mimic the solvent environment.  GaussView 3.08 was used to visualise 
the electron density difference maps and the AOMix package was used to simulate the 
UV/visible spectra.9-10 Band structures used Gaussian functions with a width at half height 
of 3000 cm-1. 
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S4.2 Synthesis and Structural Characterisation 
 
S4.2.1 Synthesis of pyrene-1-carboxylic acid (2) Synthesised according to a reported 
method.43 Yield:  brown solid, 0.671 g, (2.51 mmol, 57 %). 
1H NMR (400 MHz, DMSO-d6) (ppm): 9.23 (d, J = 9.4 Hz, 1H); 8.62 (d, J = 8.2 Hz, 1H); 
8.41 (dd, J = 8.1 Hz, 1.7, 2H); 8.37-8.33 (m, 3H); 8.26 (d, J = 9 Hz, 1H); 8.16 (t, J = 7.6 Hz, 
1H). 
S4.2.2 Synthesis of 3,6,8-(4-(dimethylamino)phenyl)pyrene-1-carboxylic acid 
(PyLa) (4) 
Over a period of 15 min bromine (1.32 g, 8.2 mmol) was added dropwise to a solution of 
pyrene-1-carboxylic acid (2) (0.517 g, 2.1 mmol) in nitrobenzene (40 mL) at 160 °C under 
vigorous stirring.  The reaction mixture was kept at 160 °C for 5 h, after which it was allowed 
to cool to room temperature.  The precipitate was filtered off and washed with EtOH and 
dried under vacuum overnight.  The reaction afforded 3,6,8-tris-bromopyrene-1-carboxylic 
acid (2) as a yellow powder (0.852 g, 1.76 mmol, 84 %).  Due to its low solubility, the product 
was used in the next step without further purification or characterisation.  Following this, (2) 
(0.169 g, 0.35 mmol), 4-(dimethylaminophenyl) boronic acid (0.348 g, 2.11 mmol), 
Pd(PPh3)4 (0.070 g, 0.061 mmol) and K2CO3 (0.5 g, 3.6 mmol) were added to a nitrogen 
saturated mixture of toluene (10 mL) and ethanol (5 mL).  The reaction mixture was then 
heated to reflux under nitrogen for 24 h.  After the mixture was allowed to cool to room 
temperature, diluted with dichloromethane (150 mL) and was then washed with water (3 x 
50 mL).  The precipitate was collected by filtration and purified on silica gel by column 
chromatography using dichloromethane/methanol (9:1) to afford PyLa (4) as an orange 
powder (0.091 g, 0.2 mmol, 57 %). 
1H NMR (600 MHz, DMSO-d6) (ppm): 13.30 (s, 1H); 9.12 (d, J = 9.6 Hz, 1H); 8.45 (s, 1H); 
8.34 (d, J = 9.6 Hz, 1H); 8.28 (d, J = 9.4 Hz, 1H); 8.17 (d, J = 9.4 Hz, 1H); 7.93 (s, 1H); 7.56-
7.49 (m, 6H); 6.94 (q, J = 6.6 Hz , 6H); 3.02 (s, 6 H); 3.018 (s, 6 H); 3.00 (s, 6 H). 
13C NMR (150 MHz, DMSO-d6): 171.76, 150.09, 149.95, 136.93, 136.72, 136.52, 129.19, 
128.97, 128.80, 128.59, 128.55, 127.56, 127.35, 127.18, 127.13, 126.43, 126.08, 124.99, 
124.45, 123.47, 112.85, 112.83, 112.81  
HR-MS (ESI-TOF) m/z: calculated for C41H37N3O2 604.2964 found 604.2964 ([M
+]) 
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S4.2.3 Synthesis of 3,6,8-tris-(4-(dimethylamino)phenyl)pyrene-1-C17-Ceramide 
(PyLa-C17Cer) (5) 
To a stirred solution of PyLa (4) (27 mg, 0.045 mmol,) and 4-(dimethylaminopyridine) (0.55 
mg, 0.0045 mmol) in DCM (2 mL), a solution of C17 ceramide (50 mg, 0.09 mmol) in DCM 
(2 mL) was added.  The reaction mixture was stirred for 5 min at room temperature.  A 
solution of DCC (10.22 mg, 0.049 mmol) in DCM (2 mL) was added and the mixture was 
stirred at room temperature overnight.  The crude mixture was concentrated to dryness via 
vacuum.  The crude product was purified by chromatography on preparative silica TLC using 
DCM/MeOH (9:1) to afford a yellow powder (6.7 mg, 0.005 mmol, 8.6 %).   
1H NMR (600 MHz, CDCl3) (ppm): 9.11 (d, J = 11 Hz, 1H); 8.54 (s, 1H); 8.44 (d, J = 10.5 
Hz, 1 H); 8.34 (d, J = 10.3 Hz, 1H); 8.20 (d, J = 6.8 Hz, 1H); 8.05 (s, 1H); 7.58-7.51 (m, 6H); 
6.91 (q, J = 6.6 Hz , 6H); 6.07 (d, J = 7.92 Hz, 1H); 5.79-5.74 (m, 1H); 5.58-5.54 (m, 1H); 
4.76 (q, J = 6.4 Hz, 1 H); 4.53 (dd, J = 11.6, 4.7 Hz, 1H); 4.47-4.43 (m, 1H); 4.31-4.25 (s, 
1H); 3.02 (s, 6 H); 3.016 (s, 6 H); 3.00 (s, 6 H); 2.2-2.17 (m, 2H); 2.02-1.95 (m, 2H); 1.29-
1.17 (m, 48H); 0.88-0.84 (m, 7H). 
MALDI TOF MS LD+ calculated for C75H101N4O4: 1136.8082 found 1136.8058 ([M
+]) 
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S4.2.4. Characterisation Data 
S4.2.4.1 Pyrene-1-carboxylic acid (2). 
 
 
Figure S4.1 1H NMR Spectrum (400 MHz) of (2) in DMSO-d6. 
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S4.2.4.2 3,6,8-tris-(4-(dimethylamino)phenyl)pyrene-1-carboxylic acid (PyLa) 
(4) 
 
Figure S4.2 1H NMR Spectrum (600 MHz) of (4) in DMSO-d6. 
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Figure S4.3 13C NMR Spectrum (150 MHz) of (4) in DMSO-d6. 
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Figure S4.4 HR-MS (ESI-QTOF): Single Mass Analysis of (4) indicating [M]+ 
 
 
Figure S5 HR-MS (ESI-QTOF): Single Mass Analysis of (4) indicating [M]+. 
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S4.2.4.3 3,6,8-tris-(4-(dimethylamino)phenyl)pyrene-1-C17-Ceramide (PyLa-
C17Cer) (5) 
 
Figure S4.6 1H NMR Spectrum (600 MHz) of (5) in CDCl3. 
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Figure S4.7 MALDI-TOF: Single Mass Analysis of (5) indicating [M]+. 
 
 
Figure S4.8 MALDI-TOF: Single Mass Analysis of (5) indicating [M]+. 
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S4.2.4 HPLC Analysis 
 
 
Figure S4.9 HPLC of reference compound (1) using C18 reverse phase column, flow rate 1.0 mL/min, 
run time 30 min. Wavelengths 394 nm and 430 nm. Solvent ACN TFA 0.1 %. 
 
Figure S4.10 HPLC of (3) using C18 reverse phase column, flow rate 1.0 mL/min, run time 20 min. 
Wavelengths 394 nm and 430 nm. Solvent ACN TFA 0.1 %. 
 
Figure S4.11 HPLC of (5) using C18 reverse phase column, flow rate 1.0 mL/min, run time 20 min. 
Wavelengths 394 nm and 430 nm. Solvent ACN 100 %. 
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S4.3 Photophysical Characterisation 
 
Table S4.1 Summary of photophysical data 
Solutions of PyLa and PyLa-C17Cer were were absorbance matched at 0.4 (a.u.) and emission spectra 
were obtained using excitation slit width 5 nm and emission slit width 2.5 nm.  Lifetime data was 
recorded in triplicate at concentrations of (10 μM) and curves conformed to tailfit criteria of χ2 < 1.3.  
Quantum yields were obtained using Atto 425 in water (ϕfl = 0.90) with slit widths 2.5 nm as a 
standard. aNot measured. *Dielectric constants of solvents at 20 °C. 
 
Figure S4.12 (a) Solvent dependence absorbance and emission spectra for PyLa (absorbance matched 
at 0.4 a.u. excitation slit width 5 nm, emission slit width 2.5 nm). (b) Solvent dependence absorbance 
and emission spectra for PyLa-C17Cer (absorbance matched at 0.4 a.u. excitation slit width 5 nm, 
emission slit width 2.5 nm).
Compound ϕfl Solvent λabs (nm) (Ɛ = x 103 M-
1 cm-1) 
λem (nm) (εr)
* τlum (ns) ± SD 
      
PyLa 0.40 DCM 431 (20.55)  552 (9.08) 4.42 ± 0.01 
a Acetone 426 (12.57)  580 (20.7) 3.34 ± 0.02 
a MeOH 396 (23.38)  525 (33.0) 3.54 ± 0.01 
0.49 Acetonitrile 399 (28.19) 520 (37.50) 3.85 ± 0.04 
 a H2O 413 (0.79) 557 (78.54) 0.38 ± 0.01 
PyLa-C17Cer 0.10 DCM 427 (13.74) 562 (9.08) 4.34 ± 0.00 
a Acetone 428 (4.61) 592 (20.7) 2.66 ± 0.17 
a MeOH 416 (4.70) 510 (33.0) 2.60 ± 0.28 
0.08 Acetonitrile 423 (9.60) 582 (37.50) 2.98 ± 0.02 
 a H2O 417 (0.76) 557 (78.54) 0.84 ± 0.006 
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Figure S4.13 Emission spectra of PyLa (4) (50 μM) in MeOH with the addition of 50 μL water 
titrations. Excitation slit width 5 nm and emission slit width 2.5 nm were used for emission 
intensity measurements.  Emission intensity decreases by 45 % following addition of water (21 
mol % water to MeOH). Inset shows maximum emission versus volume of water added. 
 
Figure S4.14 Emission spectra of PyLa-C17Cer (5) (50 μM) in MeOH with the addition of 50 μL 
water titrations. Excitation and emission slit widths 10 nm were used for emission intensity 
measurements.  Emission intensity decreases by 58 % following addition of water (11.36 mol % 
water to MeOH). Inset shows maximum emission versus volume of water added. 
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Figure S4.15 Absorbance and emission spectra of PyLa (4) and PyLa-C17Cer (5) in water 
absorbance matched at 0.4 absorbance intensity. Emission spectra were obtained with excitation 
slits widths set to 5 nm and emission slit widths set to 2.5 nm. Emission spectra show both dyes 
exhibit extremely weak emission in aqueous media. 
 
 
Figure S4.16 77K emission spectrum of PyLa (4) in butyronitrile 1 μM. Sample was excited at 
420 nm using an excitation slit width of 5 nm and an emission slit width of 10 nm. 
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Figure S4.17 77K emission spectrum of PyLa-C17Cer (5) in butyronitrile 1 μM. Sample was 
excited at 420 nm using an excitation slit width of 5 nm and an emission slit width of 10 nm. 
 
 
 
 
Figure S4.18 Absorbance and emission spectra of PyLa-C17Cer in DCM. The confocal excitation 
405 nm (__) and STED 660 depletion laser (__). 
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Figure S4.19 Concentration dependent absorption of PyLa (-) and PyLa-C17Cer (-) in 
dichloromethane using concentrations ranging between 0.5-50 μM. The graph shows that PyLa 
(4) and PyLa-C17Cer (5) does not exhibit any aggregation up to concentrations of 25 times greater 
than imaging concentration (2 μM). 
 
Figure S4.20 Time correlated Single Photon counting trace for PyLa-C17Cer in Acetonitrile (10 
µM) with IRF (red) at room temperature. 
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Figure S4.21 Fluorescent lifetime imaging decay for PyLa in lipid bilayers of composition 
DOPC/SM/Chol 4:4:2 mol % (10 µM). 
S4.4 Cell Studies 
 
 
Figure S4.22 Live HeLa cells incubated with 2 µM PyLa(D) and PyLA-C17Cer (E-H) for 1 h, 
where A, B, E, F show a group of cells, and C,D,G,H show a single cell, showing the distribution. 
Ex 405 nm, Em 520-620 nm. 
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Figure S4.23 Uptake at 4 °C in live HeLa cells. Cells were incubated at 4 °C for 1 h, then 2 µM 
PyLa (A,B) and PyLa-C17Cer (C,D) was added and incubated at 4 °C for 4 h prior to imaging. 
HeLa cells were treated with TNF-a for 16 h, then incubated at 4 °C with PyLa-C17Cer (E,F). 
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Figure S4.24 Phototoxicity of PyLa in live Hela cells. Cells were stained with PyLa (2 µM, 2 h). 
The cell highlighted in the white box was continuously scanned for 5 minutes exciting at 405 nm 
(0.06 mW/cm2) then imaged using the DRAQ7 settings (Ex 633 nm, Em 635-720 nm) to 
determine viability for a total of 20 minutes. An overlay of the four channels and DRAQ 7 channel 
at T 0 minutes and T 20 minutes shows the distribution of the dyes in the cells. 
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Figure S4.25 Phototoxicity of PyLa-C17Cer in live Hela cells. Cells were stained with (2 µM, 2 
h). The cell highlighted in the white box was continuously scanned for 5 minutes exciting at 405 
nm (0.06 mW/cm2), then imaged using the DRAQ7 settings (Ex 633 nm, Em 635-720 nm) to 
determine viability for a total of 30 minutes. An overlay of the PyLa-C17Cer channel and DRAQ 
7 channel at T 0 minutes and T 20 minutes shows the distribution of the dyes in the cells. 
 
 
Figure S4.26 Live Hela cells treated with TNF-α for 16 h. PyLA (2 µM) was added to cells and 
incubated for 2 h at 37 °C. Cells were washed and imaged using at 405 nm laser to excite PyLa, 
and the emission was collected at 520-620 nm. PyLa does not enter and stain LDs. 
 
 
 
  C25   
 
 
Figure S4.27 Control HeLa cells stained with Nile Red only (1 ng/mL, 20 minutes and washed) 
(A) (Ex 552, Em 560–700 nm), and imaged using Pyrene settings (Ex 405, Em 520-620 nm), to 
confirm no cross-talk was occurring between the 2 dyes, shown in (B) and (C) where no emission 
was recorded at the Pyrene settings. 
 
 
Figure S4.28 Control HeLa cells stained with PyLa-C17Cer (2 µM, 2 h and washed) (A) (Ex 405, 
Em 520-620 nm), and imaged using Nile Red settings (Ex 552, Em 560–700 nm), to show no 
cross talk between the 2 dyes, shown in (B) and (C) where no emission was recorded at the Pyrene 
settings. 
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Figure S4.29 False-colour FLIM of a region of the cytoplasm stained with PyLa (A) and a group 
of lipid droplets in a live HeLa cell stained with PyLa-C17Cer (B). Cells were incubated with 2 
µM PyLa (A) or PyLa-C17Cer (B) for 2 h, then washed with PBS before carrying out FLIM. (Ex 
405, Em 520-620 nM). 
 
 
Figure S4.30 FLIM lifetime decays for PyLa (A) and PyLa-C17Cer (B) in live HeLa cells. Ex 
405, Em 520-620 nm. 
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Figure S4.31 Corresponding 3D confocal z-stack of PyLa-C17Cer in live HeLa cells to the 3D 
FLIM z-stack video/image. The distribution of PyLa-C17Cer throughout a single HeLa cell (A), 
and the region of droplets chosen for 3D FLIM (B) shown in Figure 5 (C) in the main text. 
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Figure S4.32 Cell. 1 Raw data full width half maxima (FWHM) values of a live Hela cell stained 
with PyLa-C17Cer (2 µM, 2 h), where region of interest (ROI) is a lipid droplet, and the FWHM 
value for confocal and STED of each lipid droplet. Data was obtained using Image J, and FWHM 
was worked out using Origin Pro 2016 on a STED image before deconvolution. 
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Figure S4.33 Cell 2 Raw data full width half maxima (FWHM) values of a live Hela cell stained 
with PyLa-C17Cer (2 µM, 2 h) and the corresponding cell, where region of interest (ROI) is a lipid 
droplet, and the FWHM value for confocal and STED of each lipid droplet. Data was obtained 
using Image J, and FWHM was worked out using Origin Pro 2016 on a STED image before 
deconvolution.  
Standard 
Deviation 
(±) 
0.152 
  
0.080 
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Figure S4.34 STED photostability of live HeLa cells stained with PyLa-C17Cer, and Nile Red. A 
405 nm laser was used to excite PyLa-C17Cer, collecting the emission between 520-620 nm, and 
a 560 nm white light laser was used to excite Nile Red collecting the emission between 580-670 
nm. The STED 660 nm at 0.03 W/cm2 was used for both samples. The images were acquired at 
1024 x 1024 resolutions every 1 minutes for 30 minutes at a pixel dwell time of 2.43 μs. The 
emission intensity of a selected area in both samples was measured at each time interval over the 
20 minutes and plot to show stability over time. 
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Appendix D 
Supporting information associated with Chapter 5. 
S5.1 Experimental Section 
 
S5.1.1 Materials and Instrumentation  
All chemical reagents were purchased from Sigma Aldrich (Ireland) and used without 
further purification unless otherwise stated.   
S5.1.2 Instrumentation 
1H and 13C NMR spectra were recorded on a 400 MHz or 600 MHz Bruker spectrometer 
respectively and the solvent stated.  The spectra were processed using Bruker Topspin 
NMR software.  High Resolution Mass Spectrometry (HR-MS) was carried out at the 
Mass Spectrometry facility, University College Dublin. MALDI-ToF mass spectrometry 
was performed on MALDI-Q-ToF Premier instrument at Trinity College Dublin.  
Elemental analysis was carried out using an Exeter Analytical CE 440 elemental analyser 
at the Microanalytical Laboratory, University College Dublin.  Analytical HPLC was 
performed on a Varian 940-LC Liquid Chromatograph using an Agilent Pursuit XRs 5C-
C18 column (4.6x250 mm) and the solvent system stated.  Flow rates were kept at 1.6 
mL/min and run times were 20 minutes. PDAD was used for peak detection and the 
analysis was followed by monitoring 280 nm and 430 nm channels. UV-Vis absorption 
spectra were recorded on Varian Cary 50 spectrometer.  Samples were analysed in Hellma 
quartz fluorescence cuvettes, with a path length of 1 cm, and spectral range of 330 – 800 
nm unless otherwise stated.  Background measurements were carried out at room 
temperature prior to each measurement.  Emission Spectra were recorded on a Varian 
Cary Eclipse fluorescence spectrophotometer with excitation and emission slit widths 
stated.  All analyses were carried out using quartz cuvettes and background correction 
was applied prior to measurement. Fluorescence lifetime measurements were carried out 
using a PicoQuant FluoTime 100 Compact FLS TCSPC system using a 450 nm pulsed 
laser source generated from a PicoQuant PDL800-B box.  The instrument response 
function was determined using Ludox colloidal silica solution.  Lifetime decay plots were 
analysed using PicoQuant TimeHarp software.  The goodness of each fit to exponential 
decay kinetics was assessed from chi-squared values (where 2 <1.3) and visual 
inspection of residuals. 
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S5.1.3 Absorption and Fluorescence Measurements 
UV-Vis spectra were recorded on a Varian Cary 50 spectrometer. Samples were analysed 
in Hellma quartz fluorescence cuvettes, with a path length of 1 cm, and spectral range of 
280–800 nm unless otherwise stated. Background measurements were carried out at room 
temperature prior to each measurement. Emission Spectra were recorded on a Varian 
Cary Eclipse fluorescence spectrophotometer with excitation and emission slit widths 
stated. All analyses were carried out using quartz cuvettes and background correction was 
applied prior to measurement. 77 K emission spectra were obtained a Varian Cary Eclipse 
fluorescence spectrophotometer using concentrations of 1 μM using excitation slit widths 
5 nm and emission slit widths 10 nm over a spectral range of 440-800 nm.  For pH-
dependent experiments in solution, aqueous samples were prepared using phosphate 
buffer solution (PBS) with sample concentrations 100 μM, and they were titrated by 
successive of small volumes (in the order of microliters) of HCl and NaOH solutions (1 
M) to an initial volume of 5 mL for negligible changes to concentration and volume of 
the sample. pH of the samples was then measured using an EDT microprocessor pH 
meter.  
For pH-dependent experiments in organic solution, samples in acetonitrile were prepared 
with sample concentrations 50 μM, and they were titrated by successive small volumes 
(in the order of microliters) of perchloric acid and triethylamine solutions of differing 
concentrations (0.5-1 M) to an initial volume of 5 mL for negligible changes to 
concentration and volume of the sample. pH of the samples was then calculated to obtain 
an apparent pH in organic solution. Prior to use ITO was cleaned using warm soapy water 
and cotton wool, followed by deionised water and ethanol wash and sonication. For 
absorption and fluorescence measurements of PyLa on ITO glass, the fluorophore in 
ethanol (1 mM) was deposited onto an ITO glass slide and left to evaporate over 24 h in 
an enclosed petri dish. The newly formed film was then washed with ethanol and then 
used for pH measurements. The ITO slide was placed inverted onto a glass slide and a 
mother PBS solution of known pH was deposited between the ITO and coverslip glass 
slide. This solution was then added back into the mother solution and the pH was adjusted 
using small microliter volumes of HCl and NaOH. Fluorescence spectral scans were then 
carried out at different pH using a Leica TSP inverted (DMi8) confocal microscope, using 
100 x oil objective with a 405 nm excitation laser.  For fluorescence measurements of 
PyLaOT bound to flat gold, an Olympus confocal microscope attached to a Horiba Jobin-
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Y Labram HR 1000 spectrometer with a 50× long distance magnification objective (NA 
0.55) was used. The excitation light of 457 nm was delivered by a diode laser (Horiba 
Jobin-Y Labram HR 1000). The quantum yields of the samples ϕx were measured in 
solutions applying a standard reference of fluorescein in EtOH (ϕs = 0.79) and using 
equation S5.1, 
 
Φ𝑥 =  Φ𝑠 .
𝐼𝑥
𝐼𝑠
.
𝐴𝑠
𝐴𝑥
.
𝜂𝑥
2
𝜂𝑠
2                                (Equation S5.1) 
where I is the integrated emission, A is the absorbance at the excitation wavelength and 
the subscripts x and s are the sample and standard, respectively. The refractive index of 
is given by η. The excitation and emission slit widths were both set to 5 nm. 
S5.1.4 Self-assembled Monolayer Formation of PyLaOT on Gold Electrode 
Prior to self-assembled monolayer (SAM) modification, electrochemical cleaning 
procedure was carried out in 0.5 M H2SO4 from -0.2 to +1.6 V at 50 mV s-1 until 
reproducible voltammograms were obtained. Next, the electrode was rinsed with de-
ionised (DI) water and finally dried by high pure stream of N2. For the SAM modification, 
the electrode was immersed in the freshly prepared 1 mM PyLaOT in ethanolic solution 
for 48 hours. Upon removal, the electrode was washed with a copious amount of ethanol 
followed by DI water, and immediately transferred to the electrochemical cell for 
measurement. 
S5.1.5 Electrochemical Measurements 
Cyclic voltammetry was carried out using a conventional three-electrode cell using 
1 mM [Fe(CN)6]
3-/4- as an internal redox probe in 0.1 M KCl electrolyte solution 
in PBS buffer with an applied potential in the range of -0.2 to +0.8 V at a scan rate 
of 50 mV s-1. The electrodes are gold (working electrode), Ag/AgCl (reference 
electrode) and platinum wire (counter electrode). Electrochemical impedance 
measurements were performed on a CHI 760B bipotentiostat (CH Instruments Inc., 
Austin, TX) in a three-electrode cell. The EIS recording was performed in the 
frequency region between 104 and 0.01 Hz with a bias potential of 0.26 V vs 
Ag/AgCl when redox probe is used and a bias potential of 0 V vs Ag/AgCl without 
the redox probe i.e., only on PBS buffer. The EIS data were fit to equivalent circuit 
using Z view (v. 3.4e, Scribner Associates, Inc.) 
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S5.1.6 Computation 
The structural and electronic data of the pyrene derivatives (PyLa and its mono-, di- and 
triple protonated species) were obtained from quantum chemistry calculations performed 
with the Gaussian09 program.1  The optimised equilibrium geometries and vibrational 
frequencies of the ground state were calculated by means of DFT with the hybrid-
functional B3LYP2,3 in cooperation with the triple-ζ-valence-polarisation (TZVP) basis 
set.4–6 Subsequent vibrational analysis confirmed that all obtained optimised structures 
correspond to a minimum on the potential energy hypersurface. The vertical excitation 
energies and oscillator strengths within the Franck-Condon region were obtained from 
TDDFT calculations by means of the 20 lowest singlet excited states. The TDDFT 
calculations were performed with four functionals, which include different amounts of 
Hartree-Fock exchange: B3LYP (20%), PBE0 (25%)7–9, M06-2X (54%)10 and CAM-
B3LYP (19-65%)11; in cooperation with the TZVP basis set. The effects of solvation 
(Acetonitrile: ε=35.69, n=1.3442) on the ground and excited state properties were 
considered based on the integral equation formalism of the polarizable continuum 
model.12   In order to describe the influence of different mono- and di-protonated species 
of PyLa (e.g. first protonation in either the 3-, 6- or 8-position of the pyrene) on the 
absorption properties (as a mixture of several single or double-protonated forms can be 
present at room temperature) the oscillator strengths were statistically weighted using the 
Boltzmann distribution, 
𝑝𝑖 =  exp (−
𝐸𝑖
kB𝑇
) ∙ [∑ exp (−
𝐸𝑖
kB𝑇
)
4
𝑖
]
−1
 
where pi is the weight and Ei the energy of a species i contributing to the absorption 
properties, kB the Boltzmann constant and T the temperature. 
S5.2 Synthesis and Structural Characterisation 
 
S5.2.1 Synthesis of PyLa (1) 
Was synthesised as previously reported13. 
S5.2.2 Synthesis of PyLaOT (2) 
DMF (5 mL) was purged with nitrogen for 20 minutes. To a reaction mixture of PyLa (1) 
(50 mg, 0.083 mmol), PyBOP (86 mg, 0.166 mmol) and DIPEA (60 uL), 8-
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aminooctanethiol hydrochloride (32 mg, 0.166 mmol) in 1 mL DMF was added slowly 
to the reaction mixture under nitrogen over a period of 30 minutes after which point the 
reaction mixture was allowed to stir at room temperature under nitrogen overnight. 
Following this the reaction mixture was precipitated using ice-cold water, collected under 
vacuum filtration and rinsed with ice-cold water (2 x 50 mL) and ice-cold MeOH (2 x 
100 mL). The crude product was purified on silica gel by column chromatography eluent: 
Diethyl ether/DCM (80:20), dried over anhydrous Na2SO4 and concentrated to dryness 
under vacuum. Following this the compound was triturated using hot CHCl3 and ice-cold 
MeOH to give the product. Yield: yellow-brown solid, 32.8 mg (0.043 mmol, 53 %). 
1H NMR (600 MHz, CDCl3) (ppm): 8.45 (d, J = 9.5, 1H); 8.35 (d, J=9.5, 1H); 8.27 (d, J 
= 10, 1H); 8.16 (d, J =9.5, 1H); 8.03 (d, J = 2, 2H); 7.57-7.51(m, 6H); 6.91-6.89 (m, 6H); 
6.13 (t, J = 5.5, 1H); 3.59 (q, J =11.5, 7.2, 2H); 3.069 (s, 6H); 3.057 (s, 6H); 3.050 (s, 
6H); 2.50 (q, J=16.5, 8, 2H); 1.71-1.66 (m, 2H); 1.62-1.57 (m, 2H); 1.46-1.27 (m, 11H).  
13C NMR (150 MHz, CDCl3) (ppm): 170.35, 149.87, 138.26, 138.05, 136.77, 131.49, 
131.31, 130.46, 129.89, 129.04, 128.69, 127.63, 127.38, 126.65, 126.60, 126.23, 126.03, 
124.56, 123.51, 112.40, 40.67, 40.28, 34.02, 31.45, 30.21, 29.79, 29.71, 29.19, 28.98, 
28.30m 26.96, 24.63, 14.13. 
MADLI-TOF) m/z: calculated for C49H54N4OS 747.3998 found 746.4018.  
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Figure S5.1 1HNMR (600 MHz) of PyLaOT (2) in CDCl3.  
 
Figure S5.2 13CNMR (150 MHz) of PyLaOT (2) in CDCl3.  
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Figure S5.3 HR-MS (ESI-QTOF): Single Mass Analysis of PyLaOT indicating [M]+. 
 
 
Figure S5.4 HR-MS (ESI-QTOF): Single Mass Analysis of PyLaOT indicating [M]+. 
 
S5.3 Computational Studies 
Table S5.1 Electronic character, vertical excitation energies and oscillator strengths of the bright 
singlet excitations contributing to the UV-vis absorption properties of PyLa obtained at TD-DFT 
level of theory (CAM-B3LYP/TZVP) including the solvent effects of acetonitrile based on the 
integral equation formalism of the polarizable continuum model.   
 
State Transition P in % E in eV λ in nm f λexp in nm 
S1 π8,py (160) →π*9,py + π*COO(161) 91 2.99 415 1.062 429 
  D8   
 
S2 π3,ph(2) (159) →π*9,py + π*COO(161) 
π6,py (156) → π*9,py + π*COO(161) 
45 
21 
3.57 347 0.131 370 
 
S4 π8,py (160) → π*10,py + π*COO(162) 
π3,ph(2) (159) →π*9,py + π*COO(161) 
36 
32 
3.85 322 0.540 300 
S7 π6,ph(2) (156) →π*9,py + π*COO(161) 
π8,py (160) → π*10,py + π*COO(162) 
39 
22 
4.49 276 0.467 265 
 
 
 
Figure S5.5 Isocontour representations (ρ = ±0.02) of the Kohn-Sham orbitals involved in the 
main configurations of the low-lying energetic states of PyLa, which are responsible for the 
ground state absorption properties.  
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Figure S5.6 Experimental and simulated absorption spectra of PyLa. The vertical excitation 
energies are obtained via TD-DFT simulations on CAM-B3LYP/TZVP, M062X/TZVP, 
B3LYP/TZVP and PBE0/TZVP level of theory using a DFT (B3LYP/TZVP) optimised structure 
of the ground state. Some charge density differences of low-lying energetic states obtained for 
the different computational levels are depicted in the graphs (The excitation is from red (ρ = 
−0.005) to blue (ρ = +0.005).). 
 
Table S5.2 Calculated ground state energies (B3LYP/TZVP) of three different mono- (PyLa13, 
PyLa16 and PyLa18) and di-protonated forms (PyLa236, PyLa238 and PyLa268) of PyLa and 
their corresponding Boltzmann factors at room temperature.  
  
Species Relative energy Boltzmann factor 
Mono-protonated PyLa 
Py13 0.00 kJ/mol 0.369 
Py16 0.55 kJ/mol 0.296 
Py18 0.24 kJ/mol 0.335 
Di-protonated PyLa 
Py236 1.08 kJ/mol 0.287 
Py238 1.26 kJ/mol 0.268 
Py268 0.00 kJ/mol 0.445 
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Figure S5.7 Experimental (red, dashed) and simulated (TD-CAM-B3LYP/TZVP) absorption 
spectra of PyLa (A) and three of its mono- (C: PyLa13, PyLa16, PyLa18) and di-protonated forms 
(D: PyLa236, PyLa238, PyLa268) as well as its tris-protonated species (PyLa31, B). Some charge 
density differences (ρ = ± 0.005) of low-lying energetic states obtained for the different 
protonated species are depicted as inset (excitation from red to blue). For the mono- and di-
protonated species the Boltzmann weighted absorption spectra are depicted in C and D. 
 
 
 
  D11   
 
Table S5.3 Calculated vertical excitation energies (E), oscillator strengths (f) and main single-
excited configurations of the main excited states of the neutral PyLa species 
atB3LYP/TZVP//CAM-B3LYP/TZVP (IEFPCM of acetonitrile) as level of theory and 
experimental absorption maxima. 
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Table S5.4 Calculated vertical excitation energies (E), oscillator strengths (f) and main single-
excited configurations of the main excited states of the mono-protonated forms of PyLa at 
B3LYP/TZVP//CAM-B3LYP/TZVP (IEFPCM of acetonitrile) as level of theory and 
experimental absorption maxima. 
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Table S5.5 Calculated vertical excitation energies (E), oscillator strengths (f) and main single-
excited configurations of the main excited states of the di-protonated forms of PyLa at 
B3LYP/TZVP//CAM-B3LYP/TZVP (IEFPCM of acetonitrile) as level of theory and 
experimental absorption maxima. 
 
Table S5.6 Calculated vertical excitation energies (E), oscillator strengths (f ) and main single-
excited configurations of the main excited states of the tri-protonated forms of PyLa at 
B3LYP/TZVP//CAM-B3LYP/TZVP (IEFPCM of acetonitrile) as level of theory and 
experimental absorption maxima. 
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S5.4 Additional Photophysical Characterisation 
 
Table S5.7 Photophysical data including UV-Vis absorption maxima (λabs nm), emission maxima 
(λem nm), full width half maximum of emission intensity profile (FWHM), quantum fluorescence 
yield of the charge-transfer emission (ϕfl) and luminescent lifetime (τlum ns) of PyLa and PyLaOT 
in a range of different solvents. aPreviously reported in literature. 
 
 Solvent λabs (nm) λem (nm) FWHM 
 (cm-1) 
ϕfl τlum (ns) 
 1-butanol 397 487 3226 0.11 2.7 
 2-propanol 396 486 4676 0.27 2.4 
 Chloroform 437 537 2674 0.88 3.1 
 Ethanol 396 500 3471 0.82 3.2 
PyLa Tetrahydrofuran 419 501 4290 0.88 3.1 
 Methanol 396
a 525 a 3696 0.55  3.5 a 
 Acetone 426 a 580 a 3338 0.97  2.6 a 
 Acetonitrile 399
 a 520 a 3620 0.49 a 3.8 a 
 Dichloromethane 431
 a 552 a 2965 0.40 a 4.4 a 
       
 1-butanol 404 523 3652 0.15 2.7 
 2-propanol 404 524 3699 0.89 2.1 
 Chloroform 394 510 3001 - 2.5 
 Ethanol 404 530 3913 - 2.5 
PyLaOT Tetrahydrofuran 407 508 3393 0.12 2.6 
 Methanol 398 550 3767 0.67 2.2 
 Acetone 411 530 3728 - - 
 Acetonitrile 416 552 3660 0.31 4.6 
 Dichloromethane 410 515 3136 0.73 2.6 
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Table S5.8 Photophysical data (λabs nm), emission maxima (λem nm) and luminescent lifetime (τ 
ns) of PyLa and PyLaOT in PBS and acetonitrile at isolated pH.  *EDT microprocessor pH meter 
was used to measure pH in PBS samples with changes in pH due to HCl and NaOH titrations. In 
acetonitrile we refer to pH approximation; pH -log[HClO4]  as perchloric acid and triethylamine 
was used to determine apparent pH. 
 
 
 
 
 
(a) 
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Figure S5.8 Absorbance and emission spectra of PyLa (a) and PyLaOT (b) in acetonitrile (sample 
concentration 20 μM). Emission spectra were obtained using slit widths of 5 nm. 
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Figure S5.9 77 K emission spectra of PyLa in butonytrile (a), dichloromethane (b) and 
ethanol:methanol 4:1: (c) (sample concentration 1 μM). Emission spectra were obtained using an 
excitation slit width of 5 nm and emission slit width of 10 nm. 
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Figure S5.10 77 K emission spectra of PyLaOT in butonytrile (a), dichloromethane (b) and 
ethanol:methanol 4:1: (c) (sample concentration 1 μM). Emission spectra were obtained using an 
excitation slit width of 5 nm and emission slit width of 10 nm. 
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pKa determination: Ground state pKas were obtained for PyLa and PyLaOT by plotting 
absorbance versus pH as seen in Figure S5.11 below. 
Using equation: pKa = pHx+log [(AHB
+ –Ax)/ (Ax- AB)] 
AHB
+ = absolute acid absorbance 
Ax = absorbance at pH 
AB = absolute base form absorbance 
 PyLaOT PBS GS pKa = 7.2     PyLa PBS GS pKa = 6.6 
         pKa = 3.1                 pKa = 3.7  
 
 
Figure S5.11 Plot of absorbance versus pH of PyLaOT (2) (100 μM PBS) at 416 nm.  
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Figure S5.12 Absorption spectra of PyLa at decreasing pH values (c = 100 μM) in PBS. Spectra 
shows decrease in absorbance max and red-shift at approximately 428 nm with decreasing pH. 
Disappearance of this absorbance shoulder is observed below pH 3 with the formation of a pyrene 
like absorbance max at approximately 380 nm which then increases in intensity with decreasing 
pH.  
Figure S5.13 Absorption spectra of PyLaOT at decreasing pH values (c = 100 μM) in PBS. 
Spectra shows decrease in absorbance max and red-shift at approximately 434 nm with decreasing 
pH. Disappearance of this absorbance shoulder is observed below pH 3 with the formation of a 
pyrene like absorbance max at approximately 380 nm which then increases in intensity with 
decreasing pH. 
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Figure S5.14 (a) Emission spectra of PyLa at decreasing pH values (c = 100 μM) in PBS. (b)  
Emission spectra of PyLa at increasing pH values (c = 100 μM) in PBS. (c)  Emission spectra of 
PyLaOT at decreasing pH values (c = 100 μM) in PBS (d) Emission spectra of PyLaOT at 
increasing pH values (c = 100 μM) in PBS. PyLa = λEx 384 nm, PyLaOT = λEx 398 nm. 
 
Figure S5.15 Absorption spectra of PyLa at increasing pH values (c = 50 μM) in acetonitrile 
using titrations of triethylamine. At pH 1.5 the absorbance max of PyLa is approximately 378 nm. 
This absorbance max slightly decreases with addition of triethylamine until the addition of 250 
μL, at which point the normal absorbance max of approximately 420 nm is restored. 
. 
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Figure S5.16 Absorption spectra of PyLa at increasing pH values (c = 50 μM) in acetonitrile 
using titrations of triethylamine. At pH 1.5 the absorbance max of PyLa is approximately 376 nm. 
This absorbance max slightly decreases with addition of triethylamine until the addition of 300 
μL, at which point the normal absorbance max of approximately 418 nm is restored.  
 
 
Figure S5.17 (a) Emission spectra of PyLa at increasing pH values (c = 50 μM) in acetonitrile 
using titrations of triethylamine, excited at 384 nm. At pH 1.5 the emission maxima of PyLa is 
approximately 430 nm. This decreases in intensity with increasing pH. After the addition of 250 
μL of triethylamine the charge-transfer emission band at 520 nm is restored and increases slightly 
with increasing pH. Excitation slit width was 2.5 nm and emission slit width was 5 nm. and the 
emission is show after the addition of 500 μL with excitation and emission slit widths set to 5 nm 
also. (b) Inset of the appearance of the charge-transfer emission band at 520 nm after the addition 
of 250 μL and the slight increase in emission intensity with the addition of triethylamine. 
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Figure S5.18 (a) Emission spectra of PyLaOT at increasing pH values (c = 50 μM) in acetonitrile 
on addition of triethylamine, exciting at 392 nm. At pH 1.5 the emission maxima of PyLaOT is 
approximately 426 nm. This decreases in intensity with increasing pH. After the addition of 300 
μL of triethylamine the charge-transfer emission band at 552 nm is restored. Excitation and 
emission slit widths were 2.5 nm and 5 nm respectively.  
 
 
 
Figure S5.19 (a) Solution of PyLa (c = 50 μM) in acetonitrile (luminescent yellow). (b) Solution 
of PyLa (c = 50 μM) in acetonitrile upon addition of triethylamine (pH > 3) (colourless). The 
colour of the solution changes from luminescent yellow to colourless. This reversible colour 
change occurs for both PyLa and PyLaOT in both PBS and acetonitrile. 
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Figure S5.20 Emission spectra of PyLaOT (c = 50 μM) in acetonitrile. pH (7.5-4) were excited 
into the absorbance max at approximately 409 nm using excitation and emission slit widths of 5 
nm and 2.5 nm respectively. pH 1.5 was excited into the absorbance max at approximately 378 
nm and slit widths were reduced to 2.5 nm in order show full emission profile without saturating 
the detector.  
 
S5.5 References 
(1) M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, G. Scalmani, 
V. Barone, B. Mennucci, G. A. Petersson, and et al. Gaussian 09 Revision E.01. 
Gaussian Inc. Wallingford CT 2009. 
(2) A. D. Becke, J. Chem. Phys., 1993, 98, 5648–5652. 
(3) C. Lee, W. Yang and R. G. Parr, Phys. Rev. B, 1988, 37, 785–789. 
(4) T. H. Dunning, J. Chem. Phys., 1971, 55, 716–723. 
(5) A. Schäfer, H. Horn and R. Ahlrichs, J. Chem. Phys., 1992, 97, 2571–2577. 
(6) A. Schäfer, C. Huber and R. Ahlrichs, J. Chem. Phys., 1994, 100, 5829–5835. 
(7) J. P. Perdew, K. Burke and M. Ernzerhof, Phys. Rev. Lett., 1996, 77, 3865–3868. 
(9) (a) J. P. Perdew, K. Burke and M. Ernzerhof, Phys. Rev. Lett., 1997, 78, 1396–1396. 
 (b) C. Adamo and V. Barone, J. Chem. Phys., 1999, 110, 6158–6170. 
(10) Y. Zhao and D. G. Truhlar, Theor. Chem. Acc., 2008, 120, 215–241. 
(11) T. Yanai, D. P. Tew and N. C. Handy, Chem. Phys. Lett., 2004, 393, 51–57. 
(12) B. Mennucci, C. Cappelli, C. A. Guido, R. Cammi and J. Tomasi, J. Phys. Chem. A, 
2009, 113, 3009–3020. 
0
50
100
150
200
250
300
350
400
450
400 500 600 700 800
E
m
is
si
o
n
 I
n
te
n
si
ty
Wavelength (nm)
pH 7.4
 pH 5.5
pH 4.8
 pH 4
pH 1.5
  D26   
 
(13) D. O. Connor, A. Byrne, G. B. Berselli, C. Long and T. E. Keyes, Analyst, 2019, 
144, 1608–1621. 
 
 
 
 
